{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8c6d1553",
   "metadata": {},
   "source": [
    "# import data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "fbde8bf6",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import os\n",
    "import re\n",
    "from __future__ import print_function\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "cde23ca7",
   "metadata": {},
   "outputs": [],
   "source": [
    "#display the full dataframe for all cells\n",
    "pd.set_option('display.max_colwidth', None)\n",
    "pd.set_option('display.max_rows', None)\n",
    "# pd.set_option('display.max_columns', None)\n",
    "# display(df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "41c7a1f4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "..\n"
     ]
    }
   ],
   "source": [
    "PROJ_ROOT = os.pardir\n",
    "print(PROJ_ROOT)\n",
    "import sys\n",
    "src_dir = os.path.join(PROJ_ROOT, \"src\")\n",
    "sys.path.append(src_dir)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "dc6bd3c8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(161297, 7) (53766, 7)\n"
     ]
    }
   ],
   "source": [
    "from config import TRAIN_FILE_PATH, TEST_FILE_PATH\n",
    "from features.build_features import read_tsv_file\n",
    "train = read_tsv_file(TRAIN_FILE_PATH)\n",
    "test = read_tsv_file(TEST_FILE_PATH)\n",
    "print(train.shape, test.shape)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e9f7cbe5",
   "metadata": {},
   "source": [
    "join the two datasets "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "050a46f5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>32534</th>\n",
       "      <td>231459</td>\n",
       "      <td>Trazodone</td>\n",
       "      <td>Insomnia</td>\n",
       "      <td>\"Trazodone is my miracle drug! I take it &amp;amp; within 30 minutes I feel the need to go to sleep. I have very few side effects. Mostly, grogginess in the morning. I also have to go to bed right after I take it or I get dizzy and my heart races. Those side effects done happen if I go to bed before the med sets in! I highly recommend this to anyone who had sleep issues.\"</td>\n",
       "      <td>10.0</td>\n",
       "      <td>April 13, 2016</td>\n",
       "      <td>46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181227</th>\n",
       "      <td>226280</td>\n",
       "      <td>Etonogestrel</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"Absolutely and utterly, awful. I wouldn&amp;#039;t recommended this to anybody. I had the implant in for 5 days and suffered a very severe panic attack which led me to the hospital, it was very scary. After this I suffered awful, awful physical symptoms such as: weakness in limbs, extreme dizziness (vertigo symptoms) sickness, my whole body even went numb at one point! I&amp;#039;ve been on and off anti depressants which made things worse until I went back to the family planning and asked if it&amp;#039;s this that&amp;#039;s causing it of course &amp;#039;no no!! absolutely not&amp;#039; went to my doctor who told me &amp;#039;you need to have that removed&amp;#039;. A week after having it out and I&amp;#039;m starting to feel myself again, I&amp;#039;m not saying don&amp;#039;t have it but I&amp;#039;m not saying have it either, it&amp;#039;s awful.\"</td>\n",
       "      <td>1.0</td>\n",
       "      <td>September 8, 2015</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            id      drugName      condition  \\\n",
       "32534   231459     Trazodone       Insomnia   \n",
       "181227  226280  Etonogestrel  Birth Control   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               review  \\\n",
       "32534                                                                                                                                                                                                                                                                                                                                                                                                                                                              \"Trazodone is my miracle drug! I take it &amp; within 30 minutes I feel the need to go to sleep. I have very few side effects. Mostly, grogginess in the morning. I also have to go to bed right after I take it or I get dizzy and my heart races. Those side effects done happen if I go to bed before the med sets in! I highly recommend this to anyone who had sleep issues.\"   \n",
       "181227  \"Absolutely and utterly, awful. I wouldn&#039;t recommended this to anybody. I had the implant in for 5 days and suffered a very severe panic attack which led me to the hospital, it was very scary. After this I suffered awful, awful physical symptoms such as: weakness in limbs, extreme dizziness (vertigo symptoms) sickness, my whole body even went numb at one point! I&#039;ve been on and off anti depressants which made things worse until I went back to the family planning and asked if it&#039;s this that&#039;s causing it of course &#039;no no!! absolutely not&#039; went to my doctor who told me &#039;you need to have that removed&#039;. A week after having it out and I&#039;m starting to feel myself again, I&#039;m not saying don&#039;t have it but I&#039;m not saying have it either, it&#039;s awful.\"   \n",
       "\n",
       "        rating               date  usefulCount  \n",
       "32534     10.0     April 13, 2016           46  \n",
       "181227     1.0  September 8, 2015            5  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.concat([train, test], ignore_index = True)\n",
    "df.sample(2)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b7dd9bcb",
   "metadata": {},
   "source": [
    "# data wrangling"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "422ccb2f-9a97-4809-838c-ddfd4e5f6c28",
   "metadata": {},
   "source": [
    "2.1 Know the basics of the datasets:"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "033e2fc0-0da1-49f2-9413-da67b644b88f",
   "metadata": {},
   "source": [
    "1. shape of dataset\n",
    "2. data type\n",
    "3. data distribution\n",
    "4. missing value and the way to handle the missing value\n",
    "5. any duplicates\n",
    "6. any incorrect or manipulated data?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "0c15d364-68c7-49a7-8caf-e81f7dd5765c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(215063, 7)\n",
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 215063 entries, 0 to 215062\n",
      "Data columns (total 7 columns):\n",
      " #   Column       Non-Null Count   Dtype  \n",
      "---  ------       --------------   -----  \n",
      " 0   id           215063 non-null  int64  \n",
      " 1   drugName     215063 non-null  object \n",
      " 2   condition    213869 non-null  object \n",
      " 3   review       215063 non-null  object \n",
      " 4   rating       215063 non-null  float64\n",
      " 5   date         215063 non-null  object \n",
      " 6   usefulCount  215063 non-null  int64  \n",
      "dtypes: float64(1), int64(2), object(4)\n",
      "memory usage: 11.5+ MB\n",
      "None\n",
      "id                0\n",
      "drugName          0\n",
      "condition      1194\n",
      "review            0\n",
      "rating            0\n",
      "date              0\n",
      "usefulCount       0\n",
      "dtype: int64\n"
     ]
    }
   ],
   "source": [
    "print(df.shape)\n",
    "print(df.info())\n",
    "print(df.isnull().sum())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "08424e82",
   "metadata": {},
   "source": [
    "there are 1194 missing values in \"condition\", also the data type for rating should be int instead of float, the date should change to time."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "41b8655d-cf61-4485-a764-52713654e20b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "df['rating'] = df['rating'].astype('int')\n",
    "df['date'] = pd.to_datetime(df['date'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "1e302da1-b26e-46c4-bf0b-50e69e2542a3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[ 9  8  5  2  1 10  4  3  7  6]\n",
      "                  id         rating                           date  \\\n",
      "count  215063.000000  215063.000000                         215063   \n",
      "mean   116039.364814       6.990008  2014-06-11 00:32:14.793060608   \n",
      "min         0.000000       1.000000            2008-02-24 00:00:00   \n",
      "25%     58115.500000       5.000000            2012-04-12 00:00:00   \n",
      "50%    115867.000000       8.000000            2015-06-07 00:00:00   \n",
      "75%    173963.500000      10.000000            2016-08-19 00:00:00   \n",
      "max    232291.000000      10.000000            2017-12-12 00:00:00   \n",
      "std     67007.913366       3.275554                            NaN   \n",
      "\n",
      "         usefulCount  \n",
      "count  215063.000000  \n",
      "mean       28.001004  \n",
      "min         0.000000  \n",
      "25%         6.000000  \n",
      "50%        16.000000  \n",
      "75%        36.000000  \n",
      "max      1291.000000  \n",
      "std        36.346069  \n"
     ]
    }
   ],
   "source": [
    "print(df.rating.unique())\n",
    "print(df.describe())"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "6e510b79-43ed-4d8c-b180-1e31cb990887",
   "metadata": {},
   "source": [
    " There are 10 unique rating from 1 to 10.  The average rating is 6.99, with the 25% to 75% in 5 to 10, suggesing rating is skewed. \n",
    " the mean \"usefulCount\" is 28 while the max can reach to 1291 suggesting the usefulCount is widespread. "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1effe1fe-c812-41b7-bbc2-a0fb83b12451",
   "metadata": {},
   "source": [
    "Data cleaning "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "99f77765-c04b-4175-b293-25e1c93b6988",
   "metadata": {},
   "source": [
    "missing values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "0567a804-235c-482d-9579-7c681343d97e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>51452</td>\n",
       "      <td>Azithromycin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\"Very good response. It is so useful for me. \"</td>\n",
       "      <td>10</td>\n",
       "      <td>2010-08-18</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>61073</td>\n",
       "      <td>Urea</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\"Accurate information.\"</td>\n",
       "      <td>10</td>\n",
       "      <td>2011-07-02</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>488</th>\n",
       "      <td>132651</td>\n",
       "      <td>Doxepin</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\"So far so good. Good for me and I can take it everyday. Can&amp;#039;t remember the last time I slept 7 hours straight.\"</td>\n",
       "      <td>10</td>\n",
       "      <td>2010-10-20</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>733</th>\n",
       "      <td>44297</td>\n",
       "      <td>Ethinyl estradiol / norgestimate</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\"I haven&amp;#039;t been on it for a long time and I have suffered from severe nausea and have thrown up twice. My appetite has lessened even more so than it was before. My acne has gone down and my boobs have grown a lot. Although I have thrown up, if it&amp;#039;s for acne I would suggest it.\"</td>\n",
       "      <td>8</td>\n",
       "      <td>2011-01-24</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>851</th>\n",
       "      <td>68697</td>\n",
       "      <td>Medroxyprogesterone</td>\n",
       "      <td>NaN</td>\n",
       "      <td>\"I started the shot in July 2015 and ended in January 2017. Initially, I had pretty bad headaches, hot flashes, hair loss (nothing that anyone but me noticed), and quite a bit of bleeding (about 3 weeks after my first shot). After, about a month, the side affects started to wane - I stopped bleeding almost entirely (yasss!) and stopped losing hair. That said, while I did not have initial weight gain, I have gained about 15 pounds in the last year (I have never gained this much weight in this amount of time). As a result of the weight gain alone, I am discontinuing with this method of birth control.\"</td>\n",
       "      <td>6</td>\n",
       "      <td>2017-03-23</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id                          drugName condition  \\\n",
       "30    51452                      Azithromycin       NaN   \n",
       "148   61073                              Urea       NaN   \n",
       "488  132651                           Doxepin       NaN   \n",
       "733   44297  Ethinyl estradiol / norgestimate       NaN   \n",
       "851   68697               Medroxyprogesterone       NaN   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             review  \\\n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   \"Very good response. It is so useful for me. \"   \n",
       "148                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         \"Accurate information.\"   \n",
       "488                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           \"So far so good. Good for me and I can take it everyday. Can&#039;t remember the last time I slept 7 hours straight.\"   \n",
       "733                                                                                                                                                                                                                                                                                                                                \"I haven&#039;t been on it for a long time and I have suffered from severe nausea and have thrown up twice. My appetite has lessened even more so than it was before. My acne has gone down and my boobs have grown a lot. Although I have thrown up, if it&#039;s for acne I would suggest it.\"   \n",
       "851  \"I started the shot in July 2015 and ended in January 2017. Initially, I had pretty bad headaches, hot flashes, hair loss (nothing that anyone but me noticed), and quite a bit of bleeding (about 3 weeks after my first shot). After, about a month, the side affects started to wane - I stopped bleeding almost entirely (yasss!) and stopped losing hair. That said, while I did not have initial weight gain, I have gained about 15 pounds in the last year (I have never gained this much weight in this amount of time). As a result of the weight gain alone, I am discontinuing with this method of birth control.\"   \n",
       "\n",
       "     rating       date  usefulCount  \n",
       "30       10 2010-08-18            1  \n",
       "148      10 2011-07-02           13  \n",
       "488      10 2010-10-20           25  \n",
       "733       8 2011-01-24            1  \n",
       "851       6 2017-03-23            1  "
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "missing_values = df[\"condition\"].isna()\n",
    "df[missing_values].head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "243722cd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "id             0.00\n",
      "drugName       0.00\n",
      "condition      0.56\n",
      "review         0.00\n",
      "rating         0.00\n",
      "date           0.00\n",
      "usefulCount    0.00\n",
      "dtype: float64\n"
     ]
    }
   ],
   "source": [
    "missing_value_ratio = df.isna().sum()/len(df)*100\n",
    "print(round(missing_value_ratio,2))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a6f2c154",
   "metadata": {},
   "source": [
    "only 0.56% missing values, and the review of  it is safe to drop it."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "5b147aa9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(213869, 7)\n",
      "85420\n",
      "84711\n"
     ]
    }
   ],
   "source": [
    "df = df.dropna()\n",
    "print(df.shape)\n",
    "# check duplicate of data\n",
    "print (df.duplicated(subset =[\"review\"]).sum())\n",
    "print (df.duplicated(subset =[\"review\",\"condition\",\"rating\",\"usefulCount\"]).sum())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "7058aecf",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>524</th>\n",
       "      <td>109101</td>\n",
       "      <td>Nexplanon</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"First had implanon then got Nexplanon, had a period first month and I have not had one since. I&amp;#039;m due to remove it next year.  I do notice spotting  sometimes for a day but it honestly  usually coincides with when I&amp;#039;m stressed. \\r\\nHad some weight gain also.\\r\\n\\r\\nSo far the best BC I&amp;#039;ve  had in all my years.  I plan on trying for a baby next year then I will be back on it.\"</td>\n",
       "      <td>9</td>\n",
       "      <td>2017-04-21</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>574</th>\n",
       "      <td>183531</td>\n",
       "      <td>Cymbalta</td>\n",
       "      <td>Anxiety</td>\n",
       "      <td>\"Prescribed via a Psychiatrist for severe Panic attacks for 2 years.\\r\\nIf I take dosage late or forget to take it the withdrawal symptoms kick in.  \\r\\nGnawing physical pain, breathlessness, disorientation to time, difficulties in word finding while speaking, severe muscle pain and stiffness, nausea, labile emotions and panic.\\r\\n\\r\\n\"</td>\n",
       "      <td>1</td>\n",
       "      <td>2010-09-05</td>\n",
       "      <td>27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>726</th>\n",
       "      <td>5154</td>\n",
       "      <td>Orsythia</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have only been on orsythia for about 1 month and I just started my second week of my second month.  I guess I didn&amp;#039;t notice earlier but I started to get slight headaches and I didn&amp;#039;t feel very well physically and mentally.  It do help with my cramps and my period, not so much my acne but it&amp;#039;s better.  The worst part of orsythia has to be the mood swings and the sweating!  I sweat a lot even if it&amp;#039;s cold I&amp;#039;ll start a light sweat, it&amp;#039;s gross.  But the mood swings are the worst I just started feeling this and it happened while I was talking to one of my friends I just blew up on him, for no reason.  Then later on I started to feel really bad(mentally) and I cried for a while and I couldn&amp;#039;t figure out why I was crying! I don&amp;#039;t recommend!\"</td>\n",
       "      <td>2</td>\n",
       "      <td>2015-10-08</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1070</th>\n",
       "      <td>186190</td>\n",
       "      <td>Desvenlafaxine</td>\n",
       "      <td>Depression</td>\n",
       "      <td>\"I have suffered from severe anxiety (GAD) and was taking more and more Klonopin as time went on.  I am very sensitive to medication and have tried many different SSRI/SNRI&amp;#039;s through the year with horrible side effects.  Finally, I had DNA testing to see what I would respond to and the result was Pristiq.  I started it several months ago in a small dose (I split the pills even though they say don&amp;#039;t do this) and within a few days my anxiety literally went away.  I was able to cut my Klonopin in 1/2 over a two month period.  The first week or two I was extremely tired but that passed.  The only side effect I get from time to time is migraines.  It still amazes me that my anxiety has disappeared.  I no longer keep Klonopin in my  pocket!\"</td>\n",
       "      <td>8</td>\n",
       "      <td>2013-11-01</td>\n",
       "      <td>81</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1375</th>\n",
       "      <td>73940</td>\n",
       "      <td>Ethinyl estradiol / norethindrone</td>\n",
       "      <td>Birth Control</td>\n",
       "      <td>\"I have been taking my first pack of Lo Loestrin Fe and I must say it really works for me. I was a little nervous at first because this is my first time taking birth control and I&amp;#039;ve heard all the negative side effects of taking birth control. I have had spotting [brown-ish color] for three weeks after my period, but that&amp;#039;s normal for the first month. I have breast tenderness and mood swings every now and then, then again it&amp;#039;s expected for the first few months. I have not yet experienced any weight gain. So far I am satisfied, but I wish it wasn&amp;#039;t so expensive.\"</td>\n",
       "      <td>8</td>\n",
       "      <td>2012-02-01</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          id                           drugName      condition  \\\n",
       "524   109101                          Nexplanon  Birth Control   \n",
       "574   183531                           Cymbalta        Anxiety   \n",
       "726     5154                           Orsythia  Birth Control   \n",
       "1070  186190                     Desvenlafaxine     Depression   \n",
       "1375   73940  Ethinyl estradiol / norethindrone  Birth Control   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   review  \\\n",
       "524                                                                                                                                                                                                                                                                                                                                                                                                            \"First had implanon then got Nexplanon, had a period first month and I have not had one since. I&#039;m due to remove it next year.  I do notice spotting  sometimes for a day but it honestly  usually coincides with when I&#039;m stressed. \\r\\nHad some weight gain also.\\r\\n\\r\\nSo far the best BC I&#039;ve  had in all my years.  I plan on trying for a baby next year then I will be back on it.\"   \n",
       "574                                                                                                                                                                                                                                                                                                                                                                                                                                                                    \"Prescribed via a Psychiatrist for severe Panic attacks for 2 years.\\r\\nIf I take dosage late or forget to take it the withdrawal symptoms kick in.  \\r\\nGnawing physical pain, breathlessness, disorientation to time, difficulties in word finding while speaking, severe muscle pain and stiffness, nausea, labile emotions and panic.\\r\\n\\r\\n\"   \n",
       "726   \"I have only been on orsythia for about 1 month and I just started my second week of my second month.  I guess I didn&#039;t notice earlier but I started to get slight headaches and I didn&#039;t feel very well physically and mentally.  It do help with my cramps and my period, not so much my acne but it&#039;s better.  The worst part of orsythia has to be the mood swings and the sweating!  I sweat a lot even if it&#039;s cold I&#039;ll start a light sweat, it&#039;s gross.  But the mood swings are the worst I just started feeling this and it happened while I was talking to one of my friends I just blew up on him, for no reason.  Then later on I started to feel really bad(mentally) and I cried for a while and I couldn&#039;t figure out why I was crying! I don&#039;t recommend!\"   \n",
       "1070                                  \"I have suffered from severe anxiety (GAD) and was taking more and more Klonopin as time went on.  I am very sensitive to medication and have tried many different SSRI/SNRI&#039;s through the year with horrible side effects.  Finally, I had DNA testing to see what I would respond to and the result was Pristiq.  I started it several months ago in a small dose (I split the pills even though they say don&#039;t do this) and within a few days my anxiety literally went away.  I was able to cut my Klonopin in 1/2 over a two month period.  The first week or two I was extremely tired but that passed.  The only side effect I get from time to time is migraines.  It still amazes me that my anxiety has disappeared.  I no longer keep Klonopin in my  pocket!\"   \n",
       "1375                                                                                                                                                                                                         \"I have been taking my first pack of Lo Loestrin Fe and I must say it really works for me. I was a little nervous at first because this is my first time taking birth control and I&#039;ve heard all the negative side effects of taking birth control. I have had spotting [brown-ish color] for three weeks after my period, but that&#039;s normal for the first month. I have breast tenderness and mood swings every now and then, then again it&#039;s expected for the first few months. I have not yet experienced any weight gain. So far I am satisfied, but I wish it wasn&#039;t so expensive.\"   \n",
       "\n",
       "      rating       date  usefulCount  \n",
       "524        9 2017-04-21            5  \n",
       "574        1 2010-09-05           27  \n",
       "726        2 2015-10-08            7  \n",
       "1070       8 2013-11-01           81  \n",
       "1375       8 2012-02-01            7  "
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "duplicate_rows = df[df.duplicated(subset=[\"review\",\"condition\",\"rating\",\"usefulCount\"])]\n",
    "duplicate_rows.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "632f93f9",
   "metadata": {},
   "source": [
    "There are 85420 duplicated in \"reviews\", for each pair of duplicates, they share the same \"condition\", while varied in \"drugname\". Therefore, the duplicate data will be dropped."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "49331645",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(129158, 7)"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = df.drop_duplicates(subset=[\"review\",\"condition\",\"rating\",\"usefulCount\"], keep=\"first\")\n",
    "df.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a6bc2c46",
   "metadata": {},
   "source": [
    "Cleaning \"condition\" column"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "f38954cb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Left Ventricular Dysfunction', 'ADHD', 'Birth Control',\n",
       "       'Opiate Dependence', 'Benign Prostatic Hyperplasia',\n",
       "       'Emergency Contraception', 'Bipolar Disorde', 'Epilepsy',\n",
       "       'Migraine Prevention', 'Depression', \"Crohn's Disease\", 'Cough',\n",
       "       'Obesity', 'Urinary Tract Infection', 'ibromyalgia',\n",
       "       'Chronic Myelogenous Leukemia', 'HIV Infection', 'Insomnia',\n",
       "       'Rheumatoid Arthritis', 'Vaginal Yeast Infection',\n",
       "       'Chlamydia Infection', 'Hirsutism', 'Panic Disorde', 'Migraine',\n",
       "       'Pain', 'Irritable Bowel Syndrome', 'Osteoarthritis',\n",
       "       'Constipation', 'Bowel Preparation', 'Psychosis', 'Muscle Spasm',\n",
       "       'Hepatitis C', 'Overactive Bladde', 'Diabetes, Type 2',\n",
       "       'Asthma, Maintenance', 'Non-Small Cell Lung Cance',\n",
       "       'Schizophrenia', 'Dysuria', 'Smoking Cessation', 'Anxiety', 'Acne',\n",
       "       'emale Infertility', 'Constipation, Acute',\n",
       "       'Constipation, Drug Induced', 'Erectile Dysfunction',\n",
       "       'Trigeminal Neuralgia', 'Underactive Thyroid', 'Chronic Pain',\n",
       "       'Atrophic Vaginitis', 'Skin and Structure Infection', 'Tinnitus',\n",
       "       'Major Depressive Disorde', 'Anxiety and Stress', 'Rosacea',\n",
       "       'High Blood Pressure',\n",
       "       '2</span> users found this comment helpful.',\n",
       "       'Restless Legs Syndrome',\n",
       "       'Osteolytic Bone Metastases of Solid Tumors', 'Bronchitis',\n",
       "       'Skin or Soft Tissue Infection', 'Obsessive Compulsive Disorde',\n",
       "       'Endometriosis', 'Keratoconjunctivitis Sicca', 'Breakthrough Pain',\n",
       "       'Seizures', 'Neuropathic Pain', 'Sedation', 'Menstrual Disorders',\n",
       "       'Allergic Rhinitis', 'Anesthesia',\n",
       "       'Undifferentiated Connective Tissue Disease', 'Diabetes, Type 1',\n",
       "       'Abnormal Uterine Bleeding', 'Weight Loss',\n",
       "       'Constipation, Chronic', 'Breast Cancer, Metastatic',\n",
       "       'Period Pain', 'Helicobacter Pylori Infection',\n",
       "       'Atrial Fibrillation', 'Uterine Fibroids',\n",
       "       '4</span> users found this comment helpful.', 'Kidney Infections',\n",
       "       'Generalized Anxiety Disorde', 'Asthma', 'Postmenopausal Symptoms',\n",
       "       'High Cholesterol', 'Hypogonadism, Male', 'Hyperthyroidism',\n",
       "       'Back Pain', 'Anaplastic Oligodendroglioma', \"Sjogren's Syndrome\",\n",
       "       'Asthma, acute', 'Hot Flashes',\n",
       "       '3</span> users found this comment helpful.',\n",
       "       'Herpes Simplex, Suppression', 'Bacterial Infection', 'Bursitis',\n",
       "       'Diaper Rash', 'Systemic Mastocytosis', 'Trichotillomania',\n",
       "       \"Hashimoto's disease\", 'Eczema', 'Dental Abscess', 'Headache',\n",
       "       'Hypersomnia', 'Xerostomia', 'Breast Cance', 'Sore Throat',\n",
       "       \"Barrett's Esophagus\", 'Pain/Feve', 'Diverticulitis', 'Sinusitis',\n",
       "       'Polycystic Ovary Syndrome', 'Influenza',\n",
       "       'Hypothyroidism, After Thyroid Removal', 'Onychomycosis, Toenail',\n",
       "       'Progesterone Insufficiency',\n",
       "       '11</span> users found this comment helpful.', 'GERD',\n",
       "       'Nausea/Vomiting, Postoperative', 'Herpes Simplex',\n",
       "       'Gastroparesis', 'Gout, Acute', 'Motion Sickness',\n",
       "       'Multiple Sclerosis', 'Autism', 'Otitis Media',\n",
       "       'Upper Respiratory Tract Infection', 'Surgical Prophylaxis',\n",
       "       'Psoriatic Arthritis', 'Erosive Esophagitis',\n",
       "       'Premature Ventricular Depolarizations', 'Stomach Ulce',\n",
       "       'Nausea/Vomiting', 'Light Anesthesia',\n",
       "       'Angina Pectoris Prophylaxis',\n",
       "       '0</span> users found this comment helpful.', 'Paranoid Disorde',\n",
       "       'Prostatitis', 'Extrapyramidal Reaction', 'mance Anxiety',\n",
       "       'Night Terrors', 'High Cholesterol, Familial Heterozygous',\n",
       "       'Spondyloarthritis', 'Clostridial Infection', 'Dermatomyositis',\n",
       "       'Bronchiectasis', 'Nasal Congestion', 'Benign Essential Trem',\n",
       "       'Angina', 'moterol / mometasone)', 'Impetig',\n",
       "       'Conjunctivitis, Bacterial', 'Post Traumatic Stress Disorde',\n",
       "       'Alcohol Withdrawal', 'Psoriasis', 'Cold Sores', 'Hyperhidrosis',\n",
       "       '1</span> users found this comment helpful.',\n",
       "       'Ankylosing Spondylitis', 'Hemorrhoids',\n",
       "       '142</span> users found this comment helpful.',\n",
       "       'Schizoaffective Disorde', 'Not Listed / Othe', 'Rhinitis',\n",
       "       'Oral Thrush', 'Hyperlipoproteinemia',\n",
       "       'Neutropenia Associated with Chemotherapy', 'Osteoporosis',\n",
       "       'Reflex Sympathetic Dystrophy Syndrome', 'Urticaria', 'Narcolepsy',\n",
       "       'Systemic Lupus Erythematosus', 'Ulcerative Colitis',\n",
       "       'Adult Human Growth Hormone Deficiency', 'Bacterial Vaginitis',\n",
       "       'COPD, Maintenance', 'Anorexia', 'TSH Suppression',\n",
       "       'Breast Cancer, Adjuvant', 'Glaucoma',\n",
       "       'Cough and Nasal Congestion',\n",
       "       '8</span> users found this comment helpful.',\n",
       "       'Inflammatory Conditions', 'Urinary Incontinence', 'Gout',\n",
       "       'Bladder Infection', 'Human Papillomavirus Prophylaxis',\n",
       "       'Glioblastoma Multiforme', 'Strep Throat',\n",
       "       'Bacterial Skin Infection', 'Hereditary Angioedema',\n",
       "       'Cold Symptoms', 'Labor Pain', 'Dry Skin', 'Diabetes Insipidus',\n",
       "       'Methicillin-Resistant Staphylococcus Aureus Infection',\n",
       "       'Borderline Personality Disorde', 'Amenorrhea', 'Pneumonia',\n",
       "       'Seborrheic Dermatitis', 'Interstitial Cystitis',\n",
       "       'Malaria Prevention', 'Prevention of Dental Caries',\n",
       "       'Herbal Supplementation', 'Plaque Psoriasis', \"Raynaud's Syndrome\",\n",
       "       \"Addison's Disease\", 'Prostate Cance', 'Allergies',\n",
       "       'Opioid-Induced Constipation', 'moterol)',\n",
       "       '13</span> users found this comment helpful.', 'Diarrhea',\n",
       "       'Seasonal Allergic Conjunctivitis', 'Opioid Overdose',\n",
       "       'Spondylolisthesis', 'Shift Work Sleep Disorde',\n",
       "       'Obstructive Sleep Apnea/Hypopnea Syndrome',\n",
       "       'Nausea/Vomiting of Pregnancy', 'Mucositis',\n",
       "       'Ulcerative Colitis, Active', 'Head Lice',\n",
       "       'Tonsillitis/Pharyngitis', 'Pseudotumor Cerebri',\n",
       "       \"Parkinson's Disease\", 'Sciatica', 'Cance',\n",
       "       'Bacterial Endocarditis Prevention', 'Diarrhea, Chronic',\n",
       "       'Hypertensive Emergency', 'Keratosis', 'Ovarian Cysts',\n",
       "       \"Behcet's Disease\", 'Chronic Idiopathic Constipation',\n",
       "       'lic Acid Deficiency', 'Chronic Fatigue Syndrome',\n",
       "       'Basal Cell Carcinoma', 'Cataplexy',\n",
       "       \"Crohn's Disease, Maintenance\", 'Diabetic Peripheral Neuropathy',\n",
       "       'Arrhythmia', 'Primary Ovarian Failure', 'Influenza Prophylaxis',\n",
       "       'Agitated State', 'Heart Failure', 'atigue', 'Opiate Withdrawal',\n",
       "       'Endometrial Hyperplasia, Prophylaxis', 'Immunosuppression',\n",
       "       'Dystonia', 'Alopecia', 'Vulvodynia',\n",
       "       'Premenstrual Dysphoric Disorde', 'Alcohol Dependence',\n",
       "       'Myasthenia Gravis', 'Social Anxiety Disorde', 'Atopic Dermatitis',\n",
       "       'Schistosoma japonicum', 'Sinus Symptoms', 'min / sitagliptin)',\n",
       "       'Dermatitis', 'Eye Redness', 'Warts', 'Menorrhagia',\n",
       "       'Seizure Prevention', 'Ophthalmic Surgery', 'Skin Rash',\n",
       "       'Condylomata Acuminata', 'NSAID-Induced Ulcer Prophylaxis',\n",
       "       'Tinea Versicol', 'Peripheral Neuropathy', 'Deep Vein Thrombosis',\n",
       "       '6</span> users found this comment helpful.', 'Heart Attack',\n",
       "       'Pulmonary Embolism, Recurrent Event', 'Light Sedation',\n",
       "       'Acute Lymphoblastic Leukemia', 'Hyperprolactinemia',\n",
       "       'Indigestion', 'Hepatitis B', 'Dysautonomia', 'Status Epilepticus',\n",
       "       'Postpartum Depression', 'Multiple Myeloma',\n",
       "       'Prevention of Hypokalemia', 'Edema', 'Urinary Retention',\n",
       "       'Prevention of Thromboembolism in Atrial Fibrillation',\n",
       "       'Cluster Headaches', 'Sexual Dysfunction, SSRI Induced',\n",
       "       'Dermatitis Herpetiformis', 'Temporomandibular Joint Disorde',\n",
       "       'Burns, External', 'Actinic Keratosis', 'Pharyngitis',\n",
       "       'Melanoma, Metastatic', 'Atrial Flutte', 'Lyme Disease',\n",
       "       'Dry Eye Disease', 'Allergic Reactions', 'Hypertriglyceridemia',\n",
       "       'Pruritus', 'Carcinoid Tum', 'Muscle Pain', 'Colorectal Cance',\n",
       "       'Vitamin/Mineral Supplementation during Pregnancy/Lactation',\n",
       "       'Nausea/Vomiting, Chemotherapy Induced', 'Women (oxybutynin)',\n",
       "       'Primary Immunodeficiency Syndrome',\n",
       "       'New Daily Persistent Headache',\n",
       "       'Pneumococcal Disease Prophylaxis', 'Burning Mouth Syndrome',\n",
       "       'Urinary Tract Stones', 'Pseudobulbar Affect',\n",
       "       '94</span> users found this comment helpful.',\n",
       "       'Eye Redness/Itching', 'Deep Vein Thrombosis, First Event',\n",
       "       'Pulmonary Hypertension', 'Malaria', 'Sarcoidosis',\n",
       "       'Dietary Supplementation', 'Bulimia', 'Tendonitis', 'Nasal Polyps',\n",
       "       'Hypokalemia', 'Anemia, Sickle Cell', 'Uveitis',\n",
       "       'Streptococcal Infection', 'Perimenopausal Symptoms',\n",
       "       'Asperger Syndrome', 'Tinea Corporis', 'Mania',\n",
       "       'Renal Cell Carcinoma', 'COPD', 'Biliary Cirrhosis', 'Vertig',\n",
       "       'Reversal of Opioid Sedation', \"Non-Hodgkin's Lymphoma\",\n",
       "       'High Cholesterol, Familial Homozygous',\n",
       "       'Periodic Limb Movement Disorde', 'Supraventricular Tachycardia',\n",
       "       'Hypoestrogenism', 'Juvenile Idiopathic Arthritis', 'Swine Flu',\n",
       "       'Giardiasis', 'Binge Eating Disorde', \"Tourette's Syndrome\",\n",
       "       'Trichomoniasis', 'acial Wrinkles',\n",
       "       '28</span> users found this comment helpful.',\n",
       "       'Pulmonary Embolism', 'Conjunctivitis, Allergic',\n",
       "       'Avian Influenza', '16</span> users found this comment helpful.',\n",
       "       'Hemangioma', 'Nocturnal Leg Cramps', 'Thyroid Suppression Test',\n",
       "       'Muscle Twitching', 'Pupillary Dilation',\n",
       "       'Lennox-Gastaut Syndrome', 'Opiate Adjunct', 'Postoperative Pain',\n",
       "       'Candida Urinary Tract Infection', 'Cerebral Spasticity',\n",
       "       'Lipodystrophy', 'Androgenetic Alopecia', 'Computed Tomography',\n",
       "       'Mitral Valve Prolapse', 'Vitamin D Deficiency',\n",
       "       'Glaucoma, Open Angle', 'Endoscopy or Radiology Premedication',\n",
       "       \"Alzheimer's Disease\", 'Gouty Arthritis',\n",
       "       'Paroxysmal Supraventricular Tachycardia',\n",
       "       'Deep Vein Thrombosis, Prophylaxis', 'Gaucher Disease',\n",
       "       'Lymphocytic Colitis', 'Pancreatic Cance', 'Cystic Fibrosis',\n",
       "       'Noninfectious Colitis',\n",
       "       '27</span> users found this comment helpful.', 'Nephrocalcinosis',\n",
       "       'Iron Deficiency Anemia', 'mulation) (phenylephrine)', 'Hiccups',\n",
       "       '75</span> users found this comment helpful.',\n",
       "       'Bronchospasm Prophylaxis', 'Chronic Spasticity',\n",
       "       'min / saxagliptin)', 'Post-Cholecystectomy Diarrhea',\n",
       "       'Postherpetic Neuralgia', 'Insomnia, Stimulant-Associated',\n",
       "       'COPD, Acute', 'Herpes Simplex Dendritic Keratitis',\n",
       "       'Oophorectomy', 'Cyclic Vomiting Syndrome',\n",
       "       'Chronic Lymphocytic Leukemia', 'Lyme Disease, Arthritis',\n",
       "       'Pseudomembranous Colitis', 'Conjunctivitis',\n",
       "       '15</span> users found this comment helpful.', 'min)',\n",
       "       'Intraocular Hypertension', 'Aphthous Ulce',\n",
       "       'Ulcerative Colitis, Maintenance', 'Melasma',\n",
       "       'Lyme Disease, Neurologic', 'ge (amlodipine / valsartan)',\n",
       "       'Herpes Zoste', '12</span> users found this comment helpful.',\n",
       "       'Cervical Dystonia', 'Labor Induction', 'Human Papilloma Virus',\n",
       "       'Chronic Pancreatitis', 'Polycythemia Vera',\n",
       "       '9</span> users found this comment helpful.',\n",
       "       'Dermatological Disorders', 'Lewy Body Dementia',\n",
       "       'amilial Mediterranean Feve', 'Neurosurgery', 'Gastroenteritis',\n",
       "       'Macular Edema', 'Tinea Pedis',\n",
       "       '7</span> users found this comment helpful.',\n",
       "       'Diagnosis and Investigation',\n",
       "       '35</span> users found this comment helpful.', 'Gas', 'Neuralgia',\n",
       "       'Local Anesthesia', '54</span> users found this comment helpful.',\n",
       "       'Acute Coronary Syndrome', 'Aspiration Pneumonia',\n",
       "       'Idiopathic Thrombocytopenic Purpura', 'Onychomycosis, Fingernail',\n",
       "       'Photoaging of the Skin', 'Premature Lab', 'Precocious Puberty',\n",
       "       'Prevention of Bladder infection', 'Seasonal Affective Disorde',\n",
       "       'Diabetic Kidney Disease', \"Crohn's Disease, Acute\",\n",
       "       'Insulin Resistance Syndrome', 'Pudendal Neuralgia',\n",
       "       \"Reiter's Syndrome\", '17</span> users found this comment helpful.',\n",
       "       'Amyotrophic Lateral Sclerosis', 'Body Dysmorphic Disorde',\n",
       "       'Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis',\n",
       "       'Dandruff', 'Vitamin B12 Deficiency', 'Bone infection',\n",
       "       'Prosthetic Heart Valves, Tissue Valves - Thrombosis Prophylaxis',\n",
       "       'Iritis', 'Allergic Urticaria', 'Cardiovascular Risk Reduction',\n",
       "       'Giant Cell Tumor of Bone', 'Babesiosis',\n",
       "       'Secondary Hyperparathyroidism', 'Hypoparathyroidism',\n",
       "       'Performance Anxiety', 'Abortion', 'Skin Cance',\n",
       "       'Ovulation Induction', 'Liver Magnetic Resonance Imaging',\n",
       "       'Vitamin/Mineral Supplementation and Deficiency',\n",
       "       '79</span> users found this comment helpful.',\n",
       "       'Herpes Simplex, Mucocutaneous/Immunocompetent Host',\n",
       "       '10</span> users found this comment helpful.',\n",
       "       'Anemia Associated with Chronic Renal Failure',\n",
       "       'Hyperphosphatemia of Renal Failure',\n",
       "       'Dissociative Identity Disorde', 'Anal Fissure and Fistula',\n",
       "       '14</span> users found this comment helpful.',\n",
       "       'Herpes Simplex, Mucocutaneous/Immunocompromised Host', 'Scabies',\n",
       "       '5</span> users found this comment helpful.', 'Endometrial Cance',\n",
       "       'Transient Ischemic Attack', 'Granuloma Annulare',\n",
       "       \"Traveler's Diarrhea\", 'Candidemia',\n",
       "       't Pac with Cyclobenzaprine (cyclobenzaprine)',\n",
       "       'Hypoactive Sexual Desire Disorde', 'Epicondylitis, Tennis Elbow',\n",
       "       'Nightmares', 'Dientamoeba fragilis', 'Ventricular Tachycardia',\n",
       "       'Dumping Syndrome', 'Myelodysplastic Syndrome', 'Hypodermoclysis',\n",
       "       'zen Shoulde', 'Topical Disinfection', 'Perioral Dermatitis',\n",
       "       'Agitation', 'Intermittent Claudication',\n",
       "       'Prevention of Osteoporosis', 'Leukemia', 'Dermatitis Herpeti',\n",
       "       'mis', 'Eosinophilic Esophagitis',\n",
       "       'Hyperlipoproteinemia Type IIa, Elevated LDL',\n",
       "       'Endometrial Hyperplasia',\n",
       "       '19</span> users found this comment helpful.', 'Peptic Ulce',\n",
       "       'Chronic Myofascial Pain', 'Enterocolitis',\n",
       "       'Secondary Cutaneous Bacterial Infections', 'Syringomyelia',\n",
       "       'Postoperative Ocular Inflammation',\n",
       "       'Persistent Depressive Disorde', 'Otitis Externa',\n",
       "       'Organ Transplant, Rejection Prophylaxis',\n",
       "       'Intermittent Explosive Disorde', 'Dermatophytosis',\n",
       "       'Inflammatory Bowel Disease', 'Porphyria', 'Anemia',\n",
       "       'Hyperuricemia Secondary to Chemotherapy',\n",
       "       'Wolff-Parkinson-White Syndrome', 'eve', 'Ectopic Pregnancy',\n",
       "       'Thyroid Cance', 'Tuberculosis, Latent',\n",
       "       'Nasal Carriage of Staphylococcus aureus', 'Systemic Candidiasis',\n",
       "       'Ear Wax Impaction', 'Hepatocellular Carcinoma', 'Dyspareunia',\n",
       "       '41</span> users found this comment helpful.', 'Tic Disorde',\n",
       "       'Head and Neck Cance', 'Klinefelter Syndrome', 'Rhinorrhea',\n",
       "       'Soft Tissue Sarcoma', 'Diabetic Macular Edema',\n",
       "       'Menopausal Disorders', 'Anesthetic Adjunct', 'Tinea Cruris',\n",
       "       'tic (mycophenolic acid)', 'Ischemic Stroke', 'Malignant Glioma',\n",
       "       'Thrombocythemia', 'Atrophic Urethritis', 'Systemic Sclerosis',\n",
       "       'Macular Degeneration', 'AIDS Related Wasting', 'Hemophilia A',\n",
       "       'Osteolytic Bone Lesions of Multiple Myeloma',\n",
       "       'Autoimmune Hemolytic Anemia', 'ailure to Thrive',\n",
       "       'Strongyloidiasis', 'Vitamin K Deficiency', 'Ulcerative Proctitis',\n",
       "       'Premenstrual Syndrome',\n",
       "       '23</span> users found this comment helpful.',\n",
       "       'Primary Hyperaldosteronism', 'Lactose Intolerance',\n",
       "       'Anal Itching', 'amilial Cold Autoinflammatory Syndrome',\n",
       "       'Duodenal Ulce', 'Tuberculosis, Prophylaxis', 'Neurosis',\n",
       "       \"Turner's Syndrome\", 'NSAID-Induced Gastric Ulce',\n",
       "       'CNS Magnetic Resonance Imaging', 'Atherosclerosis',\n",
       "       'Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery',\n",
       "       'Gastritis/Duodenitis', 'Diarrhea, Acute', 'Costochondritis',\n",
       "       'Portal Hypertension', 'Glaucoma/Intraocular Hypertension',\n",
       "       'Toothache', 'Benzodiazepine Withdrawal', 'm Pain Disorde',\n",
       "       'Esophageal Candidiasis',\n",
       "       'Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery',\n",
       "       'Peripheral Arterial Disease',\n",
       "       'Deep Vein Thrombosis, Recurrent Event', 'Pseudogout, Prophylaxis',\n",
       "       'Lichen Planus', 'CMV Prophylaxis',\n",
       "       '64</span> users found this comment helpful.', 'Neuritis',\n",
       "       'Typhoid Feve', 'Tardive Dyskinesia', 'Ichthyosis',\n",
       "       'Juvenile Rheumatoid Arthritis', 'B12 Nutritional Deficiency',\n",
       "       '18</span> users found this comment helpful.',\n",
       "       'Primary Nocturnal Enuresis',\n",
       "       '146</span> users found this comment helpful.', \"Dercum's Disease\",\n",
       "       'Cutaneous Candidiasis', 'Gingivitis', 'Q Feve', 'Hyperekplexia',\n",
       "       '44</span> users found this comment helpful.', 'Niacin Deficiency',\n",
       "       'Dietary Fiber Supplementation', 'Nephrotic Syndrome',\n",
       "       'Pinworm Infection (Enterobius vermicularis)',\n",
       "       'Pancreatic Exocrine Dysfunction',\n",
       "       'Nausea/Vomiting, Radiation Induced', 'Schilling Test',\n",
       "       'Mild Cognitive Impairment', 'Ischemic Stroke, Prophylaxis',\n",
       "       '20</span> users found this comment helpful.',\n",
       "       'Gonococcal Infection, Uncomplicated', 'Ovarian Cance',\n",
       "       'Eyelash Hypotrichosis', \"Meniere's Disease\", 'Tinea Capitis',\n",
       "       '21</span> users found this comment helpful.', 'Lichen Sclerosus',\n",
       "       'min / pioglitazone)', 'Renal Transplant', 'Gout, Prophylaxis',\n",
       "       \"von Willebrand's Disease\",\n",
       "       'Prevention of Atherothrombotic Events', 'Small Fiber Neuropathy',\n",
       "       '110</span> users found this comment helpful.',\n",
       "       'min / rosiglitazone)', \"Peyronie's Disease\",\n",
       "       'Autoimmune Hepatitis', 'llicular Lymphoma',\n",
       "       'Auditory Processing Disorde', 'Herpes Zoster, Prophylaxis',\n",
       "       'Submental Fullness', 'Lactation Augmentation',\n",
       "       'Radionuclide Myocardial Perfusion Study',\n",
       "       'Prevention of Cardiovascular Disease', 'Varicella-Zoste',\n",
       "       'Pelvic Inflammatory Disease', 'Intraabdominal Infection', 'Croup',\n",
       "       '85</span> users found this comment helpful.',\n",
       "       'Dermatologic Lesion',\n",
       "       'Hyperlipoproteinemia Type IV, Elevated VLDL', 'Expectoration',\n",
       "       'Primary Hyperaldosteronism Diagnosis', 'Abdominal Distension',\n",
       "       'Salivary Gland Cance', 'Pulmonary Embolism, First Event',\n",
       "       'Postpartum Breast Pain',\n",
       "       'Postural Orthostatic Tachycardia Syndrome',\n",
       "       '46</span> users found this comment helpful.',\n",
       "       'Pediatric Growth Hormone Deficiency', 'Hypomagnesemia',\n",
       "       'ge HCT (amlodipine / hydrochlorothiazide / valsartan)',\n",
       "       'Hairy Cell Leukemia', 'Histoplasmosis', 'Hypoglycemia',\n",
       "       '31</span> users found this comment helpful.', 'Brain Tum',\n",
       "       'Gastrointestinal Stromal Tum', 'Tetanus',\n",
       "       'Breast Cancer, Prevention', 'ICU Agitation', 'Women (minoxidil)',\n",
       "       'Peripheral T-cell Lymphoma',\n",
       "       'Chronic Inflammatory Demyelinating Polyradiculoneuropathy',\n",
       "       'Pathological Hypersecretory Conditions',\n",
       "       'Oral and Dental Conditions', 'Antiphospholipid Syndrome',\n",
       "       'Ventricular Arrhythmia', 'Asystole', \"Wegener's Granulomatosis\",\n",
       "       'Thromboembolic Stroke Prophylaxis',\n",
       "       'Platelet Aggregation Inhibition', 'Sleep Paralysis',\n",
       "       'Rejection Prophylaxis', 'Delayed Puberty, Male', 'Ascariasis',\n",
       "       '25</span> users found this comment helpful.',\n",
       "       'Acute Promyelocytic Leukemia',\n",
       "       '32</span> users found this comment helpful.', 'Bartonellosis',\n",
       "       'Cyclothymic Disorde', 'Hypokalemic Periodic Paralysis',\n",
       "       'Varicose Veins', 'Mononucleosis', 'Cachexia', 'Hyperkalemia',\n",
       "       \"Still's Disease\", '48</span> users found this comment helpful.',\n",
       "       'Dementia', 'Ocular Rosacea', 'Hidradenitis Suppurativa', 'SIADH',\n",
       "       'Bullous Pemphigoid', 'Angioedema',\n",
       "       'Mountain Sickness / Altitude Sickness',\n",
       "       'Severe Mood Dysregulation', 'Cutaneous T-cell Lymphoma',\n",
       "       'Adrenocortical Insufficiency', 'Myxedema Coma',\n",
       "       'Small Bowel Bacterial Overgrowth', 'Sunburn',\n",
       "       '33</span> users found this comment helpful.',\n",
       "       'Transverse Myelitis', 'Squamous Cell Carcinoma', 'Parkinsonism',\n",
       "       '22</span> users found this comment helpful.', 'Thyrotoxicosis',\n",
       "       '29</span> users found this comment helpful.',\n",
       "       '30</span> users found this comment helpful.',\n",
       "       'Epididymitis, Sexually Transmitted', 'Neck Pain',\n",
       "       'Bleeding Disorde', '63</span> users found this comment helpful.',\n",
       "       'actor IX Deficiency', 'Melanoma', 'Thrombocytopenia',\n",
       "       'Esophageal Variceal Hemorrhage Prophylaxis', 'Glioblastoma Multi',\n",
       "       'Cholera', 'Anorexia/Feeding Problems',\n",
       "       '45</span> users found this comment helpful.', 'Peritonitis',\n",
       "       'AV Heart Block', 'Pe', \"Wilson's Disease\",\n",
       "       'Nonalcoholic Fatty Liver Disease',\n",
       "       '34</span> users found this comment helpful.', 'Sepsis', 'Anthrax',\n",
       "       'Body Imaging', 'Aggressive Behavi', 'Hepatic Tum', 'Ehrlichiosis',\n",
       "       'Hypopituitarism', 'Gender Dysphoria', 'Infectious Diarrhea',\n",
       "       'Ventricular Fibrillation', 'Anaphylaxis', 'Pemphigus',\n",
       "       'Multiple Endocrine Adenomas', 'Pre-Exposure Prophylaxis',\n",
       "       'Postoperative Increased Intraocular Pressure',\n",
       "       'Pruritus of Partial Biliary Obstruction', 'Pertussis',\n",
       "       'Periodontitis', 'Lymphoma', 'Hypercalcemia of Malignancy',\n",
       "       'Pityriasis rubra pilaris', 'Amebiasis', 't Care',\n",
       "       'Hepatic Encephalopathy',\n",
       "       '55</span> users found this comment helpful.',\n",
       "       'Deep Neck Infection', 'Meningitis, Meningococcal',\n",
       "       'Parkinsonian Trem', 'Rabies Prophylaxis',\n",
       "       '39</span> users found this comment helpful.', 'Hypotension',\n",
       "       'Myelofibrosis', '98</span> users found this comment helpful.',\n",
       "       'cal Segmental Glomerulosclerosis',\n",
       "       'Gastric Ulcer Maintenance Treatment', \"Paget's Disease\",\n",
       "       'Infection Prophylaxis', 'Gastrointestinal Decontamination',\n",
       "       'Mixed Connective Tissue Disease',\n",
       "       '24</span> users found this comment helpful.',\n",
       "       'Somatoform Pain Disorde', 'Esophageal Spasm',\n",
       "       'Campylobacter Gastroenteritis', 'Hyperphosphatemia',\n",
       "       'Oligospermia', 'Wound Cleansing', 'Euvolemic Hyponatremia',\n",
       "       'Gallbladder Disease',\n",
       "       '84</span> users found this comment helpful.',\n",
       "       'Mycobacterium avium-intracellulare, Treatment',\n",
       "       'Oppositional Defiant Disorde', 'Legionella Pneumonia',\n",
       "       'Breast Cancer, Palliative', 'Hydrocephalus',\n",
       "       'Hyperlipoproteinemia Type III, Elevated beta-VLDL   IDL',\n",
       "       '36</span> users found this comment helpful.',\n",
       "       'Anaplastic Astrocytoma', \"Dupuytren's contracture\",\n",
       "       '40</span> users found this comment helpful.', 'Mumps Prophylaxis',\n",
       "       'Skin Disinfection, Preoperative', 'Hyperbilirubinemia',\n",
       "       'Meningitis', 'Corneal Ulce', 'acial Lipoatrophy',\n",
       "       '43</span> users found this comment helpful.',\n",
       "       'Percutaneous Coronary Intervention', 'Hepatitis B Prevention',\n",
       "       'Tuberculosis, Active', 'Cerebrovascular Insufficiency',\n",
       "       'Head Injury', 'Anti NMDA Receptor Encephalitis',\n",
       "       'Nonoccupational Exposure',\n",
       "       '72</span> users found this comment helpful.',\n",
       "       'Gonadotropin Inhibition', 'unctional Gastric Disorde',\n",
       "       'Chronic Eosinophilic Leukemia', 'Acetaminophen Overdose',\n",
       "       'Duodenal Ulcer Prophylaxis', 'Paragonimus westermani, Lung Fluke',\n",
       "       'Alpha-1 Proteinase Inhibitor Deficiency', \"Cogan's Syndrome\",\n",
       "       'Uterine Bleeding', 'Stomach Cance', 'Sporotrichosis',\n",
       "       'Cluster-Tic Syndrome', 'Gestational Diabetes',\n",
       "       'Stress Ulcer Prophylaxis',\n",
       "       'Reversal of Nondepolarizing Muscle Relaxants', 'Solid Tumors',\n",
       "       'mist (', 'Schnitzler Syndrome', 'Hypocalcemia',\n",
       "       '26</span> users found this comment helpful.',\n",
       "       'Meningococcal Meningitis Prophylaxis', 'Nocardiosis',\n",
       "       'Hemophilia B', '42</span> users found this comment helpful.',\n",
       "       'Microscopic polyangiitis', 'Gonococcal Infection, Disseminated',\n",
       "       'Neurotic Depression', 'Keratitis',\n",
       "       '99</span> users found this comment helpful.',\n",
       "       \"Hodgkin's Lymphoma\", 'me', 'STD Prophylaxis',\n",
       "       '123</span> users found this comment helpful.',\n",
       "       'Small Bowel or Pancreatic Fistula',\n",
       "       'Prevention of Perinatal Group B Streptococcal Disease',\n",
       "       '74</span> users found this comment helpful.', 'Cerebral Edema',\n",
       "       'Testicular Cance', 'Short Stature for Age',\n",
       "       '47</span> users found this comment helpful.',\n",
       "       'Aspergillosis, Aspergilloma', 'Pemphigoid',\n",
       "       'Hyperparathyroidism Secondary to Renal Impairment',\n",
       "       '76</span> users found this comment helpful.',\n",
       "       'Ramsay Hunt Syndrome', 'Cutaneous Larva Migrans',\n",
       "       'Occipital Neuralgia', 'Blepharitis', 'Patent Ductus Arteriosus',\n",
       "       'Joint Infection', '77</span> users found this comment helpful.',\n",
       "       'Manscaping Pain', 'Strabismus',\n",
       "       'Organ Transplant, Rejection Reversal',\n",
       "       'Leukocytoclastic Vasculitis', 'Coronary Artery Disease',\n",
       "       'Gastric Cance', 'ibrocystic Breast Disease',\n",
       "       '121</span> users found this comment helpful.',\n",
       "       'ungal Infection Prophylaxis', 'Short Stature', 'Hypercalcemia',\n",
       "       'Coccidioidomycosis', 'Cyclitis', 'Anemia, Chemotherapy Induced',\n",
       "       'Upper Limb Spasticity',\n",
       "       '95</span> users found this comment helpful.',\n",
       "       '61</span> users found this comment helpful.',\n",
       "       'Diagnostic Bronchograms', 'Neoplastic Diseases',\n",
       "       '51</span> users found this comment helpful.',\n",
       "       'Mycoplasma Pneumonia', 'Linear IgA Disease',\n",
       "       'Subarachnoid Hemorrhage', 'Myeloproliferative Disorders',\n",
       "       'ungal Pneumonia', '145</span> users found this comment helpful.',\n",
       "       'Scleroderma', 'Zollinger-Ellison Syndrome', 'Tinea Barbae',\n",
       "       'Acute Nonlymphocytic Leukemia',\n",
       "       '62</span> users found this comment helpful.',\n",
       "       '92</span> users found this comment helpful.', 'Neutropenia',\n",
       "       'Rat-bite Feve', 'Uveitis, Posteri', 'Premature Ejaculation',\n",
       "       'Polymyositis/Dermatomyositis', 'Corneal Refractive Surgery',\n",
       "       'Gastrointestinal Hemorrhage', 'Bacteremia', 'Jet Lag',\n",
       "       'llicle Stimulation', 'Myotonia Congenita', 'Aplastic Anemia',\n",
       "       'Hemorrhoids (pramoxine / zinc oxide)',\n",
       "       'Salmonella Gastroenteritis', 'Somat',\n",
       "       '37</span> users found this comment helpful.',\n",
       "       'Nausea (phosphorated carbohydrate solution)',\n",
       "       'Occupational Exposure',\n",
       "       '83</span> users found this comment helpful.',\n",
       "       'Tympanostomy Tube Placement Surgery', 'Pulmonary Edema',\n",
       "       'Mantle Cell Lymphoma',\n",
       "       '70</span> users found this comment helpful.',\n",
       "       'Lyme Disease, Erythema Chronicum Migrans',\n",
       "       '100</span> users found this comment helpful.',\n",
       "       'Renal Tubular Acidosis', 'Yellow Fever Prophylaxis',\n",
       "       'Acute Otitis Externa',\n",
       "       'Steroid Responsive Inflammatory Conditions',\n",
       "       '135</span> users found this comment helpful.',\n",
       "       '38</span> users found this comment helpful.',\n",
       "       'Pertussis Prophylaxis',\n",
       "       '105</span> users found this comment helpful.'], dtype=object)"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.condition.unique()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4e5caad9",
   "metadata": {},
   "source": [
    "some conditions list are comments which can't represent the real conditions, and should be removed form the dataset. Also, some typos such as \"Cance\", \"Disorde\", and incomplete information (e.g \"eve\", which should be \"fever\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "1caa431e-7406-49c4-94e6-0ed252cb9dca",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Left Ventricular Dysfunction', 'ADHD', 'Birth Control',\n",
       "       'Opiate Dependence', 'Benign Prostatic Hyperplasia',\n",
       "       'Emergency Contraception', 'Bipolar Disorde', 'Epilepsy',\n",
       "       'Migraine Prevention', 'Depression', \"Crohn's Disease\", 'Cough',\n",
       "       'Obesity', 'Urinary Tract Infection', 'ibromyalgia',\n",
       "       'Chronic Myelogenous Leukemia', 'HIV Infection', 'Insomnia',\n",
       "       'Rheumatoid Arthritis', 'Vaginal Yeast Infection',\n",
       "       'Chlamydia Infection', 'Hirsutism', 'Panic Disorde', 'Migraine',\n",
       "       'Pain', 'Irritable Bowel Syndrome', 'Osteoarthritis',\n",
       "       'Constipation', 'Bowel Preparation', 'Psychosis', 'Muscle Spasm',\n",
       "       'Hepatitis C', 'Overactive Bladde', 'Diabetes, Type 2',\n",
       "       'Asthma, Maintenance', 'Non-Small Cell Lung Cance',\n",
       "       'Schizophrenia', 'Dysuria', 'Smoking Cessation', 'Anxiety', 'Acne',\n",
       "       'emale Infertility', 'Constipation, Acute',\n",
       "       'Constipation, Drug Induced', 'Erectile Dysfunction',\n",
       "       'Trigeminal Neuralgia', 'Underactive Thyroid', 'Chronic Pain',\n",
       "       'Atrophic Vaginitis', 'Skin and Structure Infection', 'Tinnitus',\n",
       "       'Major Depressive Disorde', 'Anxiety and Stress', 'Rosacea',\n",
       "       'High Blood Pressure', 'Restless Legs Syndrome',\n",
       "       'Osteolytic Bone Metastases of Solid Tumors', 'Bronchitis',\n",
       "       'Skin or Soft Tissue Infection', 'Obsessive Compulsive Disorde',\n",
       "       'Endometriosis', 'Keratoconjunctivitis Sicca', 'Breakthrough Pain',\n",
       "       'Seizures', 'Neuropathic Pain', 'Sedation', 'Menstrual Disorders',\n",
       "       'Allergic Rhinitis', 'Anesthesia',\n",
       "       'Undifferentiated Connective Tissue Disease', 'Diabetes, Type 1',\n",
       "       'Abnormal Uterine Bleeding', 'Weight Loss',\n",
       "       'Constipation, Chronic', 'Breast Cancer, Metastatic',\n",
       "       'Period Pain', 'Helicobacter Pylori Infection',\n",
       "       'Atrial Fibrillation', 'Uterine Fibroids', 'Kidney Infections',\n",
       "       'Generalized Anxiety Disorde', 'Asthma', 'Postmenopausal Symptoms',\n",
       "       'High Cholesterol', 'Hypogonadism, Male', 'Hyperthyroidism',\n",
       "       'Back Pain', 'Anaplastic Oligodendroglioma', \"Sjogren's Syndrome\",\n",
       "       'Asthma, acute', 'Hot Flashes', 'Herpes Simplex, Suppression',\n",
       "       'Bacterial Infection', 'Bursitis', 'Diaper Rash',\n",
       "       'Systemic Mastocytosis', 'Trichotillomania', \"Hashimoto's disease\",\n",
       "       'Eczema', 'Dental Abscess', 'Headache', 'Hypersomnia',\n",
       "       'Xerostomia', 'Breast Cance', 'Sore Throat', \"Barrett's Esophagus\",\n",
       "       'Pain/Feve', 'Diverticulitis', 'Sinusitis',\n",
       "       'Polycystic Ovary Syndrome', 'Influenza',\n",
       "       'Hypothyroidism, After Thyroid Removal', 'Onychomycosis, Toenail',\n",
       "       'Progesterone Insufficiency', 'GERD',\n",
       "       'Nausea/Vomiting, Postoperative', 'Herpes Simplex',\n",
       "       'Gastroparesis', 'Gout, Acute', 'Motion Sickness',\n",
       "       'Multiple Sclerosis', 'Autism', 'Otitis Media',\n",
       "       'Upper Respiratory Tract Infection', 'Surgical Prophylaxis',\n",
       "       'Psoriatic Arthritis', 'Erosive Esophagitis',\n",
       "       'Premature Ventricular Depolarizations', 'Stomach Ulce',\n",
       "       'Nausea/Vomiting', 'Light Anesthesia',\n",
       "       'Angina Pectoris Prophylaxis', 'Paranoid Disorde', 'Prostatitis',\n",
       "       'Extrapyramidal Reaction', 'mance Anxiety', 'Night Terrors',\n",
       "       'High Cholesterol, Familial Heterozygous', 'Spondyloarthritis',\n",
       "       'Clostridial Infection', 'Dermatomyositis', 'Bronchiectasis',\n",
       "       'Nasal Congestion', 'Benign Essential Trem', 'Angina',\n",
       "       'moterol / mometasone)', 'Impetig', 'Conjunctivitis, Bacterial',\n",
       "       'Post Traumatic Stress Disorde', 'Alcohol Withdrawal', 'Psoriasis',\n",
       "       'Cold Sores', 'Hyperhidrosis', 'Ankylosing Spondylitis',\n",
       "       'Hemorrhoids', 'Schizoaffective Disorde', 'Not Listed / Othe',\n",
       "       'Rhinitis', 'Oral Thrush', 'Hyperlipoproteinemia',\n",
       "       'Neutropenia Associated with Chemotherapy', 'Osteoporosis',\n",
       "       'Reflex Sympathetic Dystrophy Syndrome', 'Urticaria', 'Narcolepsy',\n",
       "       'Systemic Lupus Erythematosus', 'Ulcerative Colitis',\n",
       "       'Adult Human Growth Hormone Deficiency', 'Bacterial Vaginitis',\n",
       "       'COPD, Maintenance', 'Anorexia', 'TSH Suppression',\n",
       "       'Breast Cancer, Adjuvant', 'Glaucoma',\n",
       "       'Cough and Nasal Congestion', 'Inflammatory Conditions',\n",
       "       'Urinary Incontinence', 'Gout', 'Bladder Infection',\n",
       "       'Human Papillomavirus Prophylaxis', 'Glioblastoma Multiforme',\n",
       "       'Strep Throat', 'Bacterial Skin Infection',\n",
       "       'Hereditary Angioedema', 'Cold Symptoms', 'Labor Pain', 'Dry Skin',\n",
       "       'Diabetes Insipidus',\n",
       "       'Methicillin-Resistant Staphylococcus Aureus Infection',\n",
       "       'Borderline Personality Disorde', 'Amenorrhea', 'Pneumonia',\n",
       "       'Seborrheic Dermatitis', 'Interstitial Cystitis',\n",
       "       'Malaria Prevention', 'Prevention of Dental Caries',\n",
       "       'Herbal Supplementation', 'Plaque Psoriasis', \"Raynaud's Syndrome\",\n",
       "       \"Addison's Disease\", 'Prostate Cance', 'Allergies',\n",
       "       'Opioid-Induced Constipation', 'moterol)', 'Diarrhea',\n",
       "       'Seasonal Allergic Conjunctivitis', 'Opioid Overdose',\n",
       "       'Spondylolisthesis', 'Shift Work Sleep Disorde',\n",
       "       'Obstructive Sleep Apnea/Hypopnea Syndrome',\n",
       "       'Nausea/Vomiting of Pregnancy', 'Mucositis',\n",
       "       'Ulcerative Colitis, Active', 'Head Lice',\n",
       "       'Tonsillitis/Pharyngitis', 'Pseudotumor Cerebri',\n",
       "       \"Parkinson's Disease\", 'Sciatica', 'Cance',\n",
       "       'Bacterial Endocarditis Prevention', 'Diarrhea, Chronic',\n",
       "       'Hypertensive Emergency', 'Keratosis', 'Ovarian Cysts',\n",
       "       \"Behcet's Disease\", 'Chronic Idiopathic Constipation',\n",
       "       'lic Acid Deficiency', 'Chronic Fatigue Syndrome',\n",
       "       'Basal Cell Carcinoma', 'Cataplexy',\n",
       "       \"Crohn's Disease, Maintenance\", 'Diabetic Peripheral Neuropathy',\n",
       "       'Arrhythmia', 'Primary Ovarian Failure', 'Influenza Prophylaxis',\n",
       "       'Agitated State', 'Heart Failure', 'atigue', 'Opiate Withdrawal',\n",
       "       'Endometrial Hyperplasia, Prophylaxis', 'Immunosuppression',\n",
       "       'Dystonia', 'Alopecia', 'Vulvodynia',\n",
       "       'Premenstrual Dysphoric Disorde', 'Alcohol Dependence',\n",
       "       'Myasthenia Gravis', 'Social Anxiety Disorde', 'Atopic Dermatitis',\n",
       "       'Schistosoma japonicum', 'Sinus Symptoms', 'min / sitagliptin)',\n",
       "       'Dermatitis', 'Eye Redness', 'Warts', 'Menorrhagia',\n",
       "       'Seizure Prevention', 'Ophthalmic Surgery', 'Skin Rash',\n",
       "       'Condylomata Acuminata', 'NSAID-Induced Ulcer Prophylaxis',\n",
       "       'Tinea Versicol', 'Peripheral Neuropathy', 'Deep Vein Thrombosis',\n",
       "       'Heart Attack', 'Pulmonary Embolism, Recurrent Event',\n",
       "       'Light Sedation', 'Acute Lymphoblastic Leukemia',\n",
       "       'Hyperprolactinemia', 'Indigestion', 'Hepatitis B', 'Dysautonomia',\n",
       "       'Status Epilepticus', 'Postpartum Depression', 'Multiple Myeloma',\n",
       "       'Prevention of Hypokalemia', 'Edema', 'Urinary Retention',\n",
       "       'Prevention of Thromboembolism in Atrial Fibrillation',\n",
       "       'Cluster Headaches', 'Sexual Dysfunction, SSRI Induced',\n",
       "       'Dermatitis Herpetiformis', 'Temporomandibular Joint Disorde',\n",
       "       'Burns, External', 'Actinic Keratosis', 'Pharyngitis',\n",
       "       'Melanoma, Metastatic', 'Atrial Flutte', 'Lyme Disease',\n",
       "       'Dry Eye Disease', 'Allergic Reactions', 'Hypertriglyceridemia',\n",
       "       'Pruritus', 'Carcinoid Tum', 'Muscle Pain', 'Colorectal Cance',\n",
       "       'Vitamin/Mineral Supplementation during Pregnancy/Lactation',\n",
       "       'Nausea/Vomiting, Chemotherapy Induced', 'Women (oxybutynin)',\n",
       "       'Primary Immunodeficiency Syndrome',\n",
       "       'New Daily Persistent Headache',\n",
       "       'Pneumococcal Disease Prophylaxis', 'Burning Mouth Syndrome',\n",
       "       'Urinary Tract Stones', 'Pseudobulbar Affect',\n",
       "       'Eye Redness/Itching', 'Deep Vein Thrombosis, First Event',\n",
       "       'Pulmonary Hypertension', 'Malaria', 'Sarcoidosis',\n",
       "       'Dietary Supplementation', 'Bulimia', 'Tendonitis', 'Nasal Polyps',\n",
       "       'Hypokalemia', 'Anemia, Sickle Cell', 'Uveitis',\n",
       "       'Streptococcal Infection', 'Perimenopausal Symptoms',\n",
       "       'Asperger Syndrome', 'Tinea Corporis', 'Mania',\n",
       "       'Renal Cell Carcinoma', 'COPD', 'Biliary Cirrhosis', 'Vertig',\n",
       "       'Reversal of Opioid Sedation', \"Non-Hodgkin's Lymphoma\",\n",
       "       'High Cholesterol, Familial Homozygous',\n",
       "       'Periodic Limb Movement Disorde', 'Supraventricular Tachycardia',\n",
       "       'Hypoestrogenism', 'Juvenile Idiopathic Arthritis', 'Swine Flu',\n",
       "       'Giardiasis', 'Binge Eating Disorde', \"Tourette's Syndrome\",\n",
       "       'Trichomoniasis', 'acial Wrinkles', 'Pulmonary Embolism',\n",
       "       'Conjunctivitis, Allergic', 'Avian Influenza', 'Hemangioma',\n",
       "       'Nocturnal Leg Cramps', 'Thyroid Suppression Test',\n",
       "       'Muscle Twitching', 'Pupillary Dilation',\n",
       "       'Lennox-Gastaut Syndrome', 'Opiate Adjunct', 'Postoperative Pain',\n",
       "       'Candida Urinary Tract Infection', 'Cerebral Spasticity',\n",
       "       'Lipodystrophy', 'Androgenetic Alopecia', 'Computed Tomography',\n",
       "       'Mitral Valve Prolapse', 'Vitamin D Deficiency',\n",
       "       'Glaucoma, Open Angle', 'Endoscopy or Radiology Premedication',\n",
       "       \"Alzheimer's Disease\", 'Gouty Arthritis',\n",
       "       'Paroxysmal Supraventricular Tachycardia',\n",
       "       'Deep Vein Thrombosis, Prophylaxis', 'Gaucher Disease',\n",
       "       'Lymphocytic Colitis', 'Pancreatic Cance', 'Cystic Fibrosis',\n",
       "       'Noninfectious Colitis', 'Nephrocalcinosis',\n",
       "       'Iron Deficiency Anemia', 'mulation) (phenylephrine)', 'Hiccups',\n",
       "       'Bronchospasm Prophylaxis', 'Chronic Spasticity',\n",
       "       'min / saxagliptin)', 'Post-Cholecystectomy Diarrhea',\n",
       "       'Postherpetic Neuralgia', 'Insomnia, Stimulant-Associated',\n",
       "       'COPD, Acute', 'Herpes Simplex Dendritic Keratitis',\n",
       "       'Oophorectomy', 'Cyclic Vomiting Syndrome',\n",
       "       'Chronic Lymphocytic Leukemia', 'Lyme Disease, Arthritis',\n",
       "       'Pseudomembranous Colitis', 'Conjunctivitis', 'min)',\n",
       "       'Intraocular Hypertension', 'Aphthous Ulce',\n",
       "       'Ulcerative Colitis, Maintenance', 'Melasma',\n",
       "       'Lyme Disease, Neurologic', 'ge (amlodipine / valsartan)',\n",
       "       'Herpes Zoste', 'Cervical Dystonia', 'Labor Induction',\n",
       "       'Human Papilloma Virus', 'Chronic Pancreatitis',\n",
       "       'Polycythemia Vera', 'Dermatological Disorders',\n",
       "       'Lewy Body Dementia', 'amilial Mediterranean Feve', 'Neurosurgery',\n",
       "       'Gastroenteritis', 'Macular Edema', 'Tinea Pedis',\n",
       "       'Diagnosis and Investigation', 'Gas', 'Neuralgia',\n",
       "       'Local Anesthesia', 'Acute Coronary Syndrome',\n",
       "       'Aspiration Pneumonia', 'Idiopathic Thrombocytopenic Purpura',\n",
       "       'Onychomycosis, Fingernail', 'Photoaging of the Skin',\n",
       "       'Premature Lab', 'Precocious Puberty',\n",
       "       'Prevention of Bladder infection', 'Seasonal Affective Disorde',\n",
       "       'Diabetic Kidney Disease', \"Crohn's Disease, Acute\",\n",
       "       'Insulin Resistance Syndrome', 'Pudendal Neuralgia',\n",
       "       \"Reiter's Syndrome\", 'Amyotrophic Lateral Sclerosis',\n",
       "       'Body Dysmorphic Disorde',\n",
       "       'Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis',\n",
       "       'Dandruff', 'Vitamin B12 Deficiency', 'Bone infection',\n",
       "       'Prosthetic Heart Valves, Tissue Valves - Thrombosis Prophylaxis',\n",
       "       'Iritis', 'Allergic Urticaria', 'Cardiovascular Risk Reduction',\n",
       "       'Giant Cell Tumor of Bone', 'Babesiosis',\n",
       "       'Secondary Hyperparathyroidism', 'Hypoparathyroidism',\n",
       "       'Performance Anxiety', 'Abortion', 'Skin Cance',\n",
       "       'Ovulation Induction', 'Liver Magnetic Resonance Imaging',\n",
       "       'Vitamin/Mineral Supplementation and Deficiency',\n",
       "       'Herpes Simplex, Mucocutaneous/Immunocompetent Host',\n",
       "       'Anemia Associated with Chronic Renal Failure',\n",
       "       'Hyperphosphatemia of Renal Failure',\n",
       "       'Dissociative Identity Disorde', 'Anal Fissure and Fistula',\n",
       "       'Herpes Simplex, Mucocutaneous/Immunocompromised Host', 'Scabies',\n",
       "       'Endometrial Cance', 'Transient Ischemic Attack',\n",
       "       'Granuloma Annulare', \"Traveler's Diarrhea\", 'Candidemia',\n",
       "       't Pac with Cyclobenzaprine (cyclobenzaprine)',\n",
       "       'Hypoactive Sexual Desire Disorde', 'Epicondylitis, Tennis Elbow',\n",
       "       'Nightmares', 'Dientamoeba fragilis', 'Ventricular Tachycardia',\n",
       "       'Dumping Syndrome', 'Myelodysplastic Syndrome', 'Hypodermoclysis',\n",
       "       'zen Shoulde', 'Topical Disinfection', 'Perioral Dermatitis',\n",
       "       'Agitation', 'Intermittent Claudication',\n",
       "       'Prevention of Osteoporosis', 'Leukemia', 'Dermatitis Herpeti',\n",
       "       'mis', 'Eosinophilic Esophagitis',\n",
       "       'Hyperlipoproteinemia Type IIa, Elevated LDL',\n",
       "       'Endometrial Hyperplasia', 'Peptic Ulce',\n",
       "       'Chronic Myofascial Pain', 'Enterocolitis',\n",
       "       'Secondary Cutaneous Bacterial Infections', 'Syringomyelia',\n",
       "       'Postoperative Ocular Inflammation',\n",
       "       'Persistent Depressive Disorde', 'Otitis Externa',\n",
       "       'Organ Transplant, Rejection Prophylaxis',\n",
       "       'Intermittent Explosive Disorde', 'Dermatophytosis',\n",
       "       'Inflammatory Bowel Disease', 'Porphyria', 'Anemia',\n",
       "       'Hyperuricemia Secondary to Chemotherapy',\n",
       "       'Wolff-Parkinson-White Syndrome', 'eve', 'Ectopic Pregnancy',\n",
       "       'Thyroid Cance', 'Tuberculosis, Latent',\n",
       "       'Nasal Carriage of Staphylococcus aureus', 'Systemic Candidiasis',\n",
       "       'Ear Wax Impaction', 'Hepatocellular Carcinoma', 'Dyspareunia',\n",
       "       'Tic Disorde', 'Head and Neck Cance', 'Klinefelter Syndrome',\n",
       "       'Rhinorrhea', 'Soft Tissue Sarcoma', 'Diabetic Macular Edema',\n",
       "       'Menopausal Disorders', 'Anesthetic Adjunct', 'Tinea Cruris',\n",
       "       'tic (mycophenolic acid)', 'Ischemic Stroke', 'Malignant Glioma',\n",
       "       'Thrombocythemia', 'Atrophic Urethritis', 'Systemic Sclerosis',\n",
       "       'Macular Degeneration', 'AIDS Related Wasting', 'Hemophilia A',\n",
       "       'Osteolytic Bone Lesions of Multiple Myeloma',\n",
       "       'Autoimmune Hemolytic Anemia', 'ailure to Thrive',\n",
       "       'Strongyloidiasis', 'Vitamin K Deficiency', 'Ulcerative Proctitis',\n",
       "       'Premenstrual Syndrome', 'Primary Hyperaldosteronism',\n",
       "       'Lactose Intolerance', 'Anal Itching',\n",
       "       'amilial Cold Autoinflammatory Syndrome', 'Duodenal Ulce',\n",
       "       'Tuberculosis, Prophylaxis', 'Neurosis', \"Turner's Syndrome\",\n",
       "       'NSAID-Induced Gastric Ulce', 'CNS Magnetic Resonance Imaging',\n",
       "       'Atherosclerosis',\n",
       "       'Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery',\n",
       "       'Gastritis/Duodenitis', 'Diarrhea, Acute', 'Costochondritis',\n",
       "       'Portal Hypertension', 'Glaucoma/Intraocular Hypertension',\n",
       "       'Toothache', 'Benzodiazepine Withdrawal', 'm Pain Disorde',\n",
       "       'Esophageal Candidiasis',\n",
       "       'Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery',\n",
       "       'Peripheral Arterial Disease',\n",
       "       'Deep Vein Thrombosis, Recurrent Event', 'Pseudogout, Prophylaxis',\n",
       "       'Lichen Planus', 'CMV Prophylaxis', 'Neuritis', 'Typhoid Feve',\n",
       "       'Tardive Dyskinesia', 'Ichthyosis',\n",
       "       'Juvenile Rheumatoid Arthritis', 'B12 Nutritional Deficiency',\n",
       "       'Primary Nocturnal Enuresis', \"Dercum's Disease\",\n",
       "       'Cutaneous Candidiasis', 'Gingivitis', 'Q Feve', 'Hyperekplexia',\n",
       "       'Niacin Deficiency', 'Dietary Fiber Supplementation',\n",
       "       'Nephrotic Syndrome',\n",
       "       'Pinworm Infection (Enterobius vermicularis)',\n",
       "       'Pancreatic Exocrine Dysfunction',\n",
       "       'Nausea/Vomiting, Radiation Induced', 'Schilling Test',\n",
       "       'Mild Cognitive Impairment', 'Ischemic Stroke, Prophylaxis',\n",
       "       'Gonococcal Infection, Uncomplicated', 'Ovarian Cance',\n",
       "       'Eyelash Hypotrichosis', \"Meniere's Disease\", 'Tinea Capitis',\n",
       "       'Lichen Sclerosus', 'min / pioglitazone)', 'Renal Transplant',\n",
       "       'Gout, Prophylaxis', \"von Willebrand's Disease\",\n",
       "       'Prevention of Atherothrombotic Events', 'Small Fiber Neuropathy',\n",
       "       'min / rosiglitazone)', \"Peyronie's Disease\",\n",
       "       'Autoimmune Hepatitis', 'llicular Lymphoma',\n",
       "       'Auditory Processing Disorde', 'Herpes Zoster, Prophylaxis',\n",
       "       'Submental Fullness', 'Lactation Augmentation',\n",
       "       'Radionuclide Myocardial Perfusion Study',\n",
       "       'Prevention of Cardiovascular Disease', 'Varicella-Zoste',\n",
       "       'Pelvic Inflammatory Disease', 'Intraabdominal Infection', 'Croup',\n",
       "       'Dermatologic Lesion',\n",
       "       'Hyperlipoproteinemia Type IV, Elevated VLDL', 'Expectoration',\n",
       "       'Primary Hyperaldosteronism Diagnosis', 'Abdominal Distension',\n",
       "       'Salivary Gland Cance', 'Pulmonary Embolism, First Event',\n",
       "       'Postpartum Breast Pain',\n",
       "       'Postural Orthostatic Tachycardia Syndrome',\n",
       "       'Pediatric Growth Hormone Deficiency', 'Hypomagnesemia',\n",
       "       'ge HCT (amlodipine / hydrochlorothiazide / valsartan)',\n",
       "       'Hairy Cell Leukemia', 'Histoplasmosis', 'Hypoglycemia',\n",
       "       'Brain Tum', 'Gastrointestinal Stromal Tum', 'Tetanus',\n",
       "       'Breast Cancer, Prevention', 'ICU Agitation', 'Women (minoxidil)',\n",
       "       'Peripheral T-cell Lymphoma',\n",
       "       'Chronic Inflammatory Demyelinating Polyradiculoneuropathy',\n",
       "       'Pathological Hypersecretory Conditions',\n",
       "       'Oral and Dental Conditions', 'Antiphospholipid Syndrome',\n",
       "       'Ventricular Arrhythmia', 'Asystole', \"Wegener's Granulomatosis\",\n",
       "       'Thromboembolic Stroke Prophylaxis',\n",
       "       'Platelet Aggregation Inhibition', 'Sleep Paralysis',\n",
       "       'Rejection Prophylaxis', 'Delayed Puberty, Male', 'Ascariasis',\n",
       "       'Acute Promyelocytic Leukemia', 'Bartonellosis',\n",
       "       'Cyclothymic Disorde', 'Hypokalemic Periodic Paralysis',\n",
       "       'Varicose Veins', 'Mononucleosis', 'Cachexia', 'Hyperkalemia',\n",
       "       \"Still's Disease\", 'Dementia', 'Ocular Rosacea',\n",
       "       'Hidradenitis Suppurativa', 'SIADH', 'Bullous Pemphigoid',\n",
       "       'Angioedema', 'Mountain Sickness / Altitude Sickness',\n",
       "       'Severe Mood Dysregulation', 'Cutaneous T-cell Lymphoma',\n",
       "       'Adrenocortical Insufficiency', 'Myxedema Coma',\n",
       "       'Small Bowel Bacterial Overgrowth', 'Sunburn',\n",
       "       'Transverse Myelitis', 'Squamous Cell Carcinoma', 'Parkinsonism',\n",
       "       'Thyrotoxicosis', 'Epididymitis, Sexually Transmitted',\n",
       "       'Neck Pain', 'Bleeding Disorde', 'actor IX Deficiency', 'Melanoma',\n",
       "       'Thrombocytopenia', 'Esophageal Variceal Hemorrhage Prophylaxis',\n",
       "       'Glioblastoma Multi', 'Cholera', 'Anorexia/Feeding Problems',\n",
       "       'Peritonitis', 'AV Heart Block', 'Pe', \"Wilson's Disease\",\n",
       "       'Nonalcoholic Fatty Liver Disease', 'Sepsis', 'Anthrax',\n",
       "       'Body Imaging', 'Aggressive Behavi', 'Hepatic Tum', 'Ehrlichiosis',\n",
       "       'Hypopituitarism', 'Gender Dysphoria', 'Infectious Diarrhea',\n",
       "       'Ventricular Fibrillation', 'Anaphylaxis', 'Pemphigus',\n",
       "       'Multiple Endocrine Adenomas', 'Pre-Exposure Prophylaxis',\n",
       "       'Postoperative Increased Intraocular Pressure',\n",
       "       'Pruritus of Partial Biliary Obstruction', 'Pertussis',\n",
       "       'Periodontitis', 'Lymphoma', 'Hypercalcemia of Malignancy',\n",
       "       'Pityriasis rubra pilaris', 'Amebiasis', 't Care',\n",
       "       'Hepatic Encephalopathy', 'Deep Neck Infection',\n",
       "       'Meningitis, Meningococcal', 'Parkinsonian Trem',\n",
       "       'Rabies Prophylaxis', 'Hypotension', 'Myelofibrosis',\n",
       "       'cal Segmental Glomerulosclerosis',\n",
       "       'Gastric Ulcer Maintenance Treatment', \"Paget's Disease\",\n",
       "       'Infection Prophylaxis', 'Gastrointestinal Decontamination',\n",
       "       'Mixed Connective Tissue Disease', 'Somatoform Pain Disorde',\n",
       "       'Esophageal Spasm', 'Campylobacter Gastroenteritis',\n",
       "       'Hyperphosphatemia', 'Oligospermia', 'Wound Cleansing',\n",
       "       'Euvolemic Hyponatremia', 'Gallbladder Disease',\n",
       "       'Mycobacterium avium-intracellulare, Treatment',\n",
       "       'Oppositional Defiant Disorde', 'Legionella Pneumonia',\n",
       "       'Breast Cancer, Palliative', 'Hydrocephalus',\n",
       "       'Hyperlipoproteinemia Type III, Elevated beta-VLDL   IDL',\n",
       "       'Anaplastic Astrocytoma', \"Dupuytren's contracture\",\n",
       "       'Mumps Prophylaxis', 'Skin Disinfection, Preoperative',\n",
       "       'Hyperbilirubinemia', 'Meningitis', 'Corneal Ulce',\n",
       "       'acial Lipoatrophy', 'Percutaneous Coronary Intervention',\n",
       "       'Hepatitis B Prevention', 'Tuberculosis, Active',\n",
       "       'Cerebrovascular Insufficiency', 'Head Injury',\n",
       "       'Anti NMDA Receptor Encephalitis', 'Nonoccupational Exposure',\n",
       "       'Gonadotropin Inhibition', 'unctional Gastric Disorde',\n",
       "       'Chronic Eosinophilic Leukemia', 'Acetaminophen Overdose',\n",
       "       'Duodenal Ulcer Prophylaxis', 'Paragonimus westermani, Lung Fluke',\n",
       "       'Alpha-1 Proteinase Inhibitor Deficiency', \"Cogan's Syndrome\",\n",
       "       'Uterine Bleeding', 'Stomach Cance', 'Sporotrichosis',\n",
       "       'Cluster-Tic Syndrome', 'Gestational Diabetes',\n",
       "       'Stress Ulcer Prophylaxis',\n",
       "       'Reversal of Nondepolarizing Muscle Relaxants', 'Solid Tumors',\n",
       "       'mist (', 'Schnitzler Syndrome', 'Hypocalcemia',\n",
       "       'Meningococcal Meningitis Prophylaxis', 'Nocardiosis',\n",
       "       'Hemophilia B', 'Microscopic polyangiitis',\n",
       "       'Gonococcal Infection, Disseminated', 'Neurotic Depression',\n",
       "       'Keratitis', \"Hodgkin's Lymphoma\", 'me', 'STD Prophylaxis',\n",
       "       'Small Bowel or Pancreatic Fistula',\n",
       "       'Prevention of Perinatal Group B Streptococcal Disease',\n",
       "       'Cerebral Edema', 'Testicular Cance', 'Short Stature for Age',\n",
       "       'Aspergillosis, Aspergilloma', 'Pemphigoid',\n",
       "       'Hyperparathyroidism Secondary to Renal Impairment',\n",
       "       'Ramsay Hunt Syndrome', 'Cutaneous Larva Migrans',\n",
       "       'Occipital Neuralgia', 'Blepharitis', 'Patent Ductus Arteriosus',\n",
       "       'Joint Infection', 'Manscaping Pain', 'Strabismus',\n",
       "       'Organ Transplant, Rejection Reversal',\n",
       "       'Leukocytoclastic Vasculitis', 'Coronary Artery Disease',\n",
       "       'Gastric Cance', 'ibrocystic Breast Disease',\n",
       "       'ungal Infection Prophylaxis', 'Short Stature', 'Hypercalcemia',\n",
       "       'Coccidioidomycosis', 'Cyclitis', 'Anemia, Chemotherapy Induced',\n",
       "       'Upper Limb Spasticity', 'Diagnostic Bronchograms',\n",
       "       'Neoplastic Diseases', 'Mycoplasma Pneumonia',\n",
       "       'Linear IgA Disease', 'Subarachnoid Hemorrhage',\n",
       "       'Myeloproliferative Disorders', 'ungal Pneumonia', 'Scleroderma',\n",
       "       'Zollinger-Ellison Syndrome', 'Tinea Barbae',\n",
       "       'Acute Nonlymphocytic Leukemia', 'Neutropenia', 'Rat-bite Feve',\n",
       "       'Uveitis, Posteri', 'Premature Ejaculation',\n",
       "       'Polymyositis/Dermatomyositis', 'Corneal Refractive Surgery',\n",
       "       'Gastrointestinal Hemorrhage', 'Bacteremia', 'Jet Lag',\n",
       "       'llicle Stimulation', 'Myotonia Congenita', 'Aplastic Anemia',\n",
       "       'Hemorrhoids (pramoxine / zinc oxide)',\n",
       "       'Salmonella Gastroenteritis', 'Somat',\n",
       "       'Nausea (phosphorated carbohydrate solution)',\n",
       "       'Occupational Exposure', 'Tympanostomy Tube Placement Surgery',\n",
       "       'Pulmonary Edema', 'Mantle Cell Lymphoma',\n",
       "       'Lyme Disease, Erythema Chronicum Migrans',\n",
       "       'Renal Tubular Acidosis', 'Yellow Fever Prophylaxis',\n",
       "       'Acute Otitis Externa',\n",
       "       'Steroid Responsive Inflammatory Conditions',\n",
       "       'Pertussis Prophylaxis'], dtype=object)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#remove the comments in conditions\n",
    "condition_mask = df.condition.str.contains(\"users found this comment helpful\")\n",
    "df=df[~condition_mask]\n",
    "df.condition.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "a30be1c6-b63b-457f-9826-f2e80ade8157",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Left Ventricular Dysfunction', 'ADHD', 'Birth Control',\n",
       "       'Opiate Dependence', 'Benign Prostatic Hyperplasia',\n",
       "       'Emergency Contraception', 'Bipolar Disorder', 'Epilepsy',\n",
       "       'Migraine Prevention', 'Depression', \"Crohn's Disease\", 'Cough',\n",
       "       'Obesity', 'Urinary Tract Infection', 'ibromyalgia',\n",
       "       'Chronic Myelogenous Leukemia', 'HIV Infection', 'Insomnia',\n",
       "       'Rheumatoid Arthritis', 'Vaginal Yeast Infection',\n",
       "       'Chlamydia Infection', 'Hirsutism', 'Panic Disorder', 'Migraine',\n",
       "       'Pain', 'Irritable Bowel Syndrome', 'Osteoarthritis',\n",
       "       'Constipation', 'Bowel Preparation', 'Psychosis', 'Muscle Spasm',\n",
       "       'Hepatitis C', 'Overactive Bladder', 'Diabetes, Type 2',\n",
       "       'Asthma, Maintenance', 'Non-Small Cell Lung Cancer',\n",
       "       'Schizophrenia', 'Dysuria', 'Smoking Cessation', 'Anxiety', 'Acne',\n",
       "       'Female Infertility', 'Constipation, Acute',\n",
       "       'Constipation, Drug Induced', 'Erectile Dysfunction',\n",
       "       'Trigeminal Neuralgia', 'Underactive Thyroid', 'Chronic Pain',\n",
       "       'Atrophic Vaginitis', 'Skin and Structure Infection', 'Tinnitus',\n",
       "       'Major Depressive Disorder', 'Anxiety and Stress', 'Rosacea',\n",
       "       'High Blood Pressure', 'Restless Legs Syndrome',\n",
       "       'Osteolytic Bone Metastases of Solid Tumors', 'Bronchitis',\n",
       "       'Skin or Soft Tissue Infection', 'Obsessive Compulsive Disorder',\n",
       "       'Endometriosis', 'Keratoconjunctivitis Sicca', 'Breakthrough Pain',\n",
       "       'Seizures', 'Neuropathic Pain', 'Sedation', 'Menstrual Disorders',\n",
       "       'Allergic Rhinitis', 'Anesthesia',\n",
       "       'Undifferentiated Connective Tissue Disease', 'Diabetes, Type 1',\n",
       "       'Abnormal Uterine Bleeding', 'Weight Loss',\n",
       "       'Constipation, Chronic', 'Breast Cancer, Metastatic',\n",
       "       'Period Pain', 'Helicobacter Pylori Infection',\n",
       "       'Atrial Fibrillation', 'Uterine Fibroids', 'Kidney Infections',\n",
       "       'Generalized Anxiety Disorder', 'Asthma',\n",
       "       'Postmenopausal Symptoms', 'High Cholesterol',\n",
       "       'Hypogonadism, Male', 'Hyperthyroidism', 'Back Pain',\n",
       "       'Anaplastic Oligodendroglioma', \"Sjogren's Syndrome\",\n",
       "       'Asthma, acute', 'Hot Flashes', 'Herpes Simplex, Suppression',\n",
       "       'Bacterial Infection', 'Bursitis', 'Diaper Rash',\n",
       "       'Systemic Mastocytosis', 'Trichotillomania', \"Hashimoto's disease\",\n",
       "       'Eczema', 'Dental Abscess', 'Headache', 'Hypersomnia',\n",
       "       'Xerostomia', 'Breast Cancer', 'Sore Throat',\n",
       "       \"Barrett's Esophagus\", 'Pain/Feve', 'Diverticulitis', 'Sinusitis',\n",
       "       'Polycystic Ovary Syndrome', 'Influenza',\n",
       "       'Hypothyroidism, After Thyroid Removal', 'Onychomycosis, Toenail',\n",
       "       'Progesterone Insufficiency', 'GERD',\n",
       "       'Nausea/Vomiting, Postoperative', 'Herpes Simplex',\n",
       "       'Gastroparesis', 'Gout, Acute', 'Motion Sickness',\n",
       "       'Multiple Sclerosis', 'Autism', 'Otitis Media',\n",
       "       'Upper Respiratory Tract Infection', 'Surgical Prophylaxis',\n",
       "       'Psoriatic Arthritis', 'Erosive Esophagitis',\n",
       "       'Premature Ventricular Depolarizations', 'Stomach Ulcer',\n",
       "       'Nausea/Vomiting', 'Light Anesthesia',\n",
       "       'Angina Pectoris Prophylaxis', 'Paranoid Disorder', 'Prostatitis',\n",
       "       'Extrapyramidal Reaction', 'Performance Anxiety', 'Night Terrors',\n",
       "       'High Cholesterol, Familial Heterozygous', 'Spondyloarthritis',\n",
       "       'Clostridial Infection', 'Dermatomyositis', 'Bronchiectasis',\n",
       "       'Nasal Congestion', 'Benign Essential Trem', 'Angina',\n",
       "       'Formoterol Mometasone', 'Impetig', 'Conjunctivitis, Bacterial',\n",
       "       'Post Traumatic Stress Disorder', 'Alcohol Withdrawal',\n",
       "       'Psoriasis', 'Cold Sores', 'Hyperhidrosis',\n",
       "       'Ankylosing Spondylitis', 'Hemorrhoids',\n",
       "       'Schizoaffective Disorder', 'Not Listed Other', 'Rhinitis',\n",
       "       'Oral Thrush', 'Hyperlipoproteinemia',\n",
       "       'Neutropenia Associated with Chemotherapy', 'Osteoporosis',\n",
       "       'Reflex Sympathetic Dystrophy Syndrome', 'Urticaria', 'Narcolepsy',\n",
       "       'Systemic Lupus Erythematosus', 'Ulcerative Colitis',\n",
       "       'Adult Human Growth Hormone Deficiency', 'Bacterial Vaginitis',\n",
       "       'COPD, Maintenance', 'Anorexia', 'TSH Suppression',\n",
       "       'Breast Cancer, Adjuvant', 'Glaucoma',\n",
       "       'Cough and Nasal Congestion', 'Inflammatory Conditions',\n",
       "       'Urinary Incontinence', 'Gout', 'Bladder Infection',\n",
       "       'Human Papillomavirus Prophylaxis', 'Glioblastoma Multiforme',\n",
       "       'Strep Throat', 'Bacterial Skin Infection',\n",
       "       'Hereditary Angioedema', 'Cold Symptoms', 'Labor Pain', 'Dry Skin',\n",
       "       'Diabetes Insipidus',\n",
       "       'Methicillin-Resistant Staphylococcus Aureus Infection',\n",
       "       'Borderline Personality Disorder', 'Amenorrhea', 'Pneumonia',\n",
       "       'Seborrheic Dermatitis', 'Interstitial Cystitis',\n",
       "       'Malaria Prevention', 'Prevention of Dental Caries',\n",
       "       'Herbal Supplementation', 'Plaque Psoriasis', \"Raynaud's Syndrome\",\n",
       "       \"Addison's Disease\", 'Prostate Cancer', 'Allergies',\n",
       "       'Opioid-Induced Constipation', 'Diarrhea',\n",
       "       'Seasonal Allergic Conjunctivitis', 'Opioid Overdose',\n",
       "       'Spondylolisthesis', 'Shift Work Sleep Disorder',\n",
       "       'Obstructive Sleep Apnea/Hypopnea Syndrome',\n",
       "       'Nausea/Vomiting of Pregnancy', 'Mucositis',\n",
       "       'Ulcerative Colitis, Active', 'Head Lice',\n",
       "       'Tonsillitis/Pharyngitis', 'Pseudotumor Cerebri',\n",
       "       \"Parkinson's Disease\", 'Sciatica', 'Cancer',\n",
       "       'Bacterial Endocarditis Prevention', 'Diarrhea, Chronic',\n",
       "       'Hypertensive Emergency', 'Keratosis', 'Ovarian Cysts',\n",
       "       \"Behcet's Disease\", 'Chronic Idiopathic Constipation',\n",
       "       'Folic Acid Deficiency', 'Chronic Fatigue Syndrome',\n",
       "       'Basal Cell Carcinoma', 'Cataplexy',\n",
       "       \"Crohn's Disease, Maintenance\", 'Diabetic Peripheral Neuropathy',\n",
       "       'Arrhythmia', 'Primary Ovarian Failure', 'Influenza Prophylaxis',\n",
       "       'Agitated State', 'Heart Failure', 'Fatigue', 'Opiate Withdrawal',\n",
       "       'Endometrial Hyperplasia, Prophylaxis', 'Immunosuppression',\n",
       "       'Dystonia', 'Alopecia', 'Vulvodynia',\n",
       "       'Premenstrual Dysphoric Disorder', 'Alcohol Dependence',\n",
       "       'Myasthenia Gravis', 'Social Anxiety Disorder',\n",
       "       'Atopic Dermatitis', 'Schistosoma japonicum', 'Sinus Symptoms',\n",
       "       'min / sitagliptin)', 'Dermatitis', 'Eye Redness', 'Warts',\n",
       "       'Menorrhagia', 'Seizure Prevention', 'Ophthalmic Surgery',\n",
       "       'Skin Rash', 'Condylomata Acuminata',\n",
       "       'NSAID-Induced Ulcer Prophylaxis', 'Tinea Versicol',\n",
       "       'Peripheral Neuropathy', 'Deep Vein Thrombosis', 'Heart Attack',\n",
       "       'Pulmonary Embolism, Recurrent Event', 'Light Sedation',\n",
       "       'Acute Lymphoblastic Leukemia', 'Hyperprolactinemia',\n",
       "       'Indigestion', 'Hepatitis B', 'Dysautonomia', 'Status Epilepticus',\n",
       "       'Postpartum Depression', 'Multiple Myeloma',\n",
       "       'Prevention of Hypokalemia', 'Edema', 'Urinary Retention',\n",
       "       'Prevention of Thromboembolism in Atrial Fibrillation',\n",
       "       'Cluster Headaches', 'Sexual Dysfunction, SSRI Induced',\n",
       "       'Dermatitis Herpetiformis', 'Temporomandibular Joint Disorder',\n",
       "       'Burns, External', 'Actinic Keratosis', 'Pharyngitis',\n",
       "       'Melanoma, Metastatic', 'Atrial Flutte', 'Lyme Disease',\n",
       "       'Dry Eye Disease', 'Allergic Reactions', 'Hypertriglyceridemia',\n",
       "       'Pruritus', 'Carcinoid Tumor', 'Muscle Pain', 'Colorectal Cancer',\n",
       "       'Vitamin/Mineral Supplementation during Pregnancy/Lactation',\n",
       "       'Nausea/Vomiting, Chemotherapy Induced', 'Women (oxybutynin)',\n",
       "       'Primary Immunodeficiency Syndrome',\n",
       "       'New Daily Persistent Headache',\n",
       "       'Pneumococcal Disease Prophylaxis', 'Burning Mouth Syndrome',\n",
       "       'Urinary Tract Stones', 'Pseudobulbar Affect',\n",
       "       'Eye Redness/Itching', 'Deep Vein Thrombosis, First Event',\n",
       "       'Pulmonary Hypertension', 'Malaria', 'Sarcoidosis',\n",
       "       'Dietary Supplementation', 'Bulimia', 'Tendonitis', 'Nasal Polyps',\n",
       "       'Hypokalemia', 'Anemia, Sickle Cell', 'Uveitis',\n",
       "       'Streptococcal Infection', 'Perimenopausal Symptoms',\n",
       "       'Asperger Syndrome', 'Tinea Corporis', 'Mania',\n",
       "       'Renal Cell Carcinoma', 'COPD', 'Biliary Cirrhosis', 'Vertig',\n",
       "       'Reversal of Opioid Sedation', \"Non-Hodgkin's Lymphoma\",\n",
       "       'High Cholesterol, Familial Homozygous',\n",
       "       'Periodic Limb Movement Disorder', 'Supraventricular Tachycardia',\n",
       "       'Hypoestrogenism', 'Juvenile Idiopathic Arthritis', 'Swine Flu',\n",
       "       'Giardiasis', 'Binge Eating Disorder', \"Tourette's Syndrome\",\n",
       "       'Trichomoniasis', 'acial Wrinkles', 'Pulmonary Embolism',\n",
       "       'Conjunctivitis, Allergic', 'Avian Influenza', 'Hemangioma',\n",
       "       'Nocturnal Leg Cramps', 'Thyroid Suppression Test',\n",
       "       'Muscle Twitching', 'Pupillary Dilation',\n",
       "       'Lennox-Gastaut Syndrome', 'Opiate Adjunct', 'Postoperative Pain',\n",
       "       'Candida Urinary Tract Infection', 'Cerebral Spasticity',\n",
       "       'Lipodystrophy', 'Androgenetic Alopecia', 'Computed Tomography',\n",
       "       'Mitral Valve Prolapse', 'Vitamin D Deficiency',\n",
       "       'Glaucoma, Open Angle', 'Endoscopy or Radiology Premedication',\n",
       "       \"Alzheimer's Disease\", 'Gouty Arthritis',\n",
       "       'Paroxysmal Supraventricular Tachycardia',\n",
       "       'Deep Vein Thrombosis, Prophylaxis', 'Gaucher Disease',\n",
       "       'Lymphocytic Colitis', 'Pancreatic Cancer', 'Cystic Fibrosis',\n",
       "       'Noninfectious Colitis', 'Nephrocalcinosis',\n",
       "       'Iron Deficiency Anemia', 'mulation) (phenylephrine)', 'Hiccups',\n",
       "       'Bronchospasm Prophylaxis', 'Chronic Spasticity',\n",
       "       'Metformin Saxagliptin', 'Post-Cholecystectomy Diarrhea',\n",
       "       'Postherpetic Neuralgia', 'Insomnia, Stimulant-Associated',\n",
       "       'COPD, Acute', 'Herpes Simplex Dendritic Keratitis',\n",
       "       'Oophorectomy', 'Cyclic Vomiting Syndrome',\n",
       "       'Chronic Lymphocytic Leukemia', 'Lyme Disease, Arthritis',\n",
       "       'Pseudomembranous Colitis', 'Conjunctivitis',\n",
       "       'Intraocular Hypertension', 'Aphthous Ulcer',\n",
       "       'Ulcerative Colitis, Maintenance', 'Melasma',\n",
       "       'Lyme Disease, Neurologic', 'Amlodipine Valsartan', 'Herpes Zoste',\n",
       "       'Cervical Dystonia', 'Labor Induction', 'Human Papilloma Virus',\n",
       "       'Chronic Pancreatitis', 'Polycythemia Vera',\n",
       "       'Dermatological Disorders', 'Lewy Body Dementia',\n",
       "       'amilial Mediterranean Fever', 'Neurosurgery', 'Gastroenteritis',\n",
       "       'Macular Edema', 'Tinea Pedis', 'Diagnosis and Investigation',\n",
       "       'Gas', 'Neuralgia', 'Local Anesthesia', 'Acute Coronary Syndrome',\n",
       "       'Aspiration Pneumonia', 'Idiopathic Thrombocytopenic Purpura',\n",
       "       'Onychomycosis, Fingernail', 'Photoaging of the Skin',\n",
       "       'Premature Lab', 'Precocious Puberty',\n",
       "       'Prevention of Bladder infection', 'Seasonal Affective Disorder',\n",
       "       'Diabetic Kidney Disease', \"Crohn's Disease, Acute\",\n",
       "       'Insulin Resistance Syndrome', 'Pudendal Neuralgia',\n",
       "       \"Reiter's Syndrome\", 'Amyotrophic Lateral Sclerosis',\n",
       "       'Body Dysmorphic Disorder',\n",
       "       'Prosthetic Heart Valves, Mechanical Valves - Thrombosis Prophylaxis',\n",
       "       'Dandruff', 'Vitamin B12 Deficiency', 'Bone infection',\n",
       "       'Prosthetic Heart Valves, Tissue Valves - Thrombosis Prophylaxis',\n",
       "       'Iritis', 'Allergic Urticaria', 'Cardiovascular Risk Reduction',\n",
       "       'Giant Cell Tumor of Bone', 'Babesiosis',\n",
       "       'Secondary Hyperparathyroidism', 'Hypoparathyroidism', 'Abortion',\n",
       "       'Skin Cancer', 'Ovulation Induction',\n",
       "       'Liver Magnetic Resonance Imaging',\n",
       "       'Vitamin/Mineral Supplementation and Deficiency',\n",
       "       'Herpes Simplex, Mucocutaneous/Immunocompetent Host',\n",
       "       'Anemia Associated with Chronic Renal Failure',\n",
       "       'Hyperphosphatemia of Renal Failure',\n",
       "       'Dissociative Identity Disorder', 'Anal Fissure and Fistula',\n",
       "       'Herpes Simplex, Mucocutaneous/Immunocompromised Host', 'Scabies',\n",
       "       'Endometrial Cancer', 'Transient Ischemic Attack',\n",
       "       'Granuloma Annulare', \"Traveler's Diarrhea\", 'Candidemia',\n",
       "       'Comfort Pac with Cyclobenzaprine',\n",
       "       'Hypoactive Sexual Desire Disorder', 'Epicondylitis, Tennis Elbow',\n",
       "       'Nightmares', 'Dientamoeba fragilis', 'Ventricular Tachycardia',\n",
       "       'Dumping Syndrome', 'Myelodysplastic Syndrome', 'Hypodermoclysis',\n",
       "       'Frozen Shoulder', 'Topical Disinfection', 'Perioral Dermatitis',\n",
       "       'Agitation', 'Intermittent Claudication',\n",
       "       'Prevention of Osteoporosis', 'Leukemia', 'Dermatitis Herpeti',\n",
       "       'Mist', 'Eosinophilic Esophagitis',\n",
       "       'Hyperlipoproteinemia Type IIa, Elevated LDL',\n",
       "       'Endometrial Hyperplasia', 'Peptic Ulcer',\n",
       "       'Chronic Myofascial Pain', 'Enterocolitis',\n",
       "       'Secondary Cutaneous Bacterial Infections', 'Syringomyelia',\n",
       "       'Postoperative Ocular Inflammation',\n",
       "       'Persistent Depressive Disorder', 'Otitis Externa',\n",
       "       'Organ Transplant, Rejection Prophylaxis',\n",
       "       'Intermittent Explosive Disorder', 'Dermatophytosis',\n",
       "       'Inflammatory Bowel Disease', 'Porphyria', 'Anemia',\n",
       "       'Hyperuricemia Secondary to Chemotherapy',\n",
       "       'Wolff-Parkinson-White Syndrome', 'Fever', 'Ectopic Pregnancy',\n",
       "       'Thyroid Cancer', 'Tuberculosis, Latent',\n",
       "       'Nasal Carriage of Staphylococcus aureus', 'Systemic Candidiasis',\n",
       "       'Ear Wax Impaction', 'Hepatocellular Carcinoma', 'Dyspareunia',\n",
       "       'Tic Disorder', 'Head and Neck Cancer', 'Klinefelter Syndrome',\n",
       "       'Rhinorrhea', 'Soft Tissue Sarcoma', 'Diabetic Macular Edema',\n",
       "       'Menopausal Disorders', 'Anesthetic Adjunct', 'Tinea Cruris',\n",
       "       'Mycophenolic Acid', 'Ischemic Stroke', 'Malignant Glioma',\n",
       "       'Thrombocythemia', 'Atrophic Urethritis', 'Systemic Sclerosis',\n",
       "       'Macular Degeneration', 'AIDS Related Wasting', 'Hemophilia A',\n",
       "       'Osteolytic Bone Lesions of Multiple Myeloma',\n",
       "       'Autoimmune Hemolytic Anemia', 'Failure To Thrive',\n",
       "       'Strongyloidiasis', 'Vitamin K Deficiency', 'Ulcerative Proctitis',\n",
       "       'Premenstrual Syndrome', 'Primary Hyperaldosteronism',\n",
       "       'Lactose Intolerance', 'Anal Itching',\n",
       "       'amilial Cold Autoinflammatory Syndrome', 'Duodenal Ulcer',\n",
       "       'Tuberculosis, Prophylaxis', 'Neurosis', \"Turner's Syndrome\",\n",
       "       'NSAID-Induced Gastric Ulcer', 'CNS Magnetic Resonance Imaging',\n",
       "       'Atherosclerosis',\n",
       "       'Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery',\n",
       "       'Gastritis/Duodenitis', 'Diarrhea, Acute', 'Costochondritis',\n",
       "       'Portal Hypertension', 'Glaucoma/Intraocular Hypertension',\n",
       "       'Toothache', 'Benzodiazepine Withdrawal', 'Pain Disorder',\n",
       "       'Esophageal Candidiasis',\n",
       "       'Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery',\n",
       "       'Peripheral Arterial Disease',\n",
       "       'Deep Vein Thrombosis, Recurrent Event', 'Pseudogout, Prophylaxis',\n",
       "       'Lichen Planus', 'CMV Prophylaxis', 'Neuritis', 'Typhoid Fever',\n",
       "       'Tardive Dyskinesia', 'Ichthyosis',\n",
       "       'Juvenile Rheumatoid Arthritis', 'B12 Nutritional Deficiency',\n",
       "       'Primary Nocturnal Enuresis', \"Dercum's Disease\",\n",
       "       'Cutaneous Candidiasis', 'Gingivitis', 'Q Fever', 'Hyperekplexia',\n",
       "       'Niacin Deficiency', 'Dietary Fiber Supplementation',\n",
       "       'Nephrotic Syndrome',\n",
       "       'Pinworm Infection (Enterobius vermicularis)',\n",
       "       'Pancreatic Exocrine Dysfunction',\n",
       "       'Nausea/Vomiting, Radiation Induced', 'Schilling Test',\n",
       "       'Mild Cognitive Impairment', 'Ischemic Stroke, Prophylaxis',\n",
       "       'Gonococcal Infection, Uncomplicated', 'Ovarian Cancer',\n",
       "       'Eyelash Hypotrichosis', \"Meniere's Disease\", 'Tinea Capitis',\n",
       "       'Lichen Sclerosus', 'Metformin Pioglitazone', 'Renal Transplant',\n",
       "       'Gout, Prophylaxis', \"von Willebrand's Disease\",\n",
       "       'Prevention of Atherothrombotic Events', 'Small Fiber Neuropathy',\n",
       "       'Metformin Rosiglitazone', \"Peyronie's Disease\",\n",
       "       'Autoimmune Hepatitis', 'Follicular Lymphoma',\n",
       "       'Auditory Processing Disorder', 'Herpes Zoster, Prophylaxis',\n",
       "       'Submental Fullness', 'Lactation Augmentation',\n",
       "       'Radionuclide Myocardial Perfusion Study',\n",
       "       'Prevention of Cardiovascular Disease', 'Varicella-Zoste',\n",
       "       'Pelvic Inflammatory Disease', 'Intraabdominal Infection', 'Croup',\n",
       "       'Dermatologic Lesion',\n",
       "       'Hyperlipoproteinemia Type IV, Elevated VLDL', 'Expectoration',\n",
       "       'Primary Hyperaldosteronism Diagnosis', 'Abdominal Distension',\n",
       "       'Salivary Gland Cancer', 'Pulmonary Embolism, First Event',\n",
       "       'Postpartum Breast Pain',\n",
       "       'Postural Orthostatic Tachycardia Syndrome',\n",
       "       'Pediatric Growth Hormone Deficiency', 'Hypomagnesemia',\n",
       "       'Amlodipine Hydrochlorothiazide Valsartan', 'Hairy Cell Leukemia',\n",
       "       'Histoplasmosis', 'Hypoglycemia', 'Brain Tumor',\n",
       "       'Gastrointestinal Stromal Tumor', 'Tetanus',\n",
       "       'Breast Cancer, Prevention', 'ICU Agitation', 'Women (minoxidil)',\n",
       "       'Peripheral T-cell Lymphoma',\n",
       "       'Chronic Inflammatory Demyelinating Polyradiculoneuropathy',\n",
       "       'Pathological Hypersecretory Conditions',\n",
       "       'Oral and Dental Conditions', 'Antiphospholipid Syndrome',\n",
       "       'Ventricular Arrhythmia', 'Asystole', \"Wegener's Granulomatosis\",\n",
       "       'Thromboembolic Stroke Prophylaxis',\n",
       "       'Platelet Aggregation Inhibition', 'Sleep Paralysis',\n",
       "       'Rejection Prophylaxis', 'Delayed Puberty, Male', 'Ascariasis',\n",
       "       'Acute Promyelocytic Leukemia', 'Bartonellosis',\n",
       "       'Cyclothymic Disorder', 'Hypokalemic Periodic Paralysis',\n",
       "       'Varicose Veins', 'Mononucleosis', 'Cachexia', 'Hyperkalemia',\n",
       "       \"Still's Disease\", 'Dementia', 'Ocular Rosacea',\n",
       "       'Hidradenitis Suppurativa', 'SIADH', 'Bullous Pemphigoid',\n",
       "       'Angioedema', 'Mountain Sickness / Altitude Sickness',\n",
       "       'Severe Mood Dysregulation', 'Cutaneous T-cell Lymphoma',\n",
       "       'Adrenocortical Insufficiency', 'Myxedema Coma',\n",
       "       'Small Bowel Bacterial Overgrowth', 'Sunburn',\n",
       "       'Transverse Myelitis', 'Squamous Cell Carcinoma', 'Parkinsonism',\n",
       "       'Thyrotoxicosis', 'Epididymitis, Sexually Transmitted',\n",
       "       'Neck Pain', 'Bleeding Disorder', 'actor IX Deficiency',\n",
       "       'Melanoma', 'Thrombocytopenia',\n",
       "       'Esophageal Variceal Hemorrhage Prophylaxis', 'Glioblastoma Multi',\n",
       "       'Cholera', 'Anorexia/Feeding Problems', 'Peritonitis',\n",
       "       'AV Heart Block', \"Wilson's Disease\",\n",
       "       'Nonalcoholic Fatty Liver Disease', 'Sepsis', 'Anthrax',\n",
       "       'Body Imaging', 'Aggressive Behavi', 'Hepatic Tumor',\n",
       "       'Ehrlichiosis', 'Hypopituitarism', 'Gender Dysphoria',\n",
       "       'Infectious Diarrhea', 'Ventricular Fibrillation', 'Anaphylaxis',\n",
       "       'Pemphigus', 'Multiple Endocrine Adenomas',\n",
       "       'Pre-Exposure Prophylaxis',\n",
       "       'Postoperative Increased Intraocular Pressure',\n",
       "       'Pruritus of Partial Biliary Obstruction', 'Pertussis',\n",
       "       'Periodontitis', 'Lymphoma', 'Hypercalcemia of Malignancy',\n",
       "       'Pityriasis rubra pilaris', 'Amebiasis', 'Urgent Care',\n",
       "       'Hepatic Encephalopathy', 'Deep Neck Infection',\n",
       "       'Meningitis, Meningococcal', 'Parkinsonian Trem',\n",
       "       'Rabies Prophylaxis', 'Hypotension', 'Myelofibrosis',\n",
       "       'cal Segmental Glomerulosclerosis',\n",
       "       'Gastric Ulcer Maintenance Treatment', \"Paget's Disease\",\n",
       "       'Infection Prophylaxis', 'Gastrointestinal Decontamination',\n",
       "       'Mixed Connective Tissue Disease', 'Somatoform Pain Disorder',\n",
       "       'Esophageal Spasm', 'Campylobacter Gastroenteritis',\n",
       "       'Hyperphosphatemia', 'Oligospermia', 'Wound Cleansing',\n",
       "       'Euvolemic Hyponatremia', 'Gallbladder Disease',\n",
       "       'Mycobacterium avium-intracellulare, Treatment',\n",
       "       'Oppositional Defiant Disorder', 'Legionella Pneumonia',\n",
       "       'Breast Cancer, Palliative', 'Hydrocephalus',\n",
       "       'Hyperlipoproteinemia Type III, Elevated beta-VLDL   IDL',\n",
       "       'Anaplastic Astrocytoma', \"Dupuytren's contracture\",\n",
       "       'Mumps Prophylaxis', 'Skin Disinfection, Preoperative',\n",
       "       'Hyperbilirubinemia', 'Meningitis', 'Corneal Ulcer',\n",
       "       'acial Lipoatrophy', 'Percutaneous Coronary Intervention',\n",
       "       'Hepatitis B Prevention', 'Tuberculosis, Active',\n",
       "       'Cerebrovascular Insufficiency', 'Head Injury',\n",
       "       'Anti NMDA Receptor Encephalitis', 'Nonoccupational Exposure',\n",
       "       'Gonadotropin Inhibition', 'unctional Gastric Disorder',\n",
       "       'Chronic Eosinophilic Leukemia', 'Acetaminophen Overdose',\n",
       "       'Duodenal Ulcer Prophylaxis', 'Paragonimus westermani, Lung Fluke',\n",
       "       'Alpha-1 Proteinase Inhibitor Deficiency', \"Cogan's Syndrome\",\n",
       "       'Uterine Bleeding', 'Stomach Cancer', 'Sporotrichosis',\n",
       "       'Cluster-Tic Syndrome', 'Gestational Diabetes',\n",
       "       'Stress Ulcer Prophylaxis',\n",
       "       'Reversal of Nondepolarizing Muscle Relaxants', 'Solid Tumors',\n",
       "       'Schnitzler Syndrome', 'Hypocalcemia',\n",
       "       'Meningococcal Meningitis Prophylaxis', 'Nocardiosis',\n",
       "       'Hemophilia B', 'Microscopic polyangiitis',\n",
       "       'Gonococcal Infection, Disseminated', 'Neurotic Depression',\n",
       "       'Keratitis', \"Hodgkin's Lymphoma\", 'STD Prophylaxis',\n",
       "       'Small Bowel or Pancreatic Fistula',\n",
       "       'Prevention of Perinatal Group B Streptococcal Disease',\n",
       "       'Cerebral Edema', 'Testicular Cancer', 'Short Stature for Age',\n",
       "       'Aspergillosis, Aspergilloma', 'Pemphigoid',\n",
       "       'Hyperparathyroidism Secondary to Renal Impairment',\n",
       "       'Ramsay Hunt Syndrome', 'Cutaneous Larva Migrans',\n",
       "       'Occipital Neuralgia', 'Blepharitis', 'Patent Ductus Arteriosus',\n",
       "       'Joint Infection', 'Manscaping Pain', 'Strabismus',\n",
       "       'Organ Transplant, Rejection Reversal',\n",
       "       'Leukocytoclastic Vasculitis', 'Coronary Artery Disease',\n",
       "       'Gastric Cancer', 'ibrocystic Breast Disease',\n",
       "       'ungal Infection Prophylaxis', 'Short Stature', 'Hypercalcemia',\n",
       "       'Coccidioidomycosis', 'Cyclitis', 'Anemia, Chemotherapy Induced',\n",
       "       'Upper Limb Spasticity', 'Diagnostic Bronchograms',\n",
       "       'Neoplastic Diseases', 'Mycoplasma Pneumonia',\n",
       "       'Linear IgA Disease', 'Subarachnoid Hemorrhage',\n",
       "       'Myeloproliferative Disorders', 'ungal Pneumonia', 'Scleroderma',\n",
       "       'Zollinger-Ellison Syndrome', 'Tinea Barbae',\n",
       "       'Acute Nonlymphocytic Leukemia', 'Neutropenia', 'Rat-bite Fever',\n",
       "       'Uveitis, Posteri', 'Premature Ejaculation',\n",
       "       'Polymyositis/Dermatomyositis', 'Corneal Refractive Surgery',\n",
       "       'Gastrointestinal Hemorrhage', 'Bacteremia', 'Jet Lag',\n",
       "       'Follicle Stimulation', 'Myotonia Congenita', 'Aplastic Anemia',\n",
       "       'Hemorrhoids (pramoxine / zinc oxide)',\n",
       "       'Salmonella Gastroenteritis', 'Somat',\n",
       "       'Nausea (phosphorated carbohydrate solution)',\n",
       "       'Occupational Exposure', 'Tympanostomy Tube Placement Surgery',\n",
       "       'Pulmonary Edema', 'Mantle Cell Lymphoma',\n",
       "       'Lyme Disease, Erythema Chronicum Migrans',\n",
       "       'Renal Tubular Acidosis', 'Yellow Fever Prophylaxis',\n",
       "       'Acute Otitis Externa',\n",
       "       'Steroid Responsive Inflammatory Conditions',\n",
       "       'Pertussis Prophylaxis'], dtype=object)"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "repl_dict1 = {\n",
    "    'emale Infertility': 'Female Infertility',\n",
    "    'atigue':'Fatigue',\n",
    "    'Not Listed / Othe': 'Not Listed Other',\n",
    "    'moterol)':'Formoterol Mometasone',\n",
    "    't Pac with Cyclobenzaprine (cyclobenzaprine)':\n",
    "    'Comfort Pac with Cyclobenzaprine',\n",
    "    'zen Shoulde': 'Frozen Shoulder',\n",
    "    'mis': 'Mist',\n",
    "    'tic (mycophenolic acid)': 'Mycophenolic Acid',\n",
    "    'ailure to Thrive': 'Failure To Thrive',\n",
    "    'm Pain Disorde': 'Pain Disorder',\n",
    "    'mist (': 'Mist',\n",
    "    'me': 'Mist',\n",
    "    'lic Acid Deficiency': 'Folic Acid Deficiency',\n",
    "    'min / saxagliptin)': 'Metformin Saxagliptin',\n",
    "    'ge HCT (amlodipine / hydrochlorothiazide / valsartan)':\n",
    "    'Amlodipine Hydrochlorothiazide Valsartan',\n",
    "    'moterol / mometasone)':'Formoterol Mometasone',\n",
    "    'eve':'Fever',\n",
    "    'mance Anxiety':'Performance Anxiety',\n",
    "    'min)':'Metformin Saxagliptin',\n",
    "    'ge (amlodipine / valsartan)':'Amlodipine Valsartan',\n",
    "    'min / rosiglitazone)':'Metformin Rosiglitazone',\n",
    "    'llicular Lymphoma':'Follicular Lymphoma',\n",
    "    'min / pioglitazone)':'Metformin Pioglitazone',\n",
    "    'Pe':\"Performance Anxiety\",\n",
    "    't Care':'Urgent Care',\n",
    "    'llicle Stimulation':'Follicle Stimulation',\n",
    "}\n",
    "\n",
    "df.replace({\"condition\": repl_dict1},inplace=True)\n",
    "repl_dict = {\" Disorde$\":' Disorder', 'Cance$': 'Cancer',' Cance$': ' Cancer',' Tum$':' Tumor', ' Feve$':' Fever',' Ulce$': ' Ulcer', ' Bladde$':' Bladder'}\n",
    "df.replace({\"condition\": repl_dict},regex= True,inplace=True)\n",
    "df.condition.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "7b8ed32c-5e4f-4042-9f0b-1b6cd46f8b6a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import string\n",
    "def remove_punctuations(text):\n",
    "    for punctuation in string.punctuation:\n",
    "        text = text.replace(punctuation, '')\n",
    "    return text.lower()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "0f94b867-9ece-4b6e-964c-6c704945db16",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['left ventricular dysfunction', 'adhd', 'birth control',\n",
       "       'opiate dependence', 'benign prostatic hyperplasia',\n",
       "       'emergency contraception', 'bipolar disorder', 'epilepsy',\n",
       "       'migraine prevention', 'depression', 'crohns disease', 'cough',\n",
       "       'obesity', 'urinary tract infection', 'ibromyalgia',\n",
       "       'chronic myelogenous leukemia', 'hiv infection', 'insomnia',\n",
       "       'rheumatoid arthritis', 'vaginal yeast infection',\n",
       "       'chlamydia infection', 'hirsutism', 'panic disorder', 'migraine',\n",
       "       'pain', 'irritable bowel syndrome', 'osteoarthritis',\n",
       "       'constipation', 'bowel preparation', 'psychosis', 'muscle spasm',\n",
       "       'hepatitis c', 'overactive bladder', 'diabetes type 2',\n",
       "       'asthma maintenance', 'nonsmall cell lung cancer', 'schizophrenia',\n",
       "       'dysuria', 'smoking cessation', 'anxiety', 'acne',\n",
       "       'female infertility', 'constipation acute',\n",
       "       'constipation drug induced', 'erectile dysfunction',\n",
       "       'trigeminal neuralgia', 'underactive thyroid', 'chronic pain',\n",
       "       'atrophic vaginitis', 'skin and structure infection', 'tinnitus',\n",
       "       'major depressive disorder', 'anxiety and stress', 'rosacea',\n",
       "       'high blood pressure', 'restless legs syndrome',\n",
       "       'osteolytic bone metastases of solid tumors', 'bronchitis',\n",
       "       'skin or soft tissue infection', 'obsessive compulsive disorder',\n",
       "       'endometriosis', 'keratoconjunctivitis sicca', 'breakthrough pain',\n",
       "       'seizures', 'neuropathic pain', 'sedation', 'menstrual disorders',\n",
       "       'allergic rhinitis', 'anesthesia',\n",
       "       'undifferentiated connective tissue disease', 'diabetes type 1',\n",
       "       'abnormal uterine bleeding', 'weight loss', 'constipation chronic',\n",
       "       'breast cancer metastatic', 'period pain',\n",
       "       'helicobacter pylori infection', 'atrial fibrillation',\n",
       "       'uterine fibroids', 'kidney infections',\n",
       "       'generalized anxiety disorder', 'asthma',\n",
       "       'postmenopausal symptoms', 'high cholesterol', 'hypogonadism male',\n",
       "       'hyperthyroidism', 'back pain', 'anaplastic oligodendroglioma',\n",
       "       'sjogrens syndrome', 'asthma acute', 'hot flashes',\n",
       "       'herpes simplex suppression', 'bacterial infection', 'bursitis',\n",
       "       'diaper rash', 'systemic mastocytosis', 'trichotillomania',\n",
       "       'hashimotos disease', 'eczema', 'dental abscess', 'headache',\n",
       "       'hypersomnia', 'xerostomia', 'breast cancer', 'sore throat',\n",
       "       'barretts esophagus', 'painfeve', 'diverticulitis', 'sinusitis',\n",
       "       'polycystic ovary syndrome', 'influenza',\n",
       "       'hypothyroidism after thyroid removal', 'onychomycosis toenail',\n",
       "       'progesterone insufficiency', 'gerd',\n",
       "       'nauseavomiting postoperative', 'herpes simplex', 'gastroparesis',\n",
       "       'gout acute', 'motion sickness', 'multiple sclerosis', 'autism',\n",
       "       'otitis media', 'upper respiratory tract infection',\n",
       "       'surgical prophylaxis', 'psoriatic arthritis',\n",
       "       'erosive esophagitis', 'premature ventricular depolarizations',\n",
       "       'stomach ulcer', 'nauseavomiting', 'light anesthesia',\n",
       "       'angina pectoris prophylaxis', 'paranoid disorder', 'prostatitis',\n",
       "       'extrapyramidal reaction', 'performance anxiety', 'night terrors',\n",
       "       'high cholesterol familial heterozygous', 'spondyloarthritis',\n",
       "       'clostridial infection', 'dermatomyositis', 'bronchiectasis',\n",
       "       'nasal congestion', 'benign essential trem', 'angina',\n",
       "       'formoterol mometasone', 'impetig', 'conjunctivitis bacterial',\n",
       "       'post traumatic stress disorder', 'alcohol withdrawal',\n",
       "       'psoriasis', 'cold sores', 'hyperhidrosis',\n",
       "       'ankylosing spondylitis', 'hemorrhoids',\n",
       "       'schizoaffective disorder', 'not listed other', 'rhinitis',\n",
       "       'oral thrush', 'hyperlipoproteinemia',\n",
       "       'neutropenia associated with chemotherapy', 'osteoporosis',\n",
       "       'reflex sympathetic dystrophy syndrome', 'urticaria', 'narcolepsy',\n",
       "       'systemic lupus erythematosus', 'ulcerative colitis',\n",
       "       'adult human growth hormone deficiency', 'bacterial vaginitis',\n",
       "       'copd maintenance', 'anorexia', 'tsh suppression',\n",
       "       'breast cancer adjuvant', 'glaucoma', 'cough and nasal congestion',\n",
       "       'inflammatory conditions', 'urinary incontinence', 'gout',\n",
       "       'bladder infection', 'human papillomavirus prophylaxis',\n",
       "       'glioblastoma multiforme', 'strep throat',\n",
       "       'bacterial skin infection', 'hereditary angioedema',\n",
       "       'cold symptoms', 'labor pain', 'dry skin', 'diabetes insipidus',\n",
       "       'methicillinresistant staphylococcus aureus infection',\n",
       "       'borderline personality disorder', 'amenorrhea', 'pneumonia',\n",
       "       'seborrheic dermatitis', 'interstitial cystitis',\n",
       "       'malaria prevention', 'prevention of dental caries',\n",
       "       'herbal supplementation', 'plaque psoriasis', 'raynauds syndrome',\n",
       "       'addisons disease', 'prostate cancer', 'allergies',\n",
       "       'opioidinduced constipation', 'diarrhea',\n",
       "       'seasonal allergic conjunctivitis', 'opioid overdose',\n",
       "       'spondylolisthesis', 'shift work sleep disorder',\n",
       "       'obstructive sleep apneahypopnea syndrome',\n",
       "       'nauseavomiting of pregnancy', 'mucositis',\n",
       "       'ulcerative colitis active', 'head lice', 'tonsillitispharyngitis',\n",
       "       'pseudotumor cerebri', 'parkinsons disease', 'sciatica', 'cancer',\n",
       "       'bacterial endocarditis prevention', 'diarrhea chronic',\n",
       "       'hypertensive emergency', 'keratosis', 'ovarian cysts',\n",
       "       'behcets disease', 'chronic idiopathic constipation',\n",
       "       'folic acid deficiency', 'chronic fatigue syndrome',\n",
       "       'basal cell carcinoma', 'cataplexy', 'crohns disease maintenance',\n",
       "       'diabetic peripheral neuropathy', 'arrhythmia',\n",
       "       'primary ovarian failure', 'influenza prophylaxis',\n",
       "       'agitated state', 'heart failure', 'fatigue', 'opiate withdrawal',\n",
       "       'endometrial hyperplasia prophylaxis', 'immunosuppression',\n",
       "       'dystonia', 'alopecia', 'vulvodynia',\n",
       "       'premenstrual dysphoric disorder', 'alcohol dependence',\n",
       "       'myasthenia gravis', 'social anxiety disorder',\n",
       "       'atopic dermatitis', 'schistosoma japonicum', 'sinus symptoms',\n",
       "       'min  sitagliptin', 'dermatitis', 'eye redness', 'warts',\n",
       "       'menorrhagia', 'seizure prevention', 'ophthalmic surgery',\n",
       "       'skin rash', 'condylomata acuminata',\n",
       "       'nsaidinduced ulcer prophylaxis', 'tinea versicol',\n",
       "       'peripheral neuropathy', 'deep vein thrombosis', 'heart attack',\n",
       "       'pulmonary embolism recurrent event', 'light sedation',\n",
       "       'acute lymphoblastic leukemia', 'hyperprolactinemia',\n",
       "       'indigestion', 'hepatitis b', 'dysautonomia', 'status epilepticus',\n",
       "       'postpartum depression', 'multiple myeloma',\n",
       "       'prevention of hypokalemia', 'edema', 'urinary retention',\n",
       "       'prevention of thromboembolism in atrial fibrillation',\n",
       "       'cluster headaches', 'sexual dysfunction ssri induced',\n",
       "       'dermatitis herpetiformis', 'temporomandibular joint disorder',\n",
       "       'burns external', 'actinic keratosis', 'pharyngitis',\n",
       "       'melanoma metastatic', 'atrial flutte', 'lyme disease',\n",
       "       'dry eye disease', 'allergic reactions', 'hypertriglyceridemia',\n",
       "       'pruritus', 'carcinoid tumor', 'muscle pain', 'colorectal cancer',\n",
       "       'vitaminmineral supplementation during pregnancylactation',\n",
       "       'nauseavomiting chemotherapy induced', 'women oxybutynin',\n",
       "       'primary immunodeficiency syndrome',\n",
       "       'new daily persistent headache',\n",
       "       'pneumococcal disease prophylaxis', 'burning mouth syndrome',\n",
       "       'urinary tract stones', 'pseudobulbar affect',\n",
       "       'eye rednessitching', 'deep vein thrombosis first event',\n",
       "       'pulmonary hypertension', 'malaria', 'sarcoidosis',\n",
       "       'dietary supplementation', 'bulimia', 'tendonitis', 'nasal polyps',\n",
       "       'hypokalemia', 'anemia sickle cell', 'uveitis',\n",
       "       'streptococcal infection', 'perimenopausal symptoms',\n",
       "       'asperger syndrome', 'tinea corporis', 'mania',\n",
       "       'renal cell carcinoma', 'copd', 'biliary cirrhosis', 'vertig',\n",
       "       'reversal of opioid sedation', 'nonhodgkins lymphoma',\n",
       "       'high cholesterol familial homozygous',\n",
       "       'periodic limb movement disorder', 'supraventricular tachycardia',\n",
       "       'hypoestrogenism', 'juvenile idiopathic arthritis', 'swine flu',\n",
       "       'giardiasis', 'binge eating disorder', 'tourettes syndrome',\n",
       "       'trichomoniasis', 'acial wrinkles', 'pulmonary embolism',\n",
       "       'conjunctivitis allergic', 'avian influenza', 'hemangioma',\n",
       "       'nocturnal leg cramps', 'thyroid suppression test',\n",
       "       'muscle twitching', 'pupillary dilation', 'lennoxgastaut syndrome',\n",
       "       'opiate adjunct', 'postoperative pain',\n",
       "       'candida urinary tract infection', 'cerebral spasticity',\n",
       "       'lipodystrophy', 'androgenetic alopecia', 'computed tomography',\n",
       "       'mitral valve prolapse', 'vitamin d deficiency',\n",
       "       'glaucoma open angle', 'endoscopy or radiology premedication',\n",
       "       'alzheimers disease', 'gouty arthritis',\n",
       "       'paroxysmal supraventricular tachycardia',\n",
       "       'deep vein thrombosis prophylaxis', 'gaucher disease',\n",
       "       'lymphocytic colitis', 'pancreatic cancer', 'cystic fibrosis',\n",
       "       'noninfectious colitis', 'nephrocalcinosis',\n",
       "       'iron deficiency anemia', 'mulation phenylephrine', 'hiccups',\n",
       "       'bronchospasm prophylaxis', 'chronic spasticity',\n",
       "       'metformin saxagliptin', 'postcholecystectomy diarrhea',\n",
       "       'postherpetic neuralgia', 'insomnia stimulantassociated',\n",
       "       'copd acute', 'herpes simplex dendritic keratitis', 'oophorectomy',\n",
       "       'cyclic vomiting syndrome', 'chronic lymphocytic leukemia',\n",
       "       'lyme disease arthritis', 'pseudomembranous colitis',\n",
       "       'conjunctivitis', 'intraocular hypertension', 'aphthous ulcer',\n",
       "       'ulcerative colitis maintenance', 'melasma',\n",
       "       'lyme disease neurologic', 'amlodipine valsartan', 'herpes zoste',\n",
       "       'cervical dystonia', 'labor induction', 'human papilloma virus',\n",
       "       'chronic pancreatitis', 'polycythemia vera',\n",
       "       'dermatological disorders', 'lewy body dementia',\n",
       "       'amilial mediterranean fever', 'neurosurgery', 'gastroenteritis',\n",
       "       'macular edema', 'tinea pedis', 'diagnosis and investigation',\n",
       "       'gas', 'neuralgia', 'local anesthesia', 'acute coronary syndrome',\n",
       "       'aspiration pneumonia', 'idiopathic thrombocytopenic purpura',\n",
       "       'onychomycosis fingernail', 'photoaging of the skin',\n",
       "       'premature lab', 'precocious puberty',\n",
       "       'prevention of bladder infection', 'seasonal affective disorder',\n",
       "       'diabetic kidney disease', 'crohns disease acute',\n",
       "       'insulin resistance syndrome', 'pudendal neuralgia',\n",
       "       'reiters syndrome', 'amyotrophic lateral sclerosis',\n",
       "       'body dysmorphic disorder',\n",
       "       'prosthetic heart valves mechanical valves  thrombosis prophylaxis',\n",
       "       'dandruff', 'vitamin b12 deficiency', 'bone infection',\n",
       "       'prosthetic heart valves tissue valves  thrombosis prophylaxis',\n",
       "       'iritis', 'allergic urticaria', 'cardiovascular risk reduction',\n",
       "       'giant cell tumor of bone', 'babesiosis',\n",
       "       'secondary hyperparathyroidism', 'hypoparathyroidism', 'abortion',\n",
       "       'skin cancer', 'ovulation induction',\n",
       "       'liver magnetic resonance imaging',\n",
       "       'vitaminmineral supplementation and deficiency',\n",
       "       'herpes simplex mucocutaneousimmunocompetent host',\n",
       "       'anemia associated with chronic renal failure',\n",
       "       'hyperphosphatemia of renal failure',\n",
       "       'dissociative identity disorder', 'anal fissure and fistula',\n",
       "       'herpes simplex mucocutaneousimmunocompromised host', 'scabies',\n",
       "       'endometrial cancer', 'transient ischemic attack',\n",
       "       'granuloma annulare', 'travelers diarrhea', 'candidemia',\n",
       "       'comfort pac with cyclobenzaprine',\n",
       "       'hypoactive sexual desire disorder', 'epicondylitis tennis elbow',\n",
       "       'nightmares', 'dientamoeba fragilis', 'ventricular tachycardia',\n",
       "       'dumping syndrome', 'myelodysplastic syndrome', 'hypodermoclysis',\n",
       "       'frozen shoulder', 'topical disinfection', 'perioral dermatitis',\n",
       "       'agitation', 'intermittent claudication',\n",
       "       'prevention of osteoporosis', 'leukemia', 'dermatitis herpeti',\n",
       "       'mist', 'eosinophilic esophagitis',\n",
       "       'hyperlipoproteinemia type iia elevated ldl',\n",
       "       'endometrial hyperplasia', 'peptic ulcer',\n",
       "       'chronic myofascial pain', 'enterocolitis',\n",
       "       'secondary cutaneous bacterial infections', 'syringomyelia',\n",
       "       'postoperative ocular inflammation',\n",
       "       'persistent depressive disorder', 'otitis externa',\n",
       "       'organ transplant rejection prophylaxis',\n",
       "       'intermittent explosive disorder', 'dermatophytosis',\n",
       "       'inflammatory bowel disease', 'porphyria', 'anemia',\n",
       "       'hyperuricemia secondary to chemotherapy',\n",
       "       'wolffparkinsonwhite syndrome', 'fever', 'ectopic pregnancy',\n",
       "       'thyroid cancer', 'tuberculosis latent',\n",
       "       'nasal carriage of staphylococcus aureus', 'systemic candidiasis',\n",
       "       'ear wax impaction', 'hepatocellular carcinoma', 'dyspareunia',\n",
       "       'tic disorder', 'head and neck cancer', 'klinefelter syndrome',\n",
       "       'rhinorrhea', 'soft tissue sarcoma', 'diabetic macular edema',\n",
       "       'menopausal disorders', 'anesthetic adjunct', 'tinea cruris',\n",
       "       'mycophenolic acid', 'ischemic stroke', 'malignant glioma',\n",
       "       'thrombocythemia', 'atrophic urethritis', 'systemic sclerosis',\n",
       "       'macular degeneration', 'aids related wasting', 'hemophilia a',\n",
       "       'osteolytic bone lesions of multiple myeloma',\n",
       "       'autoimmune hemolytic anemia', 'failure to thrive',\n",
       "       'strongyloidiasis', 'vitamin k deficiency', 'ulcerative proctitis',\n",
       "       'premenstrual syndrome', 'primary hyperaldosteronism',\n",
       "       'lactose intolerance', 'anal itching',\n",
       "       'amilial cold autoinflammatory syndrome', 'duodenal ulcer',\n",
       "       'tuberculosis prophylaxis', 'neurosis', 'turners syndrome',\n",
       "       'nsaidinduced gastric ulcer', 'cns magnetic resonance imaging',\n",
       "       'atherosclerosis',\n",
       "       'deep vein thrombosis prophylaxis after hip replacement surgery',\n",
       "       'gastritisduodenitis', 'diarrhea acute', 'costochondritis',\n",
       "       'portal hypertension', 'glaucomaintraocular hypertension',\n",
       "       'toothache', 'benzodiazepine withdrawal', 'pain disorder',\n",
       "       'esophageal candidiasis',\n",
       "       'deep vein thrombosis prophylaxis after knee replacement surgery',\n",
       "       'peripheral arterial disease',\n",
       "       'deep vein thrombosis recurrent event', 'pseudogout prophylaxis',\n",
       "       'lichen planus', 'cmv prophylaxis', 'neuritis', 'typhoid fever',\n",
       "       'tardive dyskinesia', 'ichthyosis',\n",
       "       'juvenile rheumatoid arthritis', 'b12 nutritional deficiency',\n",
       "       'primary nocturnal enuresis', 'dercums disease',\n",
       "       'cutaneous candidiasis', 'gingivitis', 'q fever', 'hyperekplexia',\n",
       "       'niacin deficiency', 'dietary fiber supplementation',\n",
       "       'nephrotic syndrome', 'pinworm infection enterobius vermicularis',\n",
       "       'pancreatic exocrine dysfunction',\n",
       "       'nauseavomiting radiation induced', 'schilling test',\n",
       "       'mild cognitive impairment', 'ischemic stroke prophylaxis',\n",
       "       'gonococcal infection uncomplicated', 'ovarian cancer',\n",
       "       'eyelash hypotrichosis', 'menieres disease', 'tinea capitis',\n",
       "       'lichen sclerosus', 'metformin pioglitazone', 'renal transplant',\n",
       "       'gout prophylaxis', 'von willebrands disease',\n",
       "       'prevention of atherothrombotic events', 'small fiber neuropathy',\n",
       "       'metformin rosiglitazone', 'peyronies disease',\n",
       "       'autoimmune hepatitis', 'follicular lymphoma',\n",
       "       'auditory processing disorder', 'herpes zoster prophylaxis',\n",
       "       'submental fullness', 'lactation augmentation',\n",
       "       'radionuclide myocardial perfusion study',\n",
       "       'prevention of cardiovascular disease', 'varicellazoste',\n",
       "       'pelvic inflammatory disease', 'intraabdominal infection', 'croup',\n",
       "       'dermatologic lesion',\n",
       "       'hyperlipoproteinemia type iv elevated vldl', 'expectoration',\n",
       "       'primary hyperaldosteronism diagnosis', 'abdominal distension',\n",
       "       'salivary gland cancer', 'pulmonary embolism first event',\n",
       "       'postpartum breast pain',\n",
       "       'postural orthostatic tachycardia syndrome',\n",
       "       'pediatric growth hormone deficiency', 'hypomagnesemia',\n",
       "       'amlodipine hydrochlorothiazide valsartan', 'hairy cell leukemia',\n",
       "       'histoplasmosis', 'hypoglycemia', 'brain tumor',\n",
       "       'gastrointestinal stromal tumor', 'tetanus',\n",
       "       'breast cancer prevention', 'icu agitation', 'women minoxidil',\n",
       "       'peripheral tcell lymphoma',\n",
       "       'chronic inflammatory demyelinating polyradiculoneuropathy',\n",
       "       'pathological hypersecretory conditions',\n",
       "       'oral and dental conditions', 'antiphospholipid syndrome',\n",
       "       'ventricular arrhythmia', 'asystole', 'wegeners granulomatosis',\n",
       "       'thromboembolic stroke prophylaxis',\n",
       "       'platelet aggregation inhibition', 'sleep paralysis',\n",
       "       'rejection prophylaxis', 'delayed puberty male', 'ascariasis',\n",
       "       'acute promyelocytic leukemia', 'bartonellosis',\n",
       "       'cyclothymic disorder', 'hypokalemic periodic paralysis',\n",
       "       'varicose veins', 'mononucleosis', 'cachexia', 'hyperkalemia',\n",
       "       'stills disease', 'dementia', 'ocular rosacea',\n",
       "       'hidradenitis suppurativa', 'siadh', 'bullous pemphigoid',\n",
       "       'angioedema', 'mountain sickness  altitude sickness',\n",
       "       'severe mood dysregulation', 'cutaneous tcell lymphoma',\n",
       "       'adrenocortical insufficiency', 'myxedema coma',\n",
       "       'small bowel bacterial overgrowth', 'sunburn',\n",
       "       'transverse myelitis', 'squamous cell carcinoma', 'parkinsonism',\n",
       "       'thyrotoxicosis', 'epididymitis sexually transmitted', 'neck pain',\n",
       "       'bleeding disorder', 'actor ix deficiency', 'melanoma',\n",
       "       'thrombocytopenia', 'esophageal variceal hemorrhage prophylaxis',\n",
       "       'glioblastoma multi', 'cholera', 'anorexiafeeding problems',\n",
       "       'peritonitis', 'av heart block', 'wilsons disease',\n",
       "       'nonalcoholic fatty liver disease', 'sepsis', 'anthrax',\n",
       "       'body imaging', 'aggressive behavi', 'hepatic tumor',\n",
       "       'ehrlichiosis', 'hypopituitarism', 'gender dysphoria',\n",
       "       'infectious diarrhea', 'ventricular fibrillation', 'anaphylaxis',\n",
       "       'pemphigus', 'multiple endocrine adenomas',\n",
       "       'preexposure prophylaxis',\n",
       "       'postoperative increased intraocular pressure',\n",
       "       'pruritus of partial biliary obstruction', 'pertussis',\n",
       "       'periodontitis', 'lymphoma', 'hypercalcemia of malignancy',\n",
       "       'pityriasis rubra pilaris', 'amebiasis', 'urgent care',\n",
       "       'hepatic encephalopathy', 'deep neck infection',\n",
       "       'meningitis meningococcal', 'parkinsonian trem',\n",
       "       'rabies prophylaxis', 'hypotension', 'myelofibrosis',\n",
       "       'cal segmental glomerulosclerosis',\n",
       "       'gastric ulcer maintenance treatment', 'pagets disease',\n",
       "       'infection prophylaxis', 'gastrointestinal decontamination',\n",
       "       'mixed connective tissue disease', 'somatoform pain disorder',\n",
       "       'esophageal spasm', 'campylobacter gastroenteritis',\n",
       "       'hyperphosphatemia', 'oligospermia', 'wound cleansing',\n",
       "       'euvolemic hyponatremia', 'gallbladder disease',\n",
       "       'mycobacterium aviumintracellulare treatment',\n",
       "       'oppositional defiant disorder', 'legionella pneumonia',\n",
       "       'breast cancer palliative', 'hydrocephalus',\n",
       "       'hyperlipoproteinemia type iii elevated betavldl   idl',\n",
       "       'anaplastic astrocytoma', 'dupuytrens contracture',\n",
       "       'mumps prophylaxis', 'skin disinfection preoperative',\n",
       "       'hyperbilirubinemia', 'meningitis', 'corneal ulcer',\n",
       "       'acial lipoatrophy', 'percutaneous coronary intervention',\n",
       "       'hepatitis b prevention', 'tuberculosis active',\n",
       "       'cerebrovascular insufficiency', 'head injury',\n",
       "       'anti nmda receptor encephalitis', 'nonoccupational exposure',\n",
       "       'gonadotropin inhibition', 'unctional gastric disorder',\n",
       "       'chronic eosinophilic leukemia', 'acetaminophen overdose',\n",
       "       'duodenal ulcer prophylaxis', 'paragonimus westermani lung fluke',\n",
       "       'alpha1 proteinase inhibitor deficiency', 'cogans syndrome',\n",
       "       'uterine bleeding', 'stomach cancer', 'sporotrichosis',\n",
       "       'clustertic syndrome', 'gestational diabetes',\n",
       "       'stress ulcer prophylaxis',\n",
       "       'reversal of nondepolarizing muscle relaxants', 'solid tumors',\n",
       "       'schnitzler syndrome', 'hypocalcemia',\n",
       "       'meningococcal meningitis prophylaxis', 'nocardiosis',\n",
       "       'hemophilia b', 'microscopic polyangiitis',\n",
       "       'gonococcal infection disseminated', 'neurotic depression',\n",
       "       'keratitis', 'hodgkins lymphoma', 'std prophylaxis',\n",
       "       'small bowel or pancreatic fistula',\n",
       "       'prevention of perinatal group b streptococcal disease',\n",
       "       'cerebral edema', 'testicular cancer', 'short stature for age',\n",
       "       'aspergillosis aspergilloma', 'pemphigoid',\n",
       "       'hyperparathyroidism secondary to renal impairment',\n",
       "       'ramsay hunt syndrome', 'cutaneous larva migrans',\n",
       "       'occipital neuralgia', 'blepharitis', 'patent ductus arteriosus',\n",
       "       'joint infection', 'manscaping pain', 'strabismus',\n",
       "       'organ transplant rejection reversal',\n",
       "       'leukocytoclastic vasculitis', 'coronary artery disease',\n",
       "       'gastric cancer', 'ibrocystic breast disease',\n",
       "       'ungal infection prophylaxis', 'short stature', 'hypercalcemia',\n",
       "       'coccidioidomycosis', 'cyclitis', 'anemia chemotherapy induced',\n",
       "       'upper limb spasticity', 'diagnostic bronchograms',\n",
       "       'neoplastic diseases', 'mycoplasma pneumonia',\n",
       "       'linear iga disease', 'subarachnoid hemorrhage',\n",
       "       'myeloproliferative disorders', 'ungal pneumonia', 'scleroderma',\n",
       "       'zollingerellison syndrome', 'tinea barbae',\n",
       "       'acute nonlymphocytic leukemia', 'neutropenia', 'ratbite fever',\n",
       "       'uveitis posteri', 'premature ejaculation',\n",
       "       'polymyositisdermatomyositis', 'corneal refractive surgery',\n",
       "       'gastrointestinal hemorrhage', 'bacteremia', 'jet lag',\n",
       "       'follicle stimulation', 'myotonia congenita', 'aplastic anemia',\n",
       "       'hemorrhoids pramoxine  zinc oxide', 'salmonella gastroenteritis',\n",
       "       'somat', 'nausea phosphorated carbohydrate solution',\n",
       "       'occupational exposure', 'tympanostomy tube placement surgery',\n",
       "       'pulmonary edema', 'mantle cell lymphoma',\n",
       "       'lyme disease erythema chronicum migrans',\n",
       "       'renal tubular acidosis', 'yellow fever prophylaxis',\n",
       "       'acute otitis externa',\n",
       "       'steroid responsive inflammatory conditions',\n",
       "       'pertussis prophylaxis'], dtype=object)"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"condition\"] = df['condition'].apply(remove_punctuations)\n",
    "df.condition.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "a9451226-d353-4ea1-961f-ddd1ab68a8fb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1000x600 with 0 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "rating_by_condition = df.groupby('condition').agg({'rating':'count'}).sort_values(by ='rating',ascending = False)\n",
    "rating_by_condition = rating_by_condition.nlargest(20, 'rating')\n",
    "# visualize the results\n",
    "plt.figure(figsize =(10,6))\n",
    "rating_by_condition.plot(kind='bar')\n",
    "plt.title('sum of rating by conditions')\n",
    "plt.xlabel('conditions')\n",
    "plt.ylabel('count of rating')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3d8daade-33c1-4f26-8d06-5c383379b264",
   "metadata": {},
   "source": [
    "The'birth control', 'depression','pain', 'anxiety' are the conditions have most of rating. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "fe97417d-f775-4b38-81d2-4383a8487b1c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3168\n",
      "['Valsartan', 'Guanfacine', 'Lybrel', 'Ortho Evra', 'Buprenorphine / naloxone', 'Cialis', 'Levonorgestrel', 'Aripiprazole', 'Keppra', 'Ethinyl estradiol / levonorgestrel', 'Topiramate', 'L-methylfolate', 'Pentasa', 'Dextromethorphan', 'Nexplanon', 'Liraglutide', 'Trimethoprim', 'Amitriptyline', 'Lamotrigine', 'Nilotinib', 'Atripla', 'Trazodone', 'Etonogestrel', 'Etanercept', 'Tioconazole', 'Azithromycin', 'Eflornithine', 'Daytrana', 'Ativan', 'Imitrex', 'Sertraline', 'Toradol', 'Viberzi', 'Mobic', 'Dulcolax', 'Morphine', 'MoviPrep', 'Trilafon', 'Fluconazole', 'Contrave', 'Clonazepam', 'Metaxalone', 'Venlafaxine', 'Ledipasvir / sofosbuvir', 'Symbyax', 'Tamsulosin', 'Doxycycline', 'Dulaglutide', 'Intuniv', 'Buprenorphine', 'Qvar', 'Opdivo', 'Pyridium', 'Latuda', 'Bupropion', 'Implanon', 'Effexor XR', 'Drospirenone / ethinyl estradiol', 'NuvaRing', 'Prepopik', 'Tretinoin', 'Gildess Fe 1 / 20', 'Ethinyl estradiol / norgestimate', 'Elbasvir / grazoprevir', 'Clomiphene', 'Docusate / senna', 'Amitiza', 'Sildenafil', 'Lo Loestrin Fe', 'Oxcarbazepine', 'Wellbutrin', \"Phillips' Milk of Magnesia\", 'Nature-Throid', 'Lithium', 'Oxycodone', 'Estradiol', 'Sronyx', 'Augmentin XR', 'Monistat 7-Day Combination Pack', 'Plan B One-Step', 'Alprazolam', 'Fluoxetine', 'Spironolactone', 'Fluvoxamine', 'Macrobid', 'Lurasidone', 'Adapalene / benzoyl peroxide', 'Brimonidine', 'Amlodipine / olmesartan', 'Linaclotide', 'Mirtazapine', 'Acetaminophen / hydrocodone', 'Isotretinoin', 'Ropinirole', 'Zoledronic acid', 'Lamictal', 'Buspirone', 'Propranolol', 'Focalin', 'Jolivette', 'Levofloxacin', 'Phentermine / topiramate', 'Cephalexin', 'Aviane', 'Saxenda', 'Clomipramine', 'Medroxyprogesterone', 'Aczone', 'Nicoderm CQ', 'Naltrexone', 'Restasis', 'Depo-Provera', 'Olanzapine', 'Oxytrol', 'Fentanyl', 'Epiduo', 'Accutane', 'Xanax', 'Desvenlafaxine', 'Lyrica', 'Phenergan', 'Loestrin 21 1 / 20', 'Loratadine', 'Cardura XL', 'Viibryd', 'Mirena', 'Ethinyl estradiol / norelgestromin', 'Propofol', 'Camphor / menthol', 'Hydroxychloroquine', 'Lorcaserin', 'Insulin degludec', 'Trintellix', 'Lupron Depot', 'Zanaflex', 'Miconazole', 'Opana ER', 'Provera', 'Diflucan', 'Ibrance', 'Reclipsen', 'Lisinopril', 'Empagliflozin', 'Naproxen', 'Amoxicillin / clarithromycin / lansoprazole', 'Metoprolol', 'Naloxegol', 'Skyla', 'Leuprolide', 'Ulipristal', 'Benzonatate', 'Sulfamethoxazole / trimethoprim', 'Eletriptan', 'Escitalopram', 'Dulera', 'Prempro', 'Gemfibrozil', 'Depakote', 'Testosterone', 'Zomig', 'Vyvanse', 'Solodyn', 'Efavirenz / emtricitabine / tenofovir', 'Methimazole', 'Ortho Tri-Cyclen', 'Aleve', 'Tylenol with Codeine #3', 'Victoza', 'Lubiprostone', 'Ethinyl estradiol / norethindrone', 'Sovaldi', 'Pristiq', 'Temozolomide', 'Nabumetone', 'Meloxicam', 'Cevimeline', 'ProAir RespiClick', 'Gabapentin', 'Relpax', 'Levomilnacipran', 'Valtrex', 'Clindamycin', 'BuSpar', 'Plan B', 'Trolamine salicylate', 'Lisdexamfetamine', 'Qsymia', 'Rizatriptan', 'Ziana', 'Boudreaux Butt Paste', 'Cymbalta', 'Zoloft', 'Tizanidine', 'Gastrocrom', 'Seasonique', 'Amphetamine / dextroamphetamine', 'Liletta', 'Exenatide', 'Paroxetine', 'Bontril Slow Release', 'Levothroid', 'Carbamazepine', 'Adipex-P', 'Bydureon', 'Bupropion / naltrexone', 'Voltaren-XR', 'Pimecrolimus', 'Acetaminophen / oxycodone', 'Monistat 7', 'Pramipexole', 'AndroGel', 'Nitrofurantoin', 'Metronidazole', 'Ziprasidone', 'Acetaminophen / butalbital / caffeine', 'Nuvigil', 'Moxifloxacin', 'Methadone', 'Celecoxib', 'Aspirin / butalbital / caffeine', 'Montelukast', 'Saliva substitutes', 'Atomoxetine', 'Anastrozole', 'Phenol', 'Duloxetine', 'Magnesium sulfate / potassium sulfate / sodium sulfate', 'Lansoprazole', 'Nardil', 'Milnacipran', 'Oxymorphone', 'Acetaminophen / aspirin / caffeine', 'Levora', 'ParaGard', 'Levaquin', 'Ciprofloxacin', 'Avelox', 'Acidophilus', 'Metformin', 'Terconazole', 'Saphris', 'Augmentin', 'Lexapro', 'Tamiflu', 'Prazosin', 'Liothyronine', 'Seroquel', 'Terbinafine', 'Valium', 'Norco', 'Progesterone', 'Concerta', 'Ocella', 'Strattera', 'Mylanta', 'TriNessa', 'Goserelin', 'Quetiapine', 'Testim', 'Emend', 'Methylphenidate', 'Acyclovir', 'Linzess', 'Orthovisc', 'Silodosin', 'Metoclopramide', 'Indomethacin', 'Copper', 'Meclizine', 'Gilenya', 'Microgestin Fe 1 / 20', 'Klonopin', 'Codeine / guaifenesin', 'Citalopram', 'Colazal', 'Fiorinal with Codeine', 'Zolpidem', 'Wellbutrin XL', 'Climara Pro', 'Clarithromycin', 'Bactrim DS', 'Varenicline', 'Amoxicillin / clavulanate', 'Tolterodine', 'Hydroxyzine', 'Blisovi Fe 1 / 20', 'Ramelteon', 'Infliximab', 'Rabeprazole', 'Dexilant', 'Immune globulin oral', 'Nucynta', 'Hysingla ER', 'Pantoprazole', 'Sprycel', 'Tri-Sprintec', 'Zofran', 'Versed', 'Cipro', 'MS Contin', 'Avonex', 'Focalin XR', 'Loestrin 24 Fe', 'Junel Fe 1 / 20', 'Imdur', 'Diazepam', 'Bisacodyl', 'Suvorexant', 'Risperidone', 'Sprintec', 'Risperdal', 'Simponi', 'Euflexxa', 'Diclofenac', 'Dimenhydrinate', 'Benztropine', 'Ortho Tri-Cyclen Lo', 'Ibuprofen', 'Sumatriptan', 'Polyethylene glycol 3350', 'Xenical', 'Glatiramer', 'Atarax', 'Orsythia', 'Alirocumab', 'Sublimaze', 'Ethinyl estradiol / etonogestrel', 'femhrt', 'Lortab', 'Haldol', 'Tapentadol', 'Ketorolac', 'Phentermine', 'Effexor', 'Remicade', 'Flexeril', 'SMZ-TMP DS', 'Dutasteride', 'Thyroid desiccated', 'Opana', 'Zyprexa', 'Vedolizumab', 'Chantix', 'Suboxone', 'Mirapex', 'Uribel', 'Vicks Sinex Nasal Spray (old formulation)', 'Bactrim', 'Depo-Provera Contraceptive', 'Ceftriaxone', 'Ranexa', 'Trulicity', 'Percocet', 'Sitagliptin', 'Formoterol / mometasone', 'Ambien', 'Belviq', 'Retapamulin', 'Vigamox', 'Levetiracetam', 'Yaz', 'Elidel', 'Abilify Discmelt', 'Delsym 12 Hour Cough Relief', 'Baclofen', 'Halobetasol', 'Azelastine / fluticasone', 'Drysol', 'Cimzia', 'Rexulti', 'Proctofoam', 'Cefdinir', 'Tramadol', 'Norflex', 'Humira', 'Tecfidera', 'Acetaminophen / dichloralphenazone / isometheptene mucate', 'Benzoyl peroxide / clindamycin', 'Methyl salicylate', 'Monistat 3-Day Combination Pack', 'Clindamycin / tretinoin', 'Flonase', 'Norethindrone', 'Alvesco', 'Nystatin', 'EContra EZ', 'TriCor', 'Diphenhydramine', 'Neulasta', 'Zolmitriptan', 'Minastrin 24 Fe', 'Levothyroxine', 'Mononessa', 'Differin', 'Ibandronate', 'Zithromax', 'Compazine', 'Topamax', 'Ustekinumab', 'Minocycline', 'Ultram ER', 'Nortriptyline', 'Pregabalin', 'Suprep Bowel Prep Kit', 'Armour Thyroid', 'Jolessa', 'Mirvaso', 'Atralin', 'Crestor', 'Rozerem', 'Cryselle', 'Sucralfate', 'Efinaconazole', 'Cetirizine', 'Amoxicillin', 'Soma', 'Neupro', 'Valacyclovir', 'Toprol-XL', 'Sodium oxybate', 'Mesalamine', 'Orlistat', 'Butorphanol', 'Humatrope', 'Diltiazem', 'Hydrocodone', 'Ritalin', 'Kapvay', 'Prozac', 'Vicodin', 'Falmina', 'Relafen', 'Restoril', 'Frovatriptan', 'Losartan', 'Sharobel', 'Xyrem', 'Apri', 'ella', 'Spiriva', 'Tasigna', 'Dupixent', 'Lorazepam', 'Cyproheptadine', 'Repatha', 'Docusate', 'Hydrochlorothiazide', 'Scopolamine', 'Flurbiprofen', 'Femara', 'Methotrexate', 'Hypercare', 'Epinephrine', 'Brimonidine / timolol', 'Mucinex D', 'Azor', 'Voltaren', 'Vortioxetine', 'Velivet', 'Necon 1 / 35', 'Seroquel XR', 'Detrol LA', 'Sporanox', 'Febuxostat', 'Eluxadoline', 'Neurontin', 'Ondansetron', 'Gardasil', 'Avastin', 'Paliperidone', 'Nora-Be', 'Penicillin v potassium', 'Tofacitinib', \"St. john's wort\", 'Rythmol SR', 'Vytorin', 'Dilaudid', 'Vilazodone', 'Librium', 'Duac', 'Dapsone', 'Vicodin ES', 'Hydromorphone', 'Zyban', 'Ranitidine', 'Arava', 'Adderall', 'Ruconest', 'Pseudoephedrine / triprolidine', 'Etodolac', 'Emsam', 'Diovan', 'Ammonium lactate', 'Desmopressin', 'Zepatier', 'Magnesium hydroxide', 'Butrans', 'Botox', 'Azelastine', 'Xalkori', 'Zyvox', 'Rocephin', 'Kyleena', 'Toujeo', 'Dexlansoprazole', 'Brexpiprazole', 'Roxicodone Intensol', 'Reglan', 'Divalproex sodium', 'Tindamax', 'Camrese', 'MetroGel-Vaginal', 'Tadalafil', 'Flecainide', 'Junel Fe 1.5 / 30', 'Flagyl', 'Ovace Plus', 'Secobarbital', 'Empagliflozin / linagliptin', 'Raltegravir', 'Ampyra', 'Celebrex', 'Colchicine', 'Geodon', 'Aluminum chloride hexahydrate', 'Tryptophan', 'Myrbetriq', 'Malarone', 'Fetzima', 'Omeprazole', 'Fluoride', 'Jardiance', 'Turmeric', 'Desogestrel / ethinyl estradiol', 'Secukinumab', 'Ethinyl estradiol / norgestrel', 'Nifedipine', 'Celexa', 'Prednisone', 'Methocarbamol', 'Haldol Decanoate', 'Beyaz', 'Taclonex', 'Decadron', 'Vardenafil', 'Oxazepam', 'Dexmethylphenidate', 'Firmagon', 'Phenazopyridine', 'Tiotropium', 'Savella', 'Cataflam', 'Cobicistat / elvitegravir / emtricitabine / tenofovir', 'Ramipril', 'Relistor', 'Paxil', 'Stelara', 'Cambia', 'Ezetimibe', 'Mefenamic acid', 'Budesonide / formoterol', 'Doryx', 'Dymista', 'Omalizumab', 'Lunesta', 'Mometasone', 'Phenylephrine', 'VESIcare', 'Kapidex', 'Errin', 'Lomotil', 'Clomid', 'Clozapine', 'Olopatadine', 'Narcan Injection', 'Mirabegron', 'Wellbutrin SR', 'Tinidazole', 'Asenapine', 'Penicillin VK', 'Oxymetazoline', 'EpiCeram', 'Temazepam', 'Oxybutynin', 'Armodafinil', 'Epclusa', 'Dalfampridine', 'OnabotulinumtoxinA', 'Doxylamine / pyridoxine', 'Estarylla', 'Vancomycin', 'Naproxen / sumatriptan', 'Fastin', 'Protonix', 'Bazedoxifene / conjugated estrogens', 'Chloral hydrate', 'Lialda', 'Maxalt', 'Denosumab', 'Boniva', 'Sklice', 'Acetazolamide', 'Clinpro 5000', 'Zelapar', 'Desloratadine', 'Cyclobenzaprine', 'Docosanol', 'Acetaminophen', 'Chaparral', 'Hyaluronan', 'Polyethylene glycol 3350 with electrolytes', 'Mestranol / norethindrone', 'Melatonin', 'Symbicort', 'Lutera', 'Emollients', 'Colesevelam', 'Zyclara', 'Aspirin / caffeine', 'Abreva', 'Isocarboxazid', 'Correctol', 'Plecanatide', 'Xarelto', 'Prevacid', 'Simvastatin', 'Carbatrol', 'Dapagliflozin', 'Tresiba', 'Oracea', 'Abilify', 'Meperidine', 'Tamoxifen', 'Harvoni', 'Imiquimod', 'Trospium', 'Limbitrol', 'Zegerid', 'Diethylpropion', 'Limbrel', 'Verapamil', 'Premarin', 'Pentazocine', 'Apremilast', 'Ciclesonide', 'Canagliflozin', 'Megestrol', 'LoSeasonique', 'Otezla', 'Zenzedi', 'Phosphorated carbohydrate solution', 'Influenza virus vaccine, live, trivalent', 'Deplin', 'Methylprednisolone', 'Invega', 'Cutar', 'Serzone', 'Biaxin XL', 'Coreg', 'Ortho Cyclen', 'Lorcet 10 / 650', 'Letrozole', 'Cefuroxime', 'Sectral', 'Belladonna / opium', 'Flomax', 'My Way', 'Belsomra', 'Adapalene', 'Promethazine', 'Fentanyl Transdermal System', 'Desoxyn', 'Tegretol', 'Oseltamivir', 'Kombiglyze XR', 'Minoxidil', 'Enbrel', 'Adalimumab', 'Xulane', 'Elavil', 'Endocet', 'Unisom SleepGels', 'Invokana', 'Naphazoline', 'Hydrochlorothiazide / telmisartan', 'Mycophenolate mofetil', 'Eucrisa', 'Biltricide', 'Bystolic', 'Ibuprofen / pseudoephedrine', 'Alesse', 'Bisoprolol / hydrochlorothiazide', 'Fexofenadine', 'Fentora', 'Guaifenesin', 'Modafinil', 'Kadian', 'Dexamethasone', 'Atropine / diphenoxylate', 'Metformin / sitagliptin', 'Fluorouracil', 'Clobetasol', 'Commit', 'Tri-Lo-Sprintec', 'Guaifenesin / phenylephrine', 'Dexbrompheniramine / pseudoephedrine', 'FreshKote', 'Racepinephrine', 'Keflex', 'Fluticasone', 'Levemir', 'Alprostadil', 'Carbidopa / levodopa', 'Tranexamic acid', 'Esomeprazole', 'Voltaren Gel', 'Adderall XR', 'Hydrocortisone', 'Remeron', 'Genvoya', 'Podofilox', 'Tri-Previfem', 'Atorvastatin', 'Carisoprodol', 'Gildess Fe 1.5 / 30', 'Viagra', 'Famotidine / ibuprofen', 'Selenium sulfide', 'Aubra', 'Tocilizumab', 'Lacosamide', 'Axiron', 'Finacea', 'Hydrocodone / ibuprofen', 'Vantin', 'Silenor', 'Rivaroxaban', 'Motrin', 'Cholestyramine', 'Ketamine', 'Flurazepam', 'Aubagio', 'Nebivolol', 'Vandazole', 'Clopidogrel', 'Imuran', 'Avanafil', 'Robaxin-750', 'Hydrochlorothiazide / lisinopril', 'Targiniq ER', 'Drospirenone / ethinyl estradiol / levomefolate calcium', 'Breo Ellipta', 'Zonisamide', 'Diamox', 'Warfarin', 'Amlodipine', 'Midazolam', 'Parnate', 'Next Choice', 'Gleevec', 'Movantik', 'Cabergoline', 'Opcicon One-Step', 'Vivelle-Dot', 'Estrace Vaginal Cream', 'Trihexyphenidyl', 'Acetaminophen / propoxyphene', 'Invega Sustenna', 'Mephobarbital', 'Nexium', 'Insulin glargine', 'Hydromet', 'Tenofovir', 'Chlordiazepoxide', 'Taltz', 'Blisovi 24 Fe', 'Campral', 'Loratadine / pseudoephedrine', 'Sodium biphosphate / sodium phosphate', 'Risedronate', 'Lenalidomide', 'Klor-Con', 'Furosemide', 'Exemestane', 'Diclegis', 'Monodox', 'Bethanechol', 'Portia', 'Eliquis', 'Prochlorperazine', 'Diclofenac / misoprostol', 'Amlodipine / benazepril', 'Adzenys XR-ODT', 'Natalizumab', 'Aldactone', 'Benadryl', 'Niaspan', 'Citric acid / magnesium oxide / sodium picosulfate', 'Fioricet', 'Clonidine', 'Lactulose', 'Guaifenesin / pseudoephedrine', 'R-Tanna', 'Jublia', 'Atenolol', 'Solifenacin', 'Lidoderm', 'Bismuth subcitrate potassium / metronidazole / tetracycline', 'Nicotrol Inhaler', 'Levlen', 'Asacol', 'Depakote ER', 'Fortesta', 'Silvadene', 'Estring', 'Duragesic', 'Xyzal', 'Artane', 'Tafinlar', 'Orencia', 'Lyza', 'Tegretol XR', 'Ceftin', 'Tambocor', 'Previfem', 'Duavee', 'Microgestin 1 / 20', 'Ocular lubricant', 'Vascepa', 'Protonix IV', 'HC-Derma-Pax', 'Welchol', 'Tirosint', 'Sandostatin', 'Patanol', 'Olmesartan', 'Irbesartan', 'Lidocaine', 'Librax', 'Chlorthalidone', 'Naprelan', 'Prolia', 'Dolutegravir', 'Cefpodoxime', 'Clocortolone', 'Ultram', 'Afrezza', 'Tysabri', 'Lactobacillus acidophilus', 'Oxaliplatin', 'Mexiletine', 'Halcion', 'Enjuvia', 'Multivitamin, prenatal', 'Omnicef', 'Embeda', 'Triamcinolone', 'Uloric', 'Caffeine', 'Arthrotec', 'Sodium hyaluronate', 'Zarah', 'Benicar HCT', 'Hydrochlorothiazide / spironolactone', 'Sumavel DosePro', 'Immune globulin subcutaneous', 'Certolizumab', 'Aftera', 'Pemoline', 'Delsym', 'Capzasin-HP', 'Topicort', 'Carvedilol', 'Actiq', 'Phendimetrazine', 'Mysoline', 'Acamprosate', 'Prevnar 13', 'Doxazosin', 'Vistaril', 'Conjugated estrogens', 'Rapaflo', 'Vitamin B2', 'Acthar', 'Memantine', 'Heather', 'Apixaban', 'Patanase', 'Januvia', 'Nicotine', 'S-adenosylmethionine', 'Zetia', 'Feldene', 'Pradaxa', 'Abacavir / dolutegravir / lamivudine', 'Dextromethorphan / quinidine', 'Acetaminophen / tramadol', 'Tazarotene', 'Opcon-A', 'Ketoprofen', 'Golimumab', 'Kava', 'Loestrin Fe 1.5 / 30', 'Letairis', 'Coartem', 'Complera', 'Nasacort', 'Clindesse', 'Cozaar', 'Multivitamin', 'Chlorpromazine', 'Protopic', 'Migranal', 'Alli', 'Teriparatide', 'Dihydroergotamine', 'Potassium chloride', 'Chateal', 'Quasense', 'Anafranil', 'Advair Diskus', 'Nefazodone', 'Ditropan', 'Taytulla', 'Kenalog', 'Tenormin', 'Rebif', 'Copaxone', 'Generess Fe', 'Hydroxyurea', 'Retisert', 'Alfuzosin', 'Penciclovir', 'Betamethasone / calcipotriene', 'Brisdelle', 'Dyanavel XR', 'Allerx Dose Pack DF', 'Deltasone', 'Amaryl', 'Soolantra', 'Mucinex', 'Desyrel', 'Levocetirizine', 'Cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide', 'Lopinavir / ritonavir', 'Byetta', 'Catapres-TTS', 'Chlorpheniramine', 'Sustiva', 'Zaleplon', 'Farxiga', 'Janumet', 'Lo / Ovral-28', 'Docetaxel', 'Lantus Solostar', 'Oxistat', 'Selegiline', 'Sunitinib', 'Levorphanol', 'Cheratussin AC', 'Umeclidinium / vilanterol', 'Erlotinib', 'Forteo', 'Seasonale', 'Actemra', 'Urso Forte', 'Aspirin', 'Zyprexa Zydis', 'Cosentyx', 'MiraLax', 'Esgic', 'Rituximab', 'Fluticasone / vilanterol', 'Tacrolimus', 'Supartz', 'Tenuate', 'Beclomethasone', 'Fenofibric acid', 'Panlor SS', 'Benicar', 'Sofosbuvir / velpatasvir', 'Methadose', 'Calcitriol', 'Emtricitabine / rilpivirine / tenofovir', 'Didrex', 'Dextroamphetamine', 'Viorele', 'Codeine', 'Kerydin', 'Requip', 'Pylera', 'Zohydro ER', 'Octreotide', 'GoLYTELY', 'Eszopiclone', 'Bicalutamide', 'Benzoyl peroxide / erythromycin', 'Evamist', 'Glipizide', 'Dicyclomine', 'Tarina Fe 1 / 20', 'Trileptal', 'Magnesium citrate', 'Rosuvastatin', 'Primidone', 'Yasmin', 'ProAir HFA', 'Cefprozil', 'Comtan', 'Omega-3 polyunsaturated fatty acids', 'Oleptro', 'Atacand', 'Xanax XR', 'Human papillomavirus vaccine', 'Amoxil', 'Clobex', 'Bepotastine', 'Propafenone', 'Siliq', 'Prezcobix', 'Telmisartan', 'Cloderm', 'Roxicodone', 'Ubiquinone', 'Robaxin', 'Sitavig', 'Dulcolax Laxative', 'Flector Patch', 'Ribavirin', 'Ultram ODT', 'Quinine', 'Aluminum hydroxide / magnesium trisilicate', 'Ipratropium', 'Dexchlorpheniramine', 'Ephedrine / guaifenesin', 'Claravis', 'GaviLyte-C', 'Hydroxyamphetamine / tropicamide', 'MCT', 'Onfi', 'Anoro Ellipta', 'Hylan g-f 20', 'Acanya', 'Vivitrol', 'Gelnique', 'Entyvio', 'Dramamine', 'Desipramine', 'Biaxin', 'Casodex', 'Maraviroc', 'Gablofen', 'Stribild', 'Chlorpheniramine / hydrocodone', 'Egrifta', 'Propecia', 'Vagifem', 'Barium sulfate', 'Provigil', 'Cardizem LA', 'Zofran ODT', 'Cholecalciferol', 'Tafluprost', 'Singulair', 'Granisetron', 'Phenytoin', 'Gilotrif', 'Afrin', 'Exforge', 'Benzaclin', 'Xeloda', 'Vectical', 'Sancuso', 'Loestrin Fe 1 / 20', 'Zestril', 'Prednisolone', 'Pimtrea', 'Doxy 100', 'Tranxene', 'Codeine / promethazine', 'Xylometazoline', 'Acetaminophen / pamabrom', 'Lysine', 'Emla', 'Nubain', 'Digoxin', 'Clarifoam EF', 'Colchicine / probenecid', 'Hyoscyamine / methenamine / methylene blue / phenyl salicylate', 'Anexsia', 'Unisom SleepTabs', 'NuOx', 'Bonine', 'Synvisc-One', 'Iloperidone', 'Synvisc', 'Septra', 'Cerezyme', 'Stadol', 'Acetaminophen / chlorpheniramine / phenylephrine', 'Sominex', 'Plaquenil', 'Nortrel 1 / 35', 'Perampanel', 'Gianvi', 'Methadone Diskets', 'Pazopanib', 'Fondaparinux', 'Septra DS', 'Robitussin CoughGels Long-Acting', 'Chlordiazepoxide / clidinium', 'Pancrelipase', 'Acetaminophen / diphenhydramine', 'Metamucil', 'Sulfazine', 'Imipramine', 'Tessalon Perles', 'Teriflunomide', 'Pennsaid', 'HyoMax SL', 'Zymine', 'Esomeprazole / naproxen', 'Allopurinol', 'Disulfiram', 'Difluprednate', 'Methylin ER', 'Venofer', 'Ascomp with Codeine', 'Azelaic acid', 'Thorazine', 'Dronabinol', 'Formoterol', 'Prefrin', 'Verdeso', 'Tobramycin', 'Belbuca', 'Hyoscyamine', 'Metformin / saxagliptin', 'Sinemet', 'Combivent', 'Zovirax Cream', 'Keppra XR', 'Xiidra', 'Axid AR', 'Cromolyn', 'Triumeq', 'Pitavastatin', 'Roflumilast', 'Nitro-Dur', 'OxyContin', 'Aspirin / caffeine / orphenadrine', 'Rotigotine', 'Ortho-Novum 1 / 35', 'Cyclosporine', 'Isosorbide mononitrate', 'Bumex', 'Dexedrine', 'Synthroid', 'Acetaminophen / codeine', 'Zirgan', 'Tikosyn', 'Benzoyl peroxide', 'Doxylamine', 'Simply Sleep', 'Insulin lispro', 'Caffeine / ergotamine', 'Cariprazine', 'Aspirin / caffeine / salicylamide', 'Mucinex D Maximum Strength', 'Drixoral Cold and Allergy', 'Pemirolast', 'Loperamide', 'Gralise', 'Ziac', 'Lifitegrast', 'Onglyza', 'Tyvaso', 'Rosiglitazone', 'Testopel', 'Acetaminophen / butalbital / caffeine / codeine', 'Subsys', 'Medrol Dosepak', 'Prevpac', 'Emetrol', 'Orphenadrine', 'Lamisil', 'Topiragen', 'Imbruvica', 'Albuterol', 'Microgestin Fe 1.5 / 30', 'Prandin', 'Conjugated estrogens / medroxyprogesterone', 'Propoxyphene', 'Acitretin', 'Fexofenadine / pseudoephedrine', 'Leflunomide', 'Diflunisal', 'Urea', 'Acetohydroxamic acid', 'Sulfacetamide sodium / sulfur', 'Benzphetamine', 'Hydrochlorothiazide / olmesartan', 'Niacin', 'Gatifloxacin', 'Amphetamine', 'Penlac', 'Avalide', 'Evolocumab', 'Intal', 'Safyral', 'Elmiron', 'Donepezil', 'Aspirin / butalbital / caffeine / codeine', 'Brompheniramine', 'Butalbital Compound', 'Latanoprost', 'Axert', 'Amantadine', 'Maxalt-MLT', 'Albiglutide', 'Tri-Luma', 'Pegasys', 'Pentosan polysulfate sodium', 'Antabuse', 'Amlodipine / valsartan', 'Fleet Enema', 'Avinza', 'Zelnorm', 'Fingolimod', 'Bextra', 'Sonata', 'Erythromycin', 'Symax Duotab', 'Budesonide', 'Levitra', 'Glimepiride', 'Norvasc', 'Cyclopentolate', 'Lotrel', 'Kariva', 'Misoprostol', 'Bentyl', 'Bunavail', 'Alcaftadine', 'Dextromethorphan / guaifenesin / phenylephrine', 'Ortho Micronor', 'Mibelas 24 Fe', 'Hi-Vegi-Lip', 'Bromocriptine', 'Reclast', 'Zovirax Ointment', 'Doxepin', 'Claritin', 'Zolpimist', 'Desonide', 'Tigan', 'Bontril PDM', 'Sofosbuvir', 'Treximet', 'Aciphex', 'Zyrtec', 'Bactroban', 'Benzoic acid / salicylic acid', 'Senna', 'Phenelzine', 'Lasix', 'Necon 1 / 50', 'Zantac', 'Kenalog-10', 'Mefloquine', 'Magnacet', 'Clorazepate', 'Calcipotriene', 'Ivermectin', 'Atovaquone / proguanil', 'Toradol IV / IM', 'Chlorpheniramine / hydrocodone / pseudoephedrine', 'Diprivan', 'Exalgo', 'Chlorzoxazone', 'Ambien CR', 'Victrelis', 'Mebaral', 'Dilantin', 'Econazole', 'Tylenol PM', 'Levsin SL', 'Palbociclib', 'Creon', 'Ranibizumab', 'Tenex', 'Transderm-Scop', 'Gildess 24 Fe', 'Prometrium', 'Gabapentin enacarbil', 'Omacor', 'Ixekizumab', 'Zutripro', 'Naftifine', 'Epitol', 'Diphenhydramine / naproxen', 'Clotrimazole', 'Imatinib', 'Lessina', 'Fenofibrate', 'Ultravate', 'Skelaxin', 'Capsaicin', 'Xolair', 'Lexiscan', 'Xeljanz', 'Cyclafem 1 / 35', 'Factive', 'Rituxan', 'Menthol', 'Scullcap', 'Tussionex Pennkinetic', 'Gas-X', 'Rheumatrex Dose Pack', 'Zovia', 'Sutent', 'Mepivacaine', 'Pyridostigmine', 'Amerge', 'Xopenex', 'Brompheniramine / dextromethorphan / pseudoephedrine', 'Levoxyl', 'Hydralazine', 'Dextromethorphan / guaifenesin / pseudoephedrine', 'Evoxac', 'MetroGel', 'Dimethyl fumarate', 'Eskalith', 'Fioricet with Codeine', 'Dofetilide', 'Tretin-X', 'Effient', 'Quillivant XR', 'Vaniqa', 'Lacrisert', 'Nasacort Allergy 24HR', 'Acetaminophen / caffeine / isometheptene mucate', 'Dalmane', 'Terazosin', 'Atazanavir', 'Benadryl Allergy', 'Mestinon', 'Bevacizumab', 'Insulin glulisine', 'WinRho SDF', 'Sulindac', 'Proctosol-HC', 'Tranylcypromine', 'Felbatol', 'Olodaterol / tiotropium', 'Sulfasalazine', 'Opium', 'Cedax', 'Dabigatran', 'Finasteride', 'Meridia', 'Adenosine', 'Makena', 'Subutex', 'Clobazam', 'Intal Inhaler', 'Fluticasone / salmeterol', 'Selexipag', 'Lipitor', 'Lupron Depot-PED', 'Riluzole', 'Dibucaine', 'Ticagrelor', 'Azathioprine', 'Trezix', 'Amlodipine / hydrochlorothiazide / olmesartan', 'Retin-A', 'Angeliq', 'Macrodantin', 'Nuedexta', 'Entocort EC', 'Actonel', 'Indocin', 'Magnesium salicylate', 'Dermal filler', 'Amrix', 'Simeprevir', 'Vicoprofen', 'Glimepiride / pioglitazone', 'Desoximetasone', 'Tazorac', 'Necon 7 / 7 / 7', 'Nadolol', 'Xalatan', 'Salonpas Pain Patch', 'GlipiZIDE XL', 'Diphenidol', 'Perforomist', 'Livalo', 'Desogen', 'Zoladex', 'Lupron', 'Candesartan', 'Enoxaparin', 'ActoPlus Met', 'Naratriptan', 'Micardis', 'Pexeva', 'Cyred', 'Jalyn', 'Meperidine / promethazine', 'Loryna', 'Prinzide', 'Rytary', 'Daraprim', 'Pseudoephedrine', 'Valturna', 'Fidaxomicin', 'Methylnaltrexone', 'Temovate', 'Xtandi', 'Fluoxetine / olanzapine', 'Salicylic acid / sulfur', 'Hyzaar', 'Tarceva', 'Cyanocobalamin', 'Homatropine / hydrocodone', 'Cardizem', 'Loteprednol', 'Somnote', 'A + D Cracked Skin Relief', 'Rivastigmine', 'Interferon beta-1a', 'Actos', 'Paxil CR', 'Ferrous sulfate', 'Aygestin', 'Dienogest / estradiol', 'Mepron', 'Enablex', 'Cinacalcet', 'Alendronate', 'TobraDex', 'Lotensin', 'Prilosec', 'Elocon', 'Talwin', 'Inderal', 'Coal tar', 'Psyllium', 'RectiCare', 'Mydayis', 'Vimpat', 'Carac', 'Fluocinolone / hydroquinone / tretinoin', 'Natroba', 'Eovist', 'Daclatasvir', 'Monovisc', 'Alcortin A', 'Excedrin', 'Horizant', 'Nostrilla', 'Rea Lo 40', 'Empagliflozin / metformin', 'Stalevo 200', 'Glucotrol', 'Atropine / hyoscyamine / phenobarbital / scopolamine', 'Multivitamin with minerals', 'Zorvolex', 'Famciclovir', 'Aranesp', 'Fosfomycin', 'Flurandrenolide', 'Pneumococcal 13-valent vaccine', 'Terbutaline', 'Lidocaine Viscous', 'Ketoconazole', 'Carafate', 'Nalbuphine', 'Denavir', 'Estrace', 'Imitrex Statdose', 'Vraylar', 'Sarafem', 'Marplan', 'Gabitril', 'Atenolol / chlorthalidone', 'Piroxicam', 'Muse', 'Renvela', 'Evening Primrose Oil', 'Revatio', 'Lotronex', 'Zenatane', 'Methenamine', 'Entresto', 'Imitrex Nasal', 'CellCept', 'Apriso', 'Systane', 'Orudis KT', 'Nortrel 7 / 7 / 7', 'Micardis HCT', 'Advil Cold and Sinus', 'Biotin', 'Nitroglycerin', 'Vimovo', 'Acetaminophen / butalbital', 'Bepreve', 'Incivek', 'Plavix', 'Permethrin', 'Vicks Nyquil D Cold and Flu Nighttime Relief', 'Fabior', 'Arginine', 'Brilinta', 'Camila', 'Abiraterone', 'Aprepitant', 'Estradiol / levonorgestrel', 'Peginterferon alfa-2a', 'Fiorinal', 'Dolophine', 'Iressa', 'Levalbuterol', 'Hydrochlorothiazide / valsartan', 'Trocaine', 'Avapro', 'PanOxyl', 'Glycerin', 'Hydrochlorothiazide / moexipril', 'Hydrochlorothiazide / triamterene', 'Nitrolingual Pumpspray', 'Nicorette', 'Romiplostim', 'Zestoretic', 'Levsin', 'Sudafed PE Severe Cold', 'Gynazole-1', 'Aclidinium', 'Avandia', 'Tradjenta', 'Addyi', 'Zocor', 'Fanapt', 'Ranolazine', 'Cyclizine', 'Azilsartan medoxomil', 'Marinol', 'Naloxone / pentazocine', 'Roxicet', 'Benzoyl peroxide / hydrocortisone', 'Paromomycin', 'Nucynta ER', 'Ferric citrate', 'Fosrenol', 'Pentothal', 'Oruvail', 'Zonegran', 'Brivaracetam', 'Tiger Balm', 'Alrex', 'Primatene Mist', 'Calcium carbonate', 'Triamterene', 'Electrolyte replacement solutions', 'Abilify Maintena', 'Remeron SolTab', 'Nalfon', 'Stelazine', 'Advil', 'Albuterol / ipratropium', 'Pravastatin', 'Xtampza ER', 'Methscopolamine', 'Hydrochlorothiazide / losartan', 'Azacitidine', 'Donnatal', 'Lysteda', 'Edex', 'Fluocinonide', 'Briviact', 'Triazolam', 'Lioresal', 'Red yeast rice', 'Hyaluronidase', 'Hycodan', 'Megace', 'Crisaborole', 'Naloxone', 'Pindolol', 'Zantac 150', 'Lamisil AT', 'Qudexy XR', 'Ingenol', 'Asmanex Twisthaler', 'Chromium picolinate', 'Bimatoprost', 'Xerac AC', 'Ethinyl estradiol / ethynodiol', 'Ventolin HFA', 'Glucophage', 'Sevelamer', 'Avita', 'Lanacane', 'Magnesium gluconate', 'Icatibant', 'Condylox', 'Tavaborole', 'Luvox', 'Aromasin', 'Climara', 'Uroxatral', 'Levo-T', 'Povidone iodine', 'Pembrolizumab', 'Arimidex', 'Advil Liqui-Gels', 'Catapres', 'NP Thyroid', 'Linagliptin / metformin', 'Fosamax', 'Tiagabine', 'Ogestrel-28', 'Tri-Linyah', 'Almotriptan', \"Children's Motrin\", 'Dasatinib', 'Lioresal Intrathecal', 'Pentoxifylline', 'Neevo DHA', 'Sacubitril / valsartan', 'Edarbyclor', 'Omeprazole / sodium bicarbonate', 'Minocin', 'Prasugrel', 'Xifaxan', 'Meperitab', 'Ventolin', 'Tylenol with Codeine #4', 'Phenohytro', 'Morphine / naltrexone', 'Treprostinil', 'Combivent Respimat', 'Oxiconazole', 'Pegfilgrastim', 'Darvon', 'Urispas', 'Bupivacaine liposome', 'Copegus', 'Insulin detemir', 'Rasagiline', 'Nivolumab', 'Epiduo Forte', 'Humalog KwikPen', 'Multaq', 'Praluent', 'Prilosec OTC', 'Ritalin LA', 'Androderm', 'DDAVP', 'Capecitabine', 'Clozaril', 'Gefitinib', 'Uricalm', 'Penlac Nail Lacquer', 'Allantoin / camphor / phenol', 'Pravachol', 'Galantamine', 'Tekturna HCT', 'Trulance', 'Sanctura', 'Coumadin', 'Unithroid', 'Veltin', 'Belviq XR', 'Amnesteem', 'Aptiom', 'Allegra', 'Lithobid', 'Afinitor', 'Imodium A-D', 'Combivir', 'Daliresp', 'Alosetron', 'ProCentra', 'Diazepam Intensol', 'Demerol', 'Diovan HCT', 'Trilipix', 'Altoprev', 'Niravam', 'Elimite', 'Mupirocin', 'Acetaminophen / pentazocine', 'Duexis', 'Hiprex', 'Maxzide', 'Altavera', 'Chorionic gonadotropin (hcg)', 'Quibron-T', 'Tetrahydrozoline / zinc sulfate', 'Saxagliptin', 'Yuvafem', 'Cefazolin', 'Tegaserod', 'Dupilumab', 'Ilevro', 'Calan', 'Sotalol', 'Limbitrol DS', 'Avodart', 'Sodium hypochlorite', 'Votrient', 'Ciprodex', 'Bayer Aspirin', 'Valproic acid', 'Monistat 1-Day or Night Combination Pack', 'Stavzor', 'Habitrol', 'Reprexain', 'Zicam Extreme Congestion Relief', 'Prograf', 'Ginkgo', 'Ezetimibe / simvastatin', 'Biotene Mouthwash', 'Tofranil', 'Amiodarone', 'Tekturna', 'Bismuth subsalicylate', 'Travoprost', 'Rogaine', 'Juleber', 'Pamelor', 'Mercaptopurine', 'Frova', 'Proventil HFA', 'Cartia XT', 'Colcrys', 'Elestat', 'Mellaril', 'Chlorpheniramine / dextromethorphan / pseudoephedrine', 'Methylin', 'Lorzone', 'Astelin', 'CombiPatch', 'Estradiol Patch', 'Multivitamin with iron', 'Tri-Estarylla', 'Haloperidol', 'Olodaterol', 'Hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate', 'Nasonex', 'T-Diet', 'Salsalate', 'Diosmiplex', 'Metadate CD', 'Pramoxine', 'Metoprolol Tartrate', 'Penicillin g benzathine', 'Dovonex', 'Spinosad', 'Icosapent', 'Chlorpheniramine / hydrocodone / phenylephrine', 'Excedrin Sinus Headache', 'Fycompa', 'Bendamustine', 'Coal tar / salicylic acid / sulfur', 'TriNessa Lo', 'Sular', 'Cabozantinib', 'Simcor', 'Hytrin', 'Cleocin', 'Solu-Medrol', 'Stendra', 'Rhofade', 'Westcort', 'Glucosamine', 'Orap', 'Uceris', 'Privine', 'Hydrocodone / pseudoephedrine', 'Rifampin', 'Prodrin', 'Spectazole', 'Felbamate', 'Humalog', 'Lemtrada', 'Lodine', 'Lovenox', 'Toviaz', 'Buckleys Mixture', 'Bromfed DM', 'Uniphyl', 'Esgic-Plus', 'Aldara', 'Debrox', 'Cardura', 'Pataday', 'Sorafenib', 'Nupercainal', 'Tylox', 'Ospemifene', 'Psorcon E', 'Temodar', 'Tylenol', 'Cordarone', 'Erbitux', 'Ketotifen', 'Atrovent Nasal', 'Hydroxyprogesterone', 'Acetaminophen / caffeine / dihydrocodeine', 'Benlysta', 'Acetaminophen / dextromethorphan / phenylephrine', 'Bisoprolol', 'Cogentin', 'Fluocinolone', 'Dutasteride / tamsulosin', 'Dilt-XR', 'Norpace CR', 'Paregoric', 'A / B Otic', 'Estratest H.S.', 'Migergot', 'Femcon Fe', 'Hydrocortisone / pramoxine', 'Amoxapine', 'Glyburide', 'Vicodin HP', 'Vienva', 'Estazolam', 'Benazepril', 'Cordran Tape', 'Durezol', 'Keytruda', 'Astepro', 'Gemifloxacin', 'Myobloc', 'Mycophenolic acid', 'Cytomel', 'Tetracycline', 'Allegra-D 12 Hour', 'Risperdal M-Tab', 'Hylira', 'Solaraze', 'Sanctura XR', 'Myleran', 'Lidex', 'Chlorpheniramine / methscopolamine / phenylephrine', 'Inderal LA', 'Ergocalciferol', 'HyoMax SR', 'Lucentis', 'Phenylephrine / pramoxine', 'Dexamethasone / neomycin / polymyxin b', 'Repaglinide', 'Kenalog-40', 'Insulin inhalation, rapid acting', 'Lopressor', 'Zelboraf', 'Urso', 'FluMist', 'Zometa', 'Esterified estrogens', 'Phenobarbital', 'Pioglitazone', 'Ryzolt', 'Somatropin', 'Abatacept', 'Lo / Ovral', 'Stivarga', 'Claritin-D', 'Budeprion XL', 'Advate', 'Belimumab', 'Iclusig', 'Everolimus', 'Stromectol', 'Rufinamide', 'Yohimbine', 'Revlimid', 'Diamox Sequels', 'Mephyton', 'Linagliptin', 'Pulmicort Flexhaler', 'Azo-Standard', 'Degarelix', 'Epoetin alfa', 'Indocin SR', 'Symmetrel', 'Boceprevir', 'Equetro', 'Cetirizine / pseudoephedrine', 'Capsin', 'Lactase', 'Ovide', 'Dextromethorphan / guaifenesin', 'Retin A Micro', 'Riboflavin', 'Cyclophosphamide', 'Estropipate', 'Arcalyst', 'Slow Fe', 'Luvox CR', 'Prialt', 'Namenda XR', 'Zovirax', 'Isoniazid', 'Tylenol with Codeine', 'Botulinum toxin type b', 'Ashlyna', 'Senokot', 'Norgesic', 'Dronedarone', 'Avonex Pen', 'Neostigmine', 'Undecylenic acid', 'Drospirenone / estradiol', 'Drixoral Cold / Flu', 'Gadavist', 'Vagistat-1', 'Magnesium oxide', 'Valdecoxib', 'Methamphetamine', 'Lotemax', 'Naropin Polyamp', 'Humulin N', 'Sipuleucel-T', 'Rozex', 'Collagenase', 'Natazia', 'Savaysa', 'Humatin', 'Aspirin / carisoprodol', 'Griseofulvin', 'Microgestin 1.5 / 30', 'Vasodilan', 'Talwin Nx', 'Aliskiren', 'Zubsolv', 'Soma Compound', 'Coreg CR', 'Aplenzin', 'Viekira Pak', 'Fesoterodine', 'Vivarin', 'Detrol', 'Cetuximab', 'Nasacort AQ', 'Rynatan', 'Rectiv', 'Verelan', 'Flanax Pain Reliever', 'Paclitaxel protein-bound', 'Hyoscyamine / methenamine / methylene blue / sodium biphosphate', 'Foradil Aerolizer', 'Raloxifene', 'Revia', 'Ludiomil', 'Echinacea', 'Larin Fe 1 / 20', 'Vusion', 'Silver sulfadiazine', 'Avandamet', 'Analpram-HC', 'Methylergonovine', 'Oxaprozin', 'Vibramycin', 'Rifaximin', 'Hydrochlorothiazide / irbesartan', 'Truvada', 'Azelex', 'Ibrutinib', 'Ursodiol', 'Estradiol / norethindrone', 'Pimozide', 'Zipsor', 'Enalapril', 'Influenza virus vaccine, inactivated', 'Chlorpheniramine / dextromethorphan / phenylephrine', 'Exelon', 'Naprosyn', 'Quazepam', 'Dexamethasone / tobramycin', 'Azithromycin Dose Pack', 'Asthmanefrin', 'Dallergy', 'Zomig-ZMT', 'Exubera', 'Gabarone', 'Tribenzor', 'Succinylcholine', 'Pomalyst', 'Butabarbital', 'Tudorza Pressair', 'Lidocaine / prilocaine', 'Ionamin', 'Aquoral', 'Linezolid', 'Nexavar', 'Solarcaine First Aid Medicated Spray', 'Rifadin', 'Folic acid', 'Bupap', 'Norgesic Forte', 'Acetaminophen / chlorpheniramine', 'Advil Cold and Sinus Liqui-Gels', 'Depakene', 'Risperdal Consta', 'Famotidine', 'Antivert', 'Femring', 'Esterified estrogens / methyltestosterone', 'Chlorothiazide', 'M-Zole 3', 'CitraNatal 90 DHA', 'Olux', 'Monopril', 'Cholestyramine Light', 'Vitamin e', 'Eylea', 'Cefixime', 'Emtricitabine / tenofovir', 'Rayos', 'Zosyn', 'Regadenoson', 'Tussigon', 'Invega Trinza', 'Cilostazol', 'Imodium', 'Balsalazide', 'Abraxane', 'Maxichlor PSE DM', 'Carbinoxamine', 'AmLactin', 'Darifenacin', 'Timoptic', 'Asacol HD', 'Aspirin / diphenhydramine', 'Vitamin B12', 'Alphagan P', 'Doxorubicin', 'Calmoseptine', 'Veramyst', 'Aloe vera', 'Junel 1.5 / 30', 'Rythmol', 'Uptravi', 'Zylet', 'Peridex', 'Flagyl ER', 'Benzamycin', 'Aricept', 'Meprobamate', 'Cinryze', 'Ornex', 'Minipress', 'Tessalon', 'Sodium chloride', 'Onzetra Xsail', 'Gamunex', 'Crotamiton', 'Staxyn', 'Junel 1 / 20', 'Silver', 'Klonopin Wafer', 'Low-Ogestrel-21', 'Proventil', 'Ortho-Novum 7 / 7 / 7', 'Azurette', 'Rowasa', 'Brompheniramine / pseudoephedrine', 'Lactaid', 'Dilaudid-HP', 'Ascorbic acid', 'Pyrantel', 'Mircette', 'Lamivudine', 'Mono-Linyah', 'Procardia XL', 'Etravirine', 'Horse chestnut', 'Eligard', 'Chondroitin / glucosamine', 'Norvir', 'Lantus', 'Florastor', 'Trivora', 'Triavil', 'Aspirin / dipyridamole', 'Amethia Lo', 'Namenda', 'Maxifed DM', 'Opsumit', 'Jakafi', 'Zaditor', 'Ciprofloxacin / dexamethasone', 'WP Thyroid', 'Glyxambi', 'Dolgic Plus', 'Marezine', 'Caverject Impulse', 'Procardia', 'Zenchent', 'Clinoril', 'Zymar', 'Danazol', 'Natelle One', 'Cimetidine', 'Blisovi Fe 1.5 / 30', 'ProAmatine', 'Azilsartan medoxomil / chlorthalidone', 'Bioflavonoids', 'Betamethasone', 'Entacapone', 'Metformin / pioglitazone', 'CamreseLo', 'Auranofin', 'Aspirin / carisoprodol / codeine', 'NeutraSal', 'Duoplant', 'Stimate', 'Aspirin / oxycodone', 'Darbepoetin alfa', 'Allegra Allergy', 'Zinc oxide', 'Hizentra', 'Tolmetin', 'Osphena', 'Chlophedianol / guaifenesin / pseudoephedrine', 'Sine-Off Maximum Strength', 'Questran', 'Dasabuvir / ombitasvir / paritaprevir / ritonavir', 'Novolin 70 / 30', 'GaviLyte-G', 'Nimotop', 'Metformin / rosiglitazone', 'Cortenema', 'Onexton', 'Collagenase clostridium histolyticum', 'Nizoral A-D', 'Advair HFA', 'Sensipar', 'Edluar', 'Zostavax', 'Kybella', 'Serax', 'Coricidin HBP Cold & Flu', 'Quinapril', 'Acetaminophen / caffeine', 'Stiolto Respimat', 'Vanspar', 'Efavirenz', 'Soriatane', 'Simponi Aria', 'Jentadueto', 'Enskyce', 'Sinemet CR', 'Marlissa', 'Fluzone', 'Ciclopirox', 'Alemtuzumab', 'Hydroquinone', 'Afrin Sinus', 'Aluminum hydroxide / magnesium hydroxide / simethicone', 'Royal jelly', 'Taclonex Scalp', 'Acetaminophen / aspirin / caffeine / salicylamide', 'Gris-PEG', 'Asendin', 'Carbidopa / entacapone / levodopa', 'Halaven', 'Omnitrope', 'Bifidobacterium infantis / lactobacillus acidophilus', 'Balsam peru / castor oil / trypsin', 'Adempas', 'Lamictal XR', 'Famvir', 'Canasa', 'Dinoprostone', 'Vidaza', 'Requip XL', 'Trandolapril / verapamil', 'Albendazole', 'Acetylcysteine', 'Tylenol 8 Hour', 'Chlorpheniramine / phenylephrine', 'Dyazide', 'Azasite', 'Nifedical XL', 'Ditropan XL', 'Quinidine', 'Prolixin', 'Eribulin', 'Prezista', 'Citric acid / potassium citrate', 'Lumigan', 'Advil PM', 'Chlorpheniramine / pseudoephedrine', 'Urecholine', 'Concept DHA', 'Herceptin', 'Novolog', 'Sarna Sensitive', 'Ery-Tab', 'Krystexxa', 'Naphazoline / pheniramine', 'Megace ES', 'Itraconazole', 'Amikacin', 'Biafine', 'SymlinPen 60', 'Enstilar', 'Lecithin', 'Diflorasone', 'Acetaminophen / phenyltoloxamine', 'Mucinex Fast-Max Night Time Cold & Flu', 'Corticotropin', 'Canasa Pac', 'Niacin / simvastatin', 'Tev-Tropin', 'Zejula', 'Pegloticase', 'Insulin aspart', 'Systane Ultra', 'Botox Cosmetic', 'Amlodipine / hydrochlorothiazide / valsartan', 'Torsemide', 'Salofalk', 'Cladribine', 'Lopid', 'Glucose', 'Xolegel', 'Sulfur', 'Pirmella 1 / 35', 'Adoxa', 'Telaprevir', 'Olysio', 'Norinyl 1+35', 'Perphenazine', 'Simethicone', 'Parlodel', 'Glyburide / metformin', 'Methylcellulose', 'Pamine', 'Midodrine', 'Benzocaine', 'Insulin regular', 'Hemax', 'Miltown', 'Butoconazole', 'Amikin', 'BroveX PEB DM', 'Cytoxan', 'Theophylline', 'Duramorph', 'Oxaydo', 'Dostinex', 'Chlorhexidine', 'Allegra-D 24 Hour', 'Estratest', 'Polymyxin b / trimethoprim', 'Soma Compound with Codeine', 'Buprenex', 'Milk thistle', 'Tronolane Anesthetic for Hemorrhoids', 'Odefsey', 'Nizatidine', 'Bacitracin / neomycin / polymyxin b / pramoxine', 'Visine Totality Multi-Symptom Relief', 'Pralatrexate', 'Maxair Autohaler', 'Capzasin', 'Premarin Vaginal', 'Inapsine', 'X-Viate', 'Benzoyl peroxide / sulfur', 'Lomedia 24 Fe', 'Abacavir / lamivudine / zidovudine', 'Ritalin-SR', 'Pamabrom', 'Gammagard', 'Ziconotide', 'Alogliptin', 'Ruxolitinib', 'Accolate', 'Glutamine', 'Naloxone / oxycodone', 'Besifloxacin', 'Tanzeum', 'Pennyroyal', 'Kytril', 'Brodalumab', 'Dermatop', 'Daklinza', 'L-Methylfolate Calcium', 'Vanquish', 'Sotalol Hydrochloride AF', 'Topical Anesthetic Dental Gel', 'Systane Balance', 'Nizoral Shampoo', 'Sodium bicarbonate', 'Calan SR', 'Ecallantide', 'Nikki', 'Lipofen', 'GaviLyte-N', 'Ethosuximide', 'Gemzar', 'Methergine', 'Pentobarbital', 'PreNexa', 'Prednicarbate', 'Intermezzo', 'Sudafed Congestion', 'Aflibercept', 'Bromfenac', 'Symlin', 'Efudex', 'Diastat', 'Belladonna Tincture', 'Dynacin', 'Prenatal Plus', 'C1 esterase inhibitor (human)', 'Antihemophilic factor / von willebrand factor', 'Spiriva Respimat', 'Mevacor', 'Dexpanthenol', 'Lastacaft', 'Ampicillin', 'Myfortic', 'Calcitonin', 'Heme iron polypeptide', 'Raspberry', 'Caduet', 'AbobotulinumtoxinA', 'Amitriptyline / chlordiazepoxide', 'Besivance', 'Hypotears', 'Alupent', 'Lamictal ODT', 'Paremyd', 'Brompheniramine / dextromethorphan / phenylephrine', 'Evekeo', 'MG217 Medicated Tar', 'Arsenic trioxide', 'Chloraseptic Sore Throat Spray', 'Constulose', 'Xartemis XR', 'Umeclidinium', 'Panitumumab', 'Bupivacaine', 'Xeljanz XR', 'Dexamethasone Intensol', 'Reserpine', 'Nepafenac', 'Acetaminophen / pseudoephedrine', 'Chlor-Trimeton', 'Amino acids', 'Pregnyl', 'Larin 24 Fe', 'Crizotinib', 'Cylert', 'Gadopentetate dimeglumine', 'Flagyl IV', 'Cyclessa', 'Xylocaine Jelly', 'Prinivil', 'Dextromethorphan / promethazine', 'Edarbi', 'Aggrenox', 'Fuzeon', 'Procrit', 'Ketalar', 'Dichlorphenamide', 'Clove', 'Pepto-Bismol', 'DuoNeb', 'Arixtra', 'Sodium polystyrene sulfonate', 'PEG3350', 'Aptensio XR', 'Osteo Bi-Flex', 'Gildess 1 / 20', 'Semprex-D', 'B3-500-Gr', 'Maprotiline', 'Istalol', 'Relenza', 'Anakinra', 'Dorzolamide / timolol', 'Trastuzumab', 'Trandolapril', 'Alka-Seltzer Plus Cold', 'Lac-Hydrin', 'Miconazole / zinc oxide', 'Stalevo', 'Atropine / difenoxin', 'EnteraGam', 'Lorazepam Intensol', 'AirDuo Respiclick', 'Trifluoperazine', 'Delzicol', 'Declomycin', 'OxyIR', 'Vesanoid', 'Timolol', 'Nevirapine', 'Fortamet', 'Synarel', 'Acetaminophen / caffeine / pyrilamine', 'Clarinex', 'Iron sucrose', 'TheraTears Nutrition', 'Bosentan', 'Brovana', 'Pyrimethamine / sulfadoxine', 'Phenytek', 'Antipyrine / benzocaine', 'Readi-Cat 2', 'Loracarbef', 'Lariam', 'Daypro', 'Targretin', 'NoDoz', 'Viread', 'Accupril', 'Thiothixene', 'Navane', 'Unisom SleepMelts', 'Mucomyst', 'Duet DHA', 'Lovastatin', 'Viramune', 'Plegridy', 'Aloxi', 'PEG-3350 with Electolytes', 'Depo-Medrol', 'Insulin isophane / insulin regular', 'Solarcaine Burn Relief', 'Lovaza', 'Sertaconazole', 'Maxidone', 'Eltrombopag', 'Zytiga', 'Afrin Original', 'Sprix', 'Bicillin L-A', 'All Day Allergy', 'Nystatin / triamcinolone', 'Anaprox-DS', 'Nutraplus', 'Dramamine Less Drowsy', 'FML Forte Liquifilm', 'Motofen', 'Dextrostat', 'Dramamine II', 'Oxymetholone', 'Locoid Lipocream', 'Limbrel 500', 'Insulin lispro / insulin lispro protamine', 'Zenpep', 'Bosulif', 'Felodipine', 'Balziva', 'Excedrin PM', 'Fleet Glycerin Suppositories Adult', 'Molindone', 'Aveeno', 'Insulin aspart / insulin aspart protamine', 'Xigduo XR', 'Dificid', 'Cefzil', 'Podophyllum resin', 'Procyclidine', 'Synalar', 'Ortho-Cept', 'Omnaris', 'OsmoPrep', 'Zinc sulfate', 'Pepcid', 'Taxol', 'Florinef', 'Monurol', 'Damiana', 'Neoral', 'Ofloxacin', 'Dapagliflozin / metformin', 'Pramosone', 'Synjardy', 'ProFe', 'Altace', 'Compro', 'Ultracet', 'Perindopril', 'Fexmid', 'Tivicay', 'Hydrocortisone / neomycin / polymyxin b', 'Twynsta', 'Junel Fe 24', 'Primlev', 'Tandem DHA', 'Amiloride', 'Loestrin 21 1.5 / 30', 'Lonox', 'Metolazone', 'Plendil', 'Zoster vaccine live', 'Glucovance', 'Qualaquin', 'Pilocarpine', 'Chlorpheniramine / methscopolamine / pseudoephedrine', 'Interferon alfa-2b', 'Promacta', 'Cobicistat / darunavir', 'Cefditoren', 'CitraNatal Assure', 'Vasotec', 'Nizoral Topical', 'Halog', 'Epogen', 'Cyklokapron', 'Alyacen 1 / 35', 'Acticlate', 'Piperonyl butoxide / pyrethrins', 'H.P. Acthar Gel', 'QNASL', 'Methacholine', 'depo-subQ provera 104', 'Ferrous fumarate', 'Normodyne', 'CaloMist', 'Liquid Co-Q10', 'TussiCaps', 'Diphenhydramine / pseudoephedrine', 'Depo-Testosterone', 'Trelstar', 'Bortezomib', 'HalfLytely and Bisacodyl', 'Ethinyl estradiol / folic acid / levonorgestrel', 'Epinastine', 'Betaseron', 'Triptorelin', 'Suprax', 'Brompheniramine / codeine / phenylephrine', 'Ferumoxytol', 'Mepolizumab', 'Aventyl Hydrochloride', 'Lincomycin', 'Actifed', 'Primatene', 'Maxaron Forte', 'Acetaminophen / phenylephrine', 'Platinol', 'Epoprostenol', 'Velphoro', 'Fluphenazine', 'Psoriasin', 'Ferralet 90', 'Imotil', 'Penicillamine', 'Captopril', 'Gonal-f', 'Zarontin', 'Oxyfast', 'Dorzolamide', 'Irinotecan', 'Loteprednol / tobramycin', 'Codimal DM', 'Tinzaparin', 'Nedocromil', 'Norel SR', 'Gildess 1.5 / 30', 'Levodopa', 'Senokot S', 'Vemurafenib', 'Ergomar', 'Terazol', 'Excedrin Back & Body', 'Cenestin', 'Flovent', 'Nabilone', 'Pramlintide', 'Ala-Quin', 'Omnipaque 350', 'Milk of Magnesia', 'Pazeo', 'Ivabradine', 'Midol PM', 'Sulfatrim', 'Neo-Poly-Dex', 'Vincristine', 'Phillips Colon Health', 'Ambrisentan', 'BeneFix', 'Buproban', 'Anucort-HC', 'Cutivate', 'Colace', 'Humulin R U-500 (Concentrated)', 'DermaZinc Shampoo', 'Epzicom', 'Proferrin-ES', 'Lillow', 'Beconase AQ', 'Nitro-Bid', 'Tagamet', 'Magaldrate / simethicone', 'Pulmicort Turbuhaler', 'LMX 4', 'Visine Original', 'Blistex', 'Evista', 'Ponstel', 'Polytrim', 'Niferex', 'Cinqair', 'Carbamide peroxide', 'Sudafed 24-Hour', 'Adriamycin', 'Parafon Forte DSC', 'Norpramin', 'Saccharomyces boulardii lyo', 'Senna Plus', 'Corzide 80 / 5', 'Salicylic acid / urea', 'Enulose', 'Leukeran', 'IncobotulinumtoxinA', 'Lazanda', 'NovoLog Mix 70 / 30', 'Meningococcal group B vaccine', 'Aloe vera / hydrocortisone / iodoquinol', 'Ayr Saline Nasal', 'Aleve-D Sinus & Cold', 'Bensal HP', 'Ergotamine', 'Fludara', 'Mycelex Troche', 'Rhinocort', 'Zyrtec-D 12 Hour', 'Briellyn', 'Elestrin', 'Disopyramide', 'Vicks Formula 44', 'Sinequan', 'Rabies vaccine, human diploid cell', 'Isentress', 'Feverall', 'Taxotere', 'Carboplatin', 'Calcium carbonate / simethicone', 'Nucala', 'Afatinib', 'Schiff Move Free', 'Goldenseal', 'Tetracaine', 'Guaifenesin / hydrocodone', 'Dexpak Taperpak', 'Florinef Acetate', 'Dehydroepiandrosterone', 'KneeRelief', 'Proscar', 'Supprelin LA', 'Benzyl alcohol', 'Ceftibuten', 'Oramorph SR', 'Tenoretic 50', 'Glipizide / metformin', 'Mandelamine', 'Bumetanide', 'InnoPran XL', 'Nizoral', 'Claritin-D 24 Hour', 'Claritin-D 12 Hour', 'Nuwiq', 'Mebendazole', 'Parathyroid hormone', 'Seconal Sodium', 'Moexipril', 'Salivart', 'Methyldopa', 'Trelstar LA', 'Refresh Liquigel', 'Palgic', 'Absorbine Jr.', 'Zurampic', 'Azo-Cranberry', 'Elinest', 'Azasan', 'Peginterferon beta-1a', 'Hair, Skin & Nails', 'Panhematin', 'Lidocaine / menthol', 'Slo-Niacin', 'Immune globulin intravenous and subcutaneous', 'Caverject', 'Brinzolamide', 'Cytotec', 'Floxin', 'Selzentry', 'Amethia', 'Minivelle', 'Aristocort', 'Bacitracin / neomycin / polymyxin b', 'Vitamin D3', 'Mekinist', 'Ephedrine', 'Provenge', 'Fludrocortisone', 'Darunavir', 'Calcium acetate', 'Blephamide', 'Cefotaxime', 'Pemetrexed', 'NuLYTELY', 'Malathion', \"Children's Claritin Allergy\", 'Dysport', 'Acetic acid', 'Eslicarbazepine', 'Paraplatin', 'Picato', 'Vaprisol', 'Robitussin Cold Cough and Flu', 'Arnuity Ellipta', 'Phentride', 'Rolapitant', 'Calamine', \"Rogaine Women's\", 'Artemether / lumefantrine', 'Gemcitabine', 'Tolnaftate', 'Tarka', 'Lesinurad', 'Exforge HCT', 'Zafirlukast', 'Filgrastim', 'Salicylic acid', 'Jencycla', 'Faslodex', 'Micrainin', 'Epidrin', 'Cranberry', 'Bacitracin / polymyxin b', 'Emtricitabine / rilpivirine / tenofovir alafenamide', 'Torisel', 'Saw palmetto', 'Diphenhydramine / phenylephrine', 'Cesamet', 'Citric acid / simethicone / sodium bicarbonate', 'Sulfacetamide sodium', 'Triple Antibiotic', 'Halog-E', 'Rhinocort Aqua', 'Pneumococcal 23-polyvalent vaccine', 'Dong quai', 'Glucophage XR', 'Infumorph', 'Alprazolam Intensol', 'Sumadan', 'Chloramphenicol', 'Altabax', 'GenTeal', 'Chlorpheniramine / dextromethorphan', 'Mumps virus vaccine', 'Phendiet', 'Isradipine', 'Epivir', 'Indapamide', 'Dicloxacillin', 'Toujeo Solostar', 'Lanolin', 'Demeclocycline', 'Alamast', 'Adcirca', 'Vancocin', 'Menest', 'Mucinex Sinus-Max Full Force', 'Glumetza', 'Nilstat', 'Tolak', 'Alimta', 'Chlorambucil', 'Combigan', 'Inspra', 'Flibanserin', 'Melpaque HP', 'Westhroid', 'MetroCream', 'Cortisone', 'Cleocin HCl', 'Zecuity', 'Ferrous gluconate', 'Striant', 'Bivalirudin', \"Goody's Extra-Strength Headache Powders\", 'Hepatitis b adult vaccine', 'Benemid', 'Zovia 1 / 35', 'Meropenem', \"Bayer Children's Aspirin\", 'Methyltestosterone', 'Mitoxantrone', 'Sulfinpyrazone', 'Tobrex', 'Alclometasone', 'Isoxsuprine', 'Cubicin', 'Nexafed Nasal Decongestant', 'Nuvessa', 'Immune globulin intravenous', 'Doral', 'Medrol', 'Cervidil', 'Aspirin / chlorpheniramine / phenylephrine', 'Vivaglobin', 'Sansert', 'Otrexup', 'Isosorbide dinitrate', 'Sterapred DS', 'Aveed', 'Integra F', 'Vivactil', 'L-Carnitine', 'Trusopt', 'Orvaten', 'Ginseng', 'Aloprim', 'Proctofoam HC', 'Tandem', 'Norditropin', 'Ganciclovir', 'Wal-finate', 'Tums Smoothies', 'Phentercot', 'Senna Lax', 'Budeprion SR', 'Atropine', 'Praziquantel', 'Desyrel Dividose', 'Norfloxacin', 'Ridaura', 'Nasarel', 'Maxair', 'Xopenex HFA', 'Alpha 1-proteinase inhibitor', 'Potassium iodide', 'Uta', 'Creatine', 'Uristat', 'Ed A-Hist', 'Cardizem CD', 'Excedrin Tension Headache', 'Questran Light', 'Octagam', 'Vicks Sinex 12-Hour Decongestant Nasal Spray', 'Acetaminophen / pamabrom / pyrilamine', 'Orajel', 'Altretamine', 'Cafergot', 'Travel-Eze', 'Loxapine', 'Fulvestrant', 'Diprolene AF', 'Niacinamide', 'Zegerid OTC', 'Tenuate Dospan', 'Betapace AF', 'Atrovent', 'Xiaflex', 'Insulin isophane', 'Alefacept', 'Mucinex DM', 'Vivelle', 'Acyclovir / hydrocortisone', 'Co-trimoxazole', 'Attapulgite', 'Inulin', 'Menthol / zinc oxide', 'Privigen', 'Kineret', 'Vanatrip', 'Latisse', 'Bee pollen', 'Glecaprevir / pibrentasvir', 'Marcaine', 'Brimonidine / brinzolamide', 'Histrelin', 'Acebutolol', 'Hexachlorophene', 'Ponatinib', 'Oxy-10', 'Hydrocortone', 'Norlyda', 'Guarana', 'Readi-Cat', 'Menactra', 'Rajani', 'Talacen', 'Pletal', 'BiDil', 'Terazol 7', 'Cetaphil Lotion', 'Aricept ODT', 'Atelvia', 'Dazidox', 'Prolastin-C', 'Alogliptin / metformin', 'Azulfidine', 'Vitamin C', 'Alphanine SD', 'Anaprox', 'Unasyn', 'Cheratussin DAC', 'Ampicillin / sulbactam', 'Avar', 'Natpara', 'Fostex Medicated', 'Estrasorb', 'Ethacrynic acid', 'BenzEFoam', 'Acetaminophen / diphenhydramine / phenylephrine', 'Fortical', 'Hyosyne', 'Lactic acid', 'Auryxia', 'Dexchlorpheniramine / dextromethorphan / pseudoephedrine', 'Paclitaxel', 'Tri-Lo-Marzia', 'Ozurdex', 'Zinc gluconate', 'Azilect', 'Pulmicort Respules', 'Mirapex ER', 'Necitumumab', 'Novolin N', 'Corgard', 'Valerian', 'Provida DHA', 'Diprosone', 'Zanamivir', 'Chondroitin / glucosamine / methylsulfonylmethane', 'Mexitil', 'Apokyn', 'Trental', 'Vancocin HCl', 'Activella', 'Pyridoxine', 'Cosopt', 'D.H.E. 45', 'Zetran', 'Glyset', 'Ifosfamide', 'Zeasorb-AF Drying Gel', 'Acetaminophen / aspirin', 'Vitafol-OB+DHA', 'Romidepsin', 'Velcade', 'Capzasin-P', 'Percodan', 'Bacitracin', 'Sudafed PE Pressure + Pain', 'Droperidol', 'Regorafenib', 'Iron polysaccharide', 'Incruse Ellipta', 'ZzzQuil', 'Amitriptyline / perphenazine', 'Tropicamide', 'Flavoxate', 'Macugen', 'Generlac', 'Bexarotene', 'Sleep Aid', 'Resorcinol / sulfur', 'Zostrix', 'Arformoterol', 'Phenylephrine / pyrilamine', 'Fluoroplex', 'Slippery elm', 'Rayaldee', 'Lanthanum carbonate', 'Proglycem', 'Trixaicin HP', 'Norpace', 'Darvocet-N 50', 'Gramicidin / neomycin / polymyxin b', 'Estraderm', 'Oasis Tears', 'Probenecid', 'Isoptin SR', 'Palladone', 'Peganone', 'Acetic acid / antipyrine / benzocaine / polycosanol', 'Pin-X', 'Mifepristone', 'Gentian violet', 'Stalevo 150', 'Hydralazine / hydrochlorothiazide / reserpine', 'Dimethyl sulfoxide', 'Oxtellar XR', 'Devrom', 'Promethazine DM', 'Enfuvirtide', 'Fosinopril', 'Capex', 'Interferon beta-1b', 'Depakote Sprinkles', 'Verelan PM', 'Cholecalciferol / folic acid', 'Clioquinol', 'Clarinex-D 12 Hour', 'Xgeva', 'Kazano', 'CoQ10', 'Aliskiren / hydrochlorothiazide', 'Hydrea', 'Eskalith-CR', 'Valcyte', 'Dornase alfa', 'Loprox', 'Tesamorelin', 'Polidocanol', 'Eplerenone', 'Hydroxocobalamin', 'Alka-Seltzer Cold and Sinus', 'Gadoxetate disodium', 'Tranxene SD', 'Striverdi Respimat', 'Nimodipine', 'Cleocin Ovules', 'Jantoven', 'Sudafed 12-Hour', 'Ethambutol', 'Nafarelin', 'Dasetta 1 / 35', 'Intron A', 'Ery Pads', 'Hydrocortisone / lidocaine', 'Naftin', 'Dantrolene', 'Benzoyl peroxide / salicylic acid', 'Cortef', 'Trimethobenzamide', 'Vitamin D2', 'Innohep', 'Actonel with Calcium', 'Aller-Ease', 'Pirbuterol', 'Carfilzomib', 'Rocaltrol', 'Ethchlorvynol', 'Ferrlecit', 'Firazyr', 'Eurax', 'Mucinex Maximum Strength', 'Bisacodyl / polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride', 'Proleukin', 'Sensorcaine-MPF', 'Dextromethorphan / phenylephrine / pyrilamine', 'Medi-Quik Spray', 'Streptokinase', 'Rezira', 'Augmentin ES-600', 'Peppermint', 'Midostaurin', 'Calcium / vitamin d', 'Clemastine', 'Pacerone', 'Rilonacept', 'Mylanta Gas', 'Acarbose', 'Zileuton', 'Oxytocin', 'Aldomet', 'Acetaminophen / dexbrompheniramine / pseudoephedrine', 'Larin Fe 1.5 / 30', 'Q-Tapp DM', 'Ammonium lactate / halobetasol', 'Medrox', 'Adalat CC', 'Hetlioz', 'Levophed', 'Propulsid', 'Radium 223 dichloride', 'Eptifibatide', 'Garlic', 'Polycarbophil', 'Moxatag', 'Glimepiride / rosiglitazone', 'Eyebright', 'Acetaminophen / chlorpheniramine / dextromethorphan / pseudoephedrine', 'Amlodipine / atorvastatin', 'Gold sodium thiomalate', 'Acetaminophen / dextromethorphan / pseudoephedrine', 'Sotret', 'Trimipramine', 'Rocuronium', 'Chlorcyclizine / phenylephrine', 'Hyzine', 'Benazepril / hydrochlorothiazide', 'Metadate ER', 'Flunisolide', 'Salmeterol', 'Lomaira', 'Menotropins', 'Nonoxynol 9', 'Rifabutin', 'Oraqix', 'Suprenza', 'Spectracef', 'Halofantrine', 'Fleet Bisacodyl', 'Acetaminophen / dextromethorphan / guaifenesin / phenylephrine', 'Pramoxine / zinc oxide', 'Absorica', 'pHisoHex', 'Poly Iron', 'Insulin aspart / insulin degludec', 'Thioridazine', 'Sorbitol', 'Fenoprofen', 'Exparel', 'VisRx Dose Pack', 'Dobutamine', 'Atovaquone', 'Aerobid', 'Lindane', 'Gentamicin', 'Amcinonide', 'Moderiba', 'Magnesium amino acids chelate', 'Abacavir / lamivudine', 'Choline salicylate / magnesium salicylate', 'Magnesium aspartate', 'Take Action', 'Magnesium sulfate', 'Nafcillin', 'Ginger', 'Doripenem', 'Ethmozine', 'Apomorphine', 'Zaroxolyn', 'Kalydeco', 'Acetaminophen / caffeine / magnesium salicylate', 'Nutropin', 'Anacin', 'Fenugreek', 'Lovastatin / niacin', 'Tykerb', 'Nateglinide', 'Feosol Original', 'Dasetta 7 / 7 / 7', 'Tilmanocept', 'Silver nitrate', 'Vosol HC', 'Potassium citrate', 'Piperacillin / tazobactam', 'Pyrithione zinc', 'Cefepime', \"Rogaine Men's Extra Strength\", 'Yellow fever vaccine', 'Ceritinib', 'Isoproterenol', 'Fluorometholone']\n"
     ]
    }
   ],
   "source": [
    "drugName_list = df.drugName.unique().tolist()\n",
    "print(len(drugName_list))\n",
    "print(drugName_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "6e4ad793-9b14-413c-8f67-85b9982713a1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# check the most  count drugNme \n",
    "plt.figure(figsize = (10,8))\n",
    "top_drugName = df['drugName'].value_counts(ascending = False).nlargest(20)\n",
    "top_drugName.plot(kind ='bar')\n",
    "plt.title('top 20 counts of drugName')\n",
    "plt.xlabel('Drug Name')\n",
    "plt.ylabel('counts')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ac51c820-f2b3-41ab-919a-e0a764520187",
   "metadata": {},
   "source": [
    "what are the top 10 drugs used in birth contorl?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "3cc1b069-a34f-442e-8387-2879cf466038",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "d1 =df[df['condition'] =='birth control']['drugName'].value_counts()[0:10]\n",
    "d1.plot(kind = 'bar')\n",
    "plt.title('top 10 drugname in birth control ')\n",
    "plt.xlabel('Drug Name')\n",
    "plt.ylabel('counts')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a938ab39-57cb-4aad-bd84-0b6639d42339",
   "metadata": {},
   "source": [
    "what are the drugs with the highest rating?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "135423e6-cf00-4000-a462-1d42a647deb9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "top_rating_drug = df[df['rating'] == 10]['drugName'].value_counts()\n",
    "#plot the top 10 drug name with rating == 10\n",
    "top_rating_drug[0:10].plot(kind = 'bar')\n",
    "plt.title('top 10 drugname with rating =10 ')\n",
    "plt.xlabel('Drug Name')\n",
    "plt.ylabel('counts')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "dda34f6b-fa15-4b94-b82c-d1b9534eec7b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df['rating'].hist(bins=10)\n",
    "plt.title('histogram of rating in drug review')\n",
    "plt.xlabel(\"rating\")\n",
    "plt.ylabel(\"counts\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "3d0a1459-c010-4360-987a-f0c950a4ce30",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "rating_category\n",
      "positive    70.032085\n",
      "neutral     17.057255\n",
      "negative    12.910660\n",
      "Name: proportion, dtype: float64\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df['rating_category'] =pd.cut(df['rating'], bins = [1,4,7,10],labels = ['negative','neutral','positive'])\n",
    "print(df['rating_category'].value_counts(normalize = True)*100)\n",
    "\n",
    "df['rating_category'].hist(bins=10)\n",
    "plt.title('histogram of rating in drug review')\n",
    "plt.xlabel(\"rating\")\n",
    "plt.ylabel(\"counts\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "045978c3-129f-468f-b483-627ac171234b",
   "metadata": {},
   "source": [
    "The rating is not eqully distributed, about 70% positive rating, only 17 % and 13% neutral and negative rating. The data is imbalanced."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e62380db-529d-44b8-9a5c-c541120e483f",
   "metadata": {},
   "source": [
    "visulaize the distribution of 'usefulCount'."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "210e7bb5-9f86-4332-af13-7fb61c0441a2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import warnings\n",
    "warnings.simplefilter(action='ignore', category=FutureWarning)\n",
    "sns.histplot(df['usefulCount'], kde=True, bins=20, color='skyblue', edgecolor='black')\n",
    "plt.title('Kernel Density Estimation with Histogram for Useful Count')\n",
    "plt.xlabel('Useful Count')\n",
    "plt.ylabel('Density/Frequency')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e7625e61-b18e-4892-9e80-f0534293f807",
   "metadata": {},
   "source": [
    "what are the trends of reviews over years?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "24c1896d-de1a-4517-8c44-f316ae223261",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "review_trend = df['date'].dt.year.value_counts()\n",
    "review_trend.sort_index()\n",
    "sns.barplot(x= review_trend.index, y =review_trend.values,color = 'b').set_title('number of review per year')\n",
    "plt.xlabel('years')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8e934126",
   "metadata": {},
   "source": [
    "## cleaning \"review\" and EDA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "be120a20",
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "import nltk\n",
    "import re\n",
    "from bs4 import BeautifulSoup\n",
    "from nltk.tokenize import word_tokenize\n",
    "from wordcloud import WordCloud\n",
    "from textblob import TextBlob\n",
    "import contractions "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "10b4bee2",
   "metadata": {},
   "outputs": [],
   "source": [
    "def remove_special_characters(text):\n",
    "    text = text.lower()\n",
    "    text = text.replace('&#039', '').replace('\\n','').replace('\\r', '')\n",
    "    text = text.replace(r'[^\\w\\d\\s]',' ')\n",
    "    pattern = re.compile(r'[^a-zA-z0-9\\s]+')\n",
    "    cleaned_text = re.sub(pattern, '', str(text))\n",
    "    cleaned_text =' '.join(word.strip() for word in cleaned_text.split())\n",
    "    return cleaned_text                "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "8682bb51-3f87-4193-be0d-4df60db15f4d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>rating_category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>206461</td>\n",
       "      <td>Valsartan</td>\n",
       "      <td>left ventricular dysfunction</td>\n",
       "      <td>it has no side effect i take it in combination of bystolic 5 mg and fish oil</td>\n",
       "      <td>9</td>\n",
       "      <td>2012-05-20</td>\n",
       "      <td>27</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>95260</td>\n",
       "      <td>Guanfacine</td>\n",
       "      <td>adhd</td>\n",
       "      <td>my son is halfway through his fourth week of intuniv we became concerned when he began this last week when he started taking the highest dose he will be on for two days he could hardly get out of bed was very cranky and slept for nearly 8 hours on a drive home from school vacation very unusual for him i called his doctor on monday morning and she said to stick it out a few days see how he did at school and with getting up in the morning the last two days have been problem free he is much more agreeable than ever he is less emotional a good thing less cranky he is remembering all the things he should overall his behavior is better we have tried many different medications and so far this is the most effective</td>\n",
       "      <td>8</td>\n",
       "      <td>2010-04-27</td>\n",
       "      <td>192</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>92703</td>\n",
       "      <td>Lybrel</td>\n",
       "      <td>birth control</td>\n",
       "      <td>i used to take another oral contraceptive which had 21 pill cycle and was very happy very light periods max 5 days no other side effects but it contained hormone gestodene which is not available in us so i switched to lybrel because the ingredients are similar when my other pills ended i started lybrel immediately on my first day of period as the instructions said and the period lasted for two weeks when taking the second pack same two weeks and now with third pack things got even worse my third period lasted for two weeks and now its the end of the third week i still have daily brown dischargethe positive side is that i didnt have any other side effects the idea of being period free was so tempting alas</td>\n",
       "      <td>5</td>\n",
       "      <td>2009-12-14</td>\n",
       "      <td>17</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>138000</td>\n",
       "      <td>Ortho Evra</td>\n",
       "      <td>birth control</td>\n",
       "      <td>this is my first time using any form of birth control im glad i went with the patch i have been on it for 8 months at first it decreased my libido but that subsided the only downside is that it made my periods longer 56 days to be exact i used to only have periods for 34 days max also made my cramps intense for the first two days of my period i never had cramps before using birth control other than that in happy with the patch</td>\n",
       "      <td>8</td>\n",
       "      <td>2015-11-03</td>\n",
       "      <td>10</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>35696</td>\n",
       "      <td>Buprenorphine / naloxone</td>\n",
       "      <td>opiate dependence</td>\n",
       "      <td>suboxone has completely turned my life around i feel healthier im excelling at my job and i always have money in my pocket and my savings account i had none of those before suboxone and spent years abusing oxycontin my paycheck was already spent by the time i got it and i started resorting to scheming and stealing to fund my addiction all that is history if youre ready to stop theres a good chance that suboxone will put you on the path of great life again i have found the sideeffects to be minimal compared to oxycontin im actually sleeping better slight constipation is about it for me it truly is amazing the cost pales in comparison to what i spent on oxycontin</td>\n",
       "      <td>9</td>\n",
       "      <td>2016-11-27</td>\n",
       "      <td>37</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       id                  drugName                     condition  \\\n",
       "0  206461                 Valsartan  left ventricular dysfunction   \n",
       "1   95260                Guanfacine                          adhd   \n",
       "2   92703                    Lybrel                 birth control   \n",
       "3  138000                Ortho Evra                 birth control   \n",
       "4   35696  Buprenorphine / naloxone             opiate dependence   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         review  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  it has no side effect i take it in combination of bystolic 5 mg and fish oil   \n",
       "1  my son is halfway through his fourth week of intuniv we became concerned when he began this last week when he started taking the highest dose he will be on for two days he could hardly get out of bed was very cranky and slept for nearly 8 hours on a drive home from school vacation very unusual for him i called his doctor on monday morning and she said to stick it out a few days see how he did at school and with getting up in the morning the last two days have been problem free he is much more agreeable than ever he is less emotional a good thing less cranky he is remembering all the things he should overall his behavior is better we have tried many different medications and so far this is the most effective   \n",
       "2     i used to take another oral contraceptive which had 21 pill cycle and was very happy very light periods max 5 days no other side effects but it contained hormone gestodene which is not available in us so i switched to lybrel because the ingredients are similar when my other pills ended i started lybrel immediately on my first day of period as the instructions said and the period lasted for two weeks when taking the second pack same two weeks and now with third pack things got even worse my third period lasted for two weeks and now its the end of the third week i still have daily brown dischargethe positive side is that i didnt have any other side effects the idea of being period free was so tempting alas   \n",
       "3                                                                                                                                                                                                                                                                                                this is my first time using any form of birth control im glad i went with the patch i have been on it for 8 months at first it decreased my libido but that subsided the only downside is that it made my periods longer 56 days to be exact i used to only have periods for 34 days max also made my cramps intense for the first two days of my period i never had cramps before using birth control other than that in happy with the patch   \n",
       "4                                                 suboxone has completely turned my life around i feel healthier im excelling at my job and i always have money in my pocket and my savings account i had none of those before suboxone and spent years abusing oxycontin my paycheck was already spent by the time i got it and i started resorting to scheming and stealing to fund my addiction all that is history if youre ready to stop theres a good chance that suboxone will put you on the path of great life again i have found the sideeffects to be minimal compared to oxycontin im actually sleeping better slight constipation is about it for me it truly is amazing the cost pales in comparison to what i spent on oxycontin   \n",
       "\n",
       "   rating       date  usefulCount rating_category  \n",
       "0       9 2012-05-20           27        positive  \n",
       "1       8 2010-04-27          192        positive  \n",
       "2       5 2009-12-14           17         neutral  \n",
       "3       8 2015-11-03           10        positive  \n",
       "4       9 2016-11-27           37        positive  "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['review'] = df['review'].apply(remove_special_characters)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "84372c3a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'ve been super irritablemoody500mg amoxicillin 3xday co we have triedand i dont understand \\\\d how the 12 side effects can be so extreme for me when i previously was on norqd'"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "raw_text = \"&#039;ve been super irritable/moody,500mg Amoxicillin (3x/day)    co \\r\\nWe have triedand I don&#039;t understand \\n\\d how the 1/2 side effects can be so extreme for me when I previously was on Nor-Qd \"\n",
    "text = remove_special_characters(raw_text)\n",
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c49ee43a-9969-4850-8eed-dad3fcd826fa",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "d7f88f84-e39f-40e0-b1d6-d0702f4ec6d2",
   "metadata": {},
   "outputs": [],
   "source": [
    "import inflect\n",
    "p = inflect.engine()\n",
    "# convert number into words\n",
    "def convert_number(text):\n",
    "    temp_text = text.split()\n",
    "    new_text = []\n",
    "    for word in temp_text:\n",
    "        if word.isdigit():\n",
    "            temp = p.number_to_words(word)\n",
    "            new_text.append(temp)\n",
    "        else:\n",
    "            new_text.append(word)\n",
    "    temp_text = ' '.join(new_text)\n",
    "    return temp_text\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "17879762-6568-4d7c-b4ff-05f700893aba",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>drugName</th>\n",
       "      <th>condition</th>\n",
       "      <th>review</th>\n",
       "      <th>rating</th>\n",
       "      <th>date</th>\n",
       "      <th>usefulCount</th>\n",
       "      <th>rating_category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>206461</td>\n",
       "      <td>Valsartan</td>\n",
       "      <td>left ventricular dysfunction</td>\n",
       "      <td>it has no side effect i take it in combination of bystolic five mg and fish oil</td>\n",
       "      <td>9</td>\n",
       "      <td>2012-05-20</td>\n",
       "      <td>27</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>95260</td>\n",
       "      <td>Guanfacine</td>\n",
       "      <td>adhd</td>\n",
       "      <td>my son is halfway through his fourth week of intuniv we became concerned when he began this last week when he started taking the highest dose he will be on for two days he could hardly get out of bed was very cranky and slept for nearly eight hours on a drive home from school vacation very unusual for him i called his doctor on monday morning and she said to stick it out a few days see how he did at school and with getting up in the morning the last two days have been problem free he is much more agreeable than ever he is less emotional a good thing less cranky he is remembering all the things he should overall his behavior is better we have tried many different medications and so far this is the most effective</td>\n",
       "      <td>8</td>\n",
       "      <td>2010-04-27</td>\n",
       "      <td>192</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>92703</td>\n",
       "      <td>Lybrel</td>\n",
       "      <td>birth control</td>\n",
       "      <td>i used to take another oral contraceptive which had twenty-one pill cycle and was very happy very light periods max five days no other side effects but it contained hormone gestodene which is not available in us so i switched to lybrel because the ingredients are similar when my other pills ended i started lybrel immediately on my first day of period as the instructions said and the period lasted for two weeks when taking the second pack same two weeks and now with third pack things got even worse my third period lasted for two weeks and now its the end of the third week i still have daily brown dischargethe positive side is that i didnt have any other side effects the idea of being period free was so tempting alas</td>\n",
       "      <td>5</td>\n",
       "      <td>2009-12-14</td>\n",
       "      <td>17</td>\n",
       "      <td>neutral</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>138000</td>\n",
       "      <td>Ortho Evra</td>\n",
       "      <td>birth control</td>\n",
       "      <td>this is my first time using any form of birth control im glad i went with the patch i have been on it for eight months at first it decreased my libido but that subsided the only downside is that it made my periods longer fifty-six days to be exact i used to only have periods for thirty-four days max also made my cramps intense for the first two days of my period i never had cramps before using birth control other than that in happy with the patch</td>\n",
       "      <td>8</td>\n",
       "      <td>2015-11-03</td>\n",
       "      <td>10</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>35696</td>\n",
       "      <td>Buprenorphine / naloxone</td>\n",
       "      <td>opiate dependence</td>\n",
       "      <td>suboxone has completely turned my life around i feel healthier im excelling at my job and i always have money in my pocket and my savings account i had none of those before suboxone and spent years abusing oxycontin my paycheck was already spent by the time i got it and i started resorting to scheming and stealing to fund my addiction all that is history if youre ready to stop theres a good chance that suboxone will put you on the path of great life again i have found the sideeffects to be minimal compared to oxycontin im actually sleeping better slight constipation is about it for me it truly is amazing the cost pales in comparison to what i spent on oxycontin</td>\n",
       "      <td>9</td>\n",
       "      <td>2016-11-27</td>\n",
       "      <td>37</td>\n",
       "      <td>positive</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       id                  drugName                     condition  \\\n",
       "0  206461                 Valsartan  left ventricular dysfunction   \n",
       "1   95260                Guanfacine                          adhd   \n",
       "2   92703                    Lybrel                 birth control   \n",
       "3  138000                Ortho Evra                 birth control   \n",
       "4   35696  Buprenorphine / naloxone             opiate dependence   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 review  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       it has no side effect i take it in combination of bystolic five mg and fish oil   \n",
       "1      my son is halfway through his fourth week of intuniv we became concerned when he began this last week when he started taking the highest dose he will be on for two days he could hardly get out of bed was very cranky and slept for nearly eight hours on a drive home from school vacation very unusual for him i called his doctor on monday morning and she said to stick it out a few days see how he did at school and with getting up in the morning the last two days have been problem free he is much more agreeable than ever he is less emotional a good thing less cranky he is remembering all the things he should overall his behavior is better we have tried many different medications and so far this is the most effective   \n",
       "2  i used to take another oral contraceptive which had twenty-one pill cycle and was very happy very light periods max five days no other side effects but it contained hormone gestodene which is not available in us so i switched to lybrel because the ingredients are similar when my other pills ended i started lybrel immediately on my first day of period as the instructions said and the period lasted for two weeks when taking the second pack same two weeks and now with third pack things got even worse my third period lasted for two weeks and now its the end of the third week i still have daily brown dischargethe positive side is that i didnt have any other side effects the idea of being period free was so tempting alas   \n",
       "3                                                                                                                                                                                                                                                                                    this is my first time using any form of birth control im glad i went with the patch i have been on it for eight months at first it decreased my libido but that subsided the only downside is that it made my periods longer fifty-six days to be exact i used to only have periods for thirty-four days max also made my cramps intense for the first two days of my period i never had cramps before using birth control other than that in happy with the patch   \n",
       "4                                                         suboxone has completely turned my life around i feel healthier im excelling at my job and i always have money in my pocket and my savings account i had none of those before suboxone and spent years abusing oxycontin my paycheck was already spent by the time i got it and i started resorting to scheming and stealing to fund my addiction all that is history if youre ready to stop theres a good chance that suboxone will put you on the path of great life again i have found the sideeffects to be minimal compared to oxycontin im actually sleeping better slight constipation is about it for me it truly is amazing the cost pales in comparison to what i spent on oxycontin   \n",
       "\n",
       "   rating       date  usefulCount rating_category  \n",
       "0       9 2012-05-20           27        positive  \n",
       "1       8 2010-04-27          192        positive  \n",
       "2       5 2009-12-14           17         neutral  \n",
       "3       8 2015-11-03           10        positive  \n",
       "4       9 2016-11-27           37        positive  "
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df['review'] = df['review'].apply(convert_number)\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "2c8c9def-df79-44d3-ab80-da72afb953c4",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import contractions \n",
    "def expand_contractions(text):\n",
    "    cleaned_text = contractions.fix(text)\n",
    "    return cleaned_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "5f610905-6db1-4069-aae8-09e68cb6bb74",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"'ve been super irritablemoody500            mg amoxicillin 3xday co we have triedand i do not understand \\\\d how the 12 side effects can be so extreme for me when i previously was on norqd'1/2 side effects can be so extreme for me when I previously was on Nor-Qd \""
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "raw_text = \"'ve been super irritablemoody500            mg amoxicillin 3xday co we have triedand i dont understand \\\\d how the 12 side effects can be so extreme for me when i previously was on norqd'1/2 side effects can be so extreme for me when I previously was on Nor-Qd \"\n",
    "text = expand_contractions(raw_text)\n",
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "e9ae23be-bb62-4133-bbd3-07e45d8fe559",
   "metadata": {},
   "outputs": [],
   "source": [
    "def remove_whitespace(text):\n",
    "    return ' '.join(text.split())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "839866a8-d31e-45ab-9595-89c3d13db833",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"'ve been super irritablemoody500 mg amoxicillin 3xday co we have triedand i dont understand \\\\d how the 12 side effects can be so extreme for me when i previously was on norqd'1/2 side effects can be so extreme for me when I previously was on Nor-Qd\""
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text = remove_whitespace(raw_text)\n",
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "42d9dd99-25c8-44b5-afa5-d59737e08cb8",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to C:\\Users\\Yan\n",
      "[nltk_data]     Zhang\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "# import en_core_web_sm\n",
    "# nltk.download('stopwords')\n",
    "# from nltk.corpus import stopwords\n",
    "# nlp= spacy.load('en_core_web_sm')\n",
    "# # stop_words = set(stopwords.words('english'))\n",
    "import nltk\n",
    "nltk.download('punkt')\n",
    "def remove_stopwords(text):\n",
    "    stop_words = set(stopwords.words('english'))\n",
    "    word_tokens = word_tokenize(text)\n",
    "    filtered_text = [word for word in word_tokens if word not in stop_words]\n",
    "    return  ' '.join(filtered_text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "9bad13e2-fa21-4b7d-973d-f4923deee697",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"'ve super irritablemoody500 mg amoxicillin 3xday co triedand dont understand \\\\d 12 side effects extreme previously norqd ' 1/2 side effects extreme I previously Nor-Qd\""
      ]
     },
     "execution_count": 78,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# import nltk\n",
    "# nltk.download('punkt')\n",
    "\n",
    "text = remove_stopwords(raw_text)\n",
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "b3aea382-4a11-4c08-a482-efbfff2d3a23",
   "metadata": {},
   "outputs": [],
   "source": [
    "# import nltk\n",
    "# from nltk.tokenize import word_tokenize\n",
    "# stemmer = nltk.stem.SnowballStemmer('english')\n",
    " \n",
    "# # stem words in the list of tokenized words\n",
    "# def stem_words(text):\n",
    "#     word_tokens = word_tokenize(text)\n",
    "#     stems = [stemmer.stem(word) for word in word_tokens]\n",
    "#     return stems"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "958b8a9a-8cee-4ef1-a620-27d975ade04d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ff9a786c-cf8c-4461-9415-634412d04059",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "30099c88-c5f3-4e78-ab42-ea6425482fb9",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "e59bdb96",
   "metadata": {},
   "source": [
    "### remove special characters"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "e2816d9b",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "id": "e5618897-39d7-45bd-8369-0ca9305b0572",
   "metadata": {},
   "source": [
    "what are the top words in review? build a word count plot:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2ee599a7-6ffc-406e-ad4b-d60ada7db3f4",
   "metadata": {},
   "outputs": [],
   "source": [
    "from collections import Counter\n",
    "stop_words = set(stopwords.words('english'))\n",
    "df['review'] = df['review'].str.lower()\n",
    "text = df['review'].apply(lambda x: ' '.join(word for word in x.split() if word not in stop_words))\n",
    "tokens = word_tokenize(text)\n",
    "count = Counter(tokens)\n",
    "v,counts = zip(count*.most_common(10))\n",
    "plt.bar(v,count)\n",
    "plt.xlabel(\"word\")\n",
    "plt.ylabel(\"counts\")\n",
    "plt.title(\"Top words in drug review\")\n",
    "plt.show()\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2d4dc3a5",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "812c5f9a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "c72ebad0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ffbc6067",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d9e4fb20",
   "metadata": {},
   "outputs": [],
   "source": [
    "#check what are the top conditions.\n",
    "top_conditions = df.condition.value_counts().head(30)\n",
    "top_conditions.plot(kind = \"bar\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "825a8e83",
   "metadata": {},
   "outputs": [],
   "source": [
    "chunk_size = 50000\n",
    "chunks = [df[i:i + chunk_size] for i in range(0, len(df), chunk_size)]\n",
    "result = pd.concat([chunk.groupby('condition').agg({'rating':'sum','usefulcount':'sum'}) for chunk in chunks])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ceed6902",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Capstone_Three_Project",
   "language": "python",
   "name": "capstone_three_project"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
